| 1 |
Cai J, Cooke FE, Sherborne BS. Antagonists of the orexin receptors. Expert Opinion on Therapeutic Patents 2006;16:631-46. [DOI: 10.1517/13543776.16.5.631] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 2 |
Bazar KA, Yun A, Lee PY. Debunking a myth: neurohormonal and vagal modulation of sleep centers, not redistribution of blood flow, may account for postprandial somnolence. Medical Hypotheses 2004;63:778-82. [DOI: 10.1016/j.mehy.2004.04.015] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 3 |
Al-Barazanji KA, Wilson S, Baker J, Jessop DS, Harbuz MS. Central orexin-A activates hypothalamic-pituitary-adrenal axis and stimulates hypothalamic corticotropin releasing factor and arginine vasopressin neurones in conscious rats. J Neuroendocrinol 2001;13:421-4. [PMID: 11328451 DOI: 10.1046/j.1365-2826.2001.00655.x] [Cited by in Crossref: 93] [Cited by in F6Publishing: 84] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 4 |
Carter ME, Brill J, Bonnavion P, Huguenard JR, Huerta R, de Lecea L. Mechanism for Hypocretin-mediated sleep-to-wake transitions. Proc Natl Acad Sci U S A 2012;109:E2635-44. [PMID: 22955882 DOI: 10.1073/pnas.1202526109] [Cited by in Crossref: 151] [Cited by in F6Publishing: 140] [Article Influence: 15.1] [Reference Citation Analysis]
|
| 5 |
Liu ZB, Song NN, Geng WY, Jin WZ, Li L, Cao YX, Qian Y, Zhu DN, Shen LL. Orexin-A and respiration in a rat model of smoke-induced chronic obstructive pulmonary disease. Clin Exp Pharmacol Physiol 2010;37:963-8. [PMID: 20528981 DOI: 10.1111/j.1440-1681.2010.05411.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 6 |
Roman A, Meftah S, Arthaud S, Luppi P, Peyron C. The inappropriate occurrence of rapid eye movement sleep in narcolepsy is not due to a defect in homeostatic regulation of rapid eye movement sleep. Sleep 2018;41. [DOI: 10.1093/sleep/zsy046] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 7 |
Dye TJ, Gurbani N, Simakajornboon N. Epidemiology and Pathophysiology of Childhood Narcolepsy. Paediatr Respir Rev 2018;25:14-8. [PMID: 28108192 DOI: 10.1016/j.prrv.2016.12.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 8 |
Satoh S, Matsumura H, Nakajima T, Nakahama K, Kanbayashi T, Nishino S, Yoneda H, Shigeyoshi Y. Inhibition of rostral basal forebrain neurons promotes wakefulness and induces FOS in orexin neurons. Eur J Neurosci 2003;17:1635-45. [PMID: 12752381 DOI: 10.1046/j.1460-9568.2003.02577.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 9 |
Desarnaud F, Murillo-Rodriguez E, Lin L, Xu M, Gerashchenko D, Shiromani SN, Nishino S, Mignot E, Shiromani PJ. The diurnal rhythm of hypocretin in young and old F344 rats. Sleep 2004;27:851-6. [PMID: 15453542 DOI: 10.1093/sleep/27.5.851] [Cited by in Crossref: 65] [Cited by in F6Publishing: 58] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 10 |
Russell SH, Small CJ, Sunter D, Morgan I, Dakin CL, Cohen MA, Bloom SR. Chronic intraparaventricular nuclear administration of orexin A in male rats does not alter thyroid axis or uncoupling protein-1 in brown adipose tissue. Regul Pept 2002;104:61-8. [PMID: 11830278 DOI: 10.1016/s0167-0115(01)00349-4] [Cited by in Crossref: 31] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 11 |
Ida T, Nakahara K, Murakami T, Hanada R, Nakazato M, Murakami N. Possible involvement of orexin in the stress reaction in rats. Biochem Biophys Res Commun 2000;270:318-23. [PMID: 10733946 DOI: 10.1006/bbrc.2000.2412] [Cited by in Crossref: 198] [Cited by in F6Publishing: 191] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 12 |
Fulong X, Spruyt K, Chao L, Dianjiang Z, Jun Z, Fang H. Resting-state brain network topological properties and the correlation with neuropsychological assessment in adolescent narcolepsy. Sleep 2020;43:zsaa018. [DOI: 10.1093/sleep/zsaa018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 13 |
Sunter D, Morgan I, Edwards CM, Dakin CL, Murphy KG, Gardiner J, Taheri S, Rayes E, Bloom SR. Orexins: effects on behavior and localisation of orexin receptor 2 messenger ribonucleic acid in the rat brainstem. Brain Res 2001;907:27-34. [PMID: 11430882 DOI: 10.1016/s0006-8993(01)02344-7] [Cited by in Crossref: 43] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 14 |
Donjacour CE, Aziz NA, Roelfsema F, Frölich M, Overeem S, Lammers GJ, Pijl H. Effect of sodium oxybate on growth hormone secretion in narcolepsy patients and healthy controls. Am J Physiol Endocrinol Metab 2011;300:E1069-75. [PMID: 21447786 DOI: 10.1152/ajpendo.00623.2010] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 15 |
Haynes AC, Jackson B, Overend P, Buckingham RE, Wilson S, Tadayyon M, Arch JR. Effects of single and chronic intracerebroventricular administration of the orexins on feeding in the rat. Peptides 1999;20:1099-105. [DOI: 10.1016/s0196-9781(99)00105-9] [Cited by in Crossref: 226] [Cited by in F6Publishing: 54] [Article Influence: 9.8] [Reference Citation Analysis]
|
| 16 |
Hoang QV, Zhao P, Nakajima S, Nakajima Y. Orexin (hypocretin) effects on constitutively active inward rectifier K+ channels in cultured nucleus basalis neurons. J Neurophysiol 2004;92:3183-91. [PMID: 15269229 DOI: 10.1152/jn.01222.2003] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 17 |
Jászberényi M, Bujdosó E, Pataki I, Telegdy G. Effects of orexins on the hypothalamic-pituitary-adrenal system. J Neuroendocrinol 2000;12:1174-8. [PMID: 11106974 DOI: 10.1046/j.1365-2826.2000.00572.x] [Cited by in Crossref: 127] [Cited by in F6Publishing: 132] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 18 |
Neylan TC, Richards A, Metzler TJ, Ruoff LM, Varbel J, O'Donovan A, Sivasubramanian M, Motraghi T, Hlavin J, Batki SL, Inslicht SS, Samuelson K, Morairty SR, Kilduff TS. Acute cognitive effects of the hypocretin receptor antagonist almorexant relative to zolpidem and placebo: a randomized clinical trial. Sleep 2020;43:zsaa080. [PMID: 32303763 DOI: 10.1093/sleep/zsaa080] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 19 |
Fakhari M, Azizi H, Semnanian S. Central antagonism of orexin type-1 receptors attenuates the development of morphine dependence in rat locus coeruleus neurons. Neuroscience 2017;363:1-10. [DOI: 10.1016/j.neuroscience.2017.08.054] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 20 |
Han F. Narcolepsy, orexins and respiratory regulation: Respiratory regulation in narcolepsy. Sleep and Biological Rhythms 2011;9:44-51. [DOI: 10.1111/j.1479-8425.2010.00467.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 21 |
Vyse TJ. Narcolepsy and the T-cell receptor. Nat Genet 2009;41:640-1. [PMID: 19471301 DOI: 10.1038/ng0609-640] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 22 |
Guan JL, Suzuki R, Funahashi H, Wang QP, Kageyama H, Uehara K, Yamada S, Tsurugano S, Shioda S. Ultrastructural localization of orexin-1 receptor in pre- and post-synaptic neurons in the rat arcuate nucleus. Neurosci Lett 2002;329:209-12. [PMID: 12165414 DOI: 10.1016/s0304-3940(02)00660-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 23 |
Tyree SM, Borniger JC, de Lecea L. Hypocretin as a Hub for Arousal and Motivation. Front Neurol 2018;9:413. [PMID: 29928253 DOI: 10.3389/fneur.2018.00413] [Cited by in Crossref: 37] [Cited by in F6Publishing: 28] [Article Influence: 9.3] [Reference Citation Analysis]
|
| 24 |
Ouyang M, Hellman K, Abel T, Thomas SA. Adrenergic signaling plays a critical role in the maintenance of waking and in the regulation of REM sleep. J Neurophysiol 2004;92:2071-82. [PMID: 15190089 DOI: 10.1152/jn.00226.2004] [Cited by in Crossref: 67] [Cited by in F6Publishing: 71] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 25 |
Downs JL, Dunn MR, Borok E, Shanabrough M, Horvath TL, Kohama SG, Urbanski HF. Orexin neuronal changes in the locus coeruleus of the aging rhesus macaque. Neurobiol Aging 2007;28:1286-95. [PMID: 16870307 DOI: 10.1016/j.neurobiolaging.2006.05.025] [Cited by in Crossref: 57] [Cited by in F6Publishing: 55] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 26 |
Sinton CM. Orexin/hypocretin plays a role in the response to physiological disequilibrium. Sleep Med Rev 2011;15:197-207. [PMID: 21269851 DOI: 10.1016/j.smrv.2010.12.003] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 27 |
Szabadi E. Functional neuroanatomy of the central noradrenergic system. J Psychopharmacol. 2013;27:659-693. [PMID: 23761387 DOI: 10.1177/0269881113490326] [Cited by in Crossref: 167] [Cited by in F6Publishing: 152] [Article Influence: 18.6] [Reference Citation Analysis]
|
| 28 |
Kumar A, Chanana P, Choudhary S. Emerging role of orexin antagonists in insomnia therapeutics: An update on SORAs and DORAs. Pharmacological Reports 2016;68:231-42. [DOI: 10.1016/j.pharep.2015.09.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 29 |
Kim J, Nakajima K, Oomura Y, Wayner MJ, Sasaki K. Electrophysiological effects of orexins/hypocretins on pedunculopontine tegmental neurons in rats: an in vitro study. Peptides 2009;30:191-209. [PMID: 18977258 DOI: 10.1016/j.peptides.2008.09.023] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 30 |
Kushikata T, Hirota K, Yoshida H, Kudo M, Lambert DG, Smart D, Jerman JC, Matsuki A. Orexinergic neurons and barbiturate anesthesia. Neuroscience 2003;121:855-63. [PMID: 14580935 DOI: 10.1016/s0306-4522(03)00554-2] [Cited by in Crossref: 63] [Cited by in F6Publishing: 19] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 31 |
Taheri S, Gardiner J, Hafizi S, Murphy K, Dakin C, Seal L, Small C, Ghatei M, Bloom S. Orexin A immunoreactivity and prepro-orexin mRNA in the brain of Zucker and WKY rats: . Neuroreport 2001;12:459-64. [DOI: 10.1097/00001756-200103050-00008] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 32 |
Jiménez A, Caba M, Escobar C. Food-entrained patterns in orexin cells reveal subregion differential activation. Brain Research 2013;1513:41-50. [DOI: 10.1016/j.brainres.2013.03.031] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 33 |
Eisinger BE, Zhao C, Driessen TM, Saul MC, Gammie SC. Large scale expression changes of genes related to neuronal signaling and developmental processes found in lateral septum of postpartum outbred mice. PLoS One 2013;8:e63824. [PMID: 23717492 DOI: 10.1371/journal.pone.0063824] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 34 |
Dhillo WS. Appetite Regulation: An Overview. Thyroid 2007;17:433-45. [DOI: 10.1089/thy.2007.0018] [Cited by in Crossref: 77] [Cited by in F6Publishing: 69] [Article Influence: 5.1] [Reference Citation Analysis]
|
| 35 |
Hoffmann J, Supronsinchai W, Akerman S, Andreou AP, Winrow CJ, Renger J, Hargreaves R, Goadsby PJ. Evidence for orexinergic mechanisms in migraine. Neurobiology of Disease 2015;74:137-43. [DOI: 10.1016/j.nbd.2014.10.022] [Cited by in Crossref: 50] [Cited by in F6Publishing: 43] [Article Influence: 7.1] [Reference Citation Analysis]
|
| 36 |
Ishii Y, Blundell JE, Halford JC, Upton N, Porter R, Johns A, Rodgers RJ. Satiety enhancement by selective orexin-1 receptor antagonist SB-334867: influence of test context and profile comparison with CCK-8S. Behav Brain Res 2005;160:11-24. [PMID: 15836896 DOI: 10.1016/j.bbr.2004.11.011] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 37 |
Deporter DP, Coborn JE, Teske JA. Partial Sleep Deprivation Reduces the Efficacy of Orexin-A to Stimulate Physical Activity and Energy Expenditure: Sleep Deprivation Dampens EE During Physical Activity. Obesity 2017;25:1716-22. [DOI: 10.1002/oby.21944] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 38 |
Kohlmeier KA, Watanabe S, Tyler CJ, Burlet S, Leonard CS. Dual orexin actions on dorsal raphe and laterodorsal tegmentum neurons: noisy cation current activation and selective enhancement of Ca2+ transients mediated by L-type calcium channels. J Neurophysiol 2008;100:2265-81. [PMID: 18667550 DOI: 10.1152/jn.01388.2007] [Cited by in Crossref: 59] [Cited by in F6Publishing: 65] [Article Influence: 4.2] [Reference Citation Analysis]
|
| 39 |
Fernø J, Señarís R, Diéguez C, Tena-Sempere M, López M. Orexins (hypocretins) and energy balance: More than feeding. Mol Cell Endocrinol 2015;418 Pt 1:17-26. [PMID: 26213323 DOI: 10.1016/j.mce.2015.07.022] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 40 |
Acuna-Goycolea C, van den Pol AN. Neuroendocrine proopiomelanocortin neurons are excited by hypocretin/orexin. J Neurosci 2009;29:1503-13. [PMID: 19193897 DOI: 10.1523/JNEUROSCI.5147-08.2009] [Cited by in Crossref: 39] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 41 |
Soffin EM, Evans ML, Gill CH, Harries MH, Benham CD, Davies CH. SB-334867-A antagonises orexin mediated excitation in the locus coeruleus. Neuropharmacology 2002;42:127-33. [PMID: 11750922 DOI: 10.1016/s0028-3908(01)00156-3] [Cited by in Crossref: 65] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 42 |
Morales A, Bonnet C, Bourgoin N, Touvier T, Nadam J, Laglaine A, Navarro F, Moulin C, Georges B, Pequignot JM, Bezin L. Unexpected expression of orexin-B in basal conditions and increased levels in the adult rat hippocampus during pilocarpine-induced epileptogenesis. Brain Res 2006;1109:164-75. [PMID: 16904080 DOI: 10.1016/j.brainres.2006.06.075] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 43 |
Flores Á, Julià-Hernández M, Maldonado R, Berrendero F. Involvement of the orexin/hypocretin system in the pharmacological effects induced by Δ(9) -tetrahydrocannabinol. Br J Pharmacol 2016;173:1381-92. [PMID: 26799708 DOI: 10.1111/bph.13440] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 44 |
Li JX, Yoshida T, Monk KJ, Katz DB. Lateral hypothalamus contains two types of palatability-related taste responses with distinct dynamics. J Neurosci 2013;33:9462-73. [PMID: 23719813 DOI: 10.1523/JNEUROSCI.3935-12.2013] [Cited by in Crossref: 41] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 45 |
Vogel V, Sanchez C, Jennum P. EEG measurements by means of radiotelemetry after intracerebroventricular (ICV) cannulation in rodents. Journal of Neuroscience Methods 2002;118:89-96. [DOI: 10.1016/s0165-0270(02)00148-6] [Cited by in Crossref: 25] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 46 |
Semba K. Multiple output pathways of the basal forebrain: organization, chemical heterogeneity, and roles in vigilance. Behavioural Brain Research 2000;115:117-41. [DOI: 10.1016/s0166-4328(00)00254-0] [Cited by in Crossref: 178] [Cited by in F6Publishing: 62] [Article Influence: 8.1] [Reference Citation Analysis]
|
| 47 |
Equihua AC, De La Herrán-Arita AK, Drucker-Colin R. Orexin receptor antagonists as therapeutic agents for insomnia. Front Pharmacol 2013;4:163. [PMID: 24416019 DOI: 10.3389/fphar.2013.00163] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 48 |
Rusyniak DE, Zaretsky DV, Zaretskaia MV, Durant PJ, DiMicco JA. The orexin-1 receptor antagonist SB-334867 decreases sympathetic responses to a moderate dose of methamphetamine and stress. Physiol Behav 2012;107:743-50. [PMID: 22361264 DOI: 10.1016/j.physbeh.2012.02.010] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 49 |
Hou RH, Freeman C, Langley RW, Szabadi E, Bradshaw CM. Does modafinil activate the locus coeruleus in man? Comparison of modafinil and clonidine on arousal and autonomic functions in human volunteers. Psychopharmacology 2005;181:537-49. [DOI: 10.1007/s00213-005-0013-8] [Cited by in Crossref: 82] [Cited by in F6Publishing: 81] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 50 |
Carter ME, Adamantidis A, Ohtsu H, Deisseroth K, de Lecea L. Sleep homeostasis modulates hypocretin-mediated sleep-to-wake transitions. J Neurosci 2009;29:10939-49. [PMID: 19726652 DOI: 10.1523/JNEUROSCI.1205-09.2009] [Cited by in Crossref: 155] [Cited by in F6Publishing: 89] [Article Influence: 11.9] [Reference Citation Analysis]
|
| 51 |
Su J, Lei Z, Zhang W, Ning H, Ping J. Distribution of orexin B and its relationship with GnRH in the pig hypothalamus. Res Vet Sci 2008;85:315-23. [PMID: 18255106 DOI: 10.1016/j.rvsc.2007.12.007] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 52 |
Aracri P, Banfi D, Pasini ME, Amadeo A, Becchetti A. Hypocretin (orexin) regulates glutamate input to fast-spiking interneurons in layer V of the Fr2 region of the murine prefrontal cortex. Cereb Cortex 2015;25:1330-47. [PMID: 24297328 DOI: 10.1093/cercor/bht326] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 53 |
Boss C, Roch-brisbare C, Steiner MA, Treiber A, Dietrich H, Jenck F, von Raumer M, Sifferlen T, Brotschi C, Heidmann B, Williams JT, Aissaoui H, Siegrist R, Gatfield J. Structure-Activity Relationship, Biological, and Pharmacological Characterization of the Proline Sulfonamide ACT-462206: a Potent, Brain-Penetrant Dual Orexin 1/Orexin 2 Receptor Antagonist. ChemMedChem 2014;9:2486-96. [DOI: 10.1002/cmdc.201402258] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 54 |
He C, Chen QH, Ye JN, Li C, Yang L, Zhang J, Xia JX, Hu ZA. Functional inactivation of hypocretin 1 receptors in the medial prefrontal cortex affects the pyramidal neuron activity and gamma oscillations: An in vivo multiple-channel single-unit recording study. Neuroscience 2015;297:1-10. [PMID: 25838117 DOI: 10.1016/j.neuroscience.2015.03.044] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 55 |
Rosin DL, Weston MC, Sevigny CP, Stornetta RL, Guyenet PG. Hypothalamic orexin (hypocretin) neurons express vesicular glutamate transporters VGLUT1 or VGLUT2. J Comp Neurol 2003;465:593-603. [PMID: 12975818 DOI: 10.1002/cne.10860] [Cited by in Crossref: 166] [Cited by in F6Publishing: 170] [Article Influence: 8.7] [Reference Citation Analysis]
|
| 56 |
Overeem S, Mignot E, van Dijk JG, Lammers GJ. Narcolepsy: clinical features, new pathophysiologic insights, and future perspectives. J Clin Neurophysiol 2001;18:78-105. [PMID: 11435802 DOI: 10.1097/00004691-200103000-00002] [Cited by in Crossref: 217] [Cited by in F6Publishing: 164] [Article Influence: 10.3] [Reference Citation Analysis]
|
| 57 |
Zhang T, Jiang X, Xu M, Wang H, Sang X, Qin M, Bao P, Wang R, Zhang C, Lu H, Li Y, Ren J, Chang HC, Yan J, Sun Q, Xu J. Sleep and circadian abnormalities precede cognitive deficits in R521C FUS knockin rats. Neurobiol Aging 2018;72:159-70. [PMID: 30273830 DOI: 10.1016/j.neurobiolaging.2018.08.025] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 58 |
Sargin D. The role of the orexin system in stress response. Neuropharmacology 2019;154:68-78. [PMID: 30266600 DOI: 10.1016/j.neuropharm.2018.09.034] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 59 |
Arrigoni E, Mochizuki T, Scammell TE. Activation of the basal forebrain by the orexin/hypocretin neurones. Acta Physiol (Oxf) 2010;198:223-35. [PMID: 19723027 DOI: 10.1111/j.1748-1716.2009.02036.x] [Cited by in Crossref: 58] [Cited by in F6Publishing: 55] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 60 |
Orlowska-Feuer P, Smyk MK, Palus-Chramiec K, Dyl K, Lewandowski MH. Orexin A as a modulator of dorsal lateral geniculate neuronal activity: a comprehensive electrophysiological study on adult rats. Sci Rep 2019;9:16729. [PMID: 31723155 DOI: 10.1038/s41598-019-53012-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 61 |
Anaclet C, Parmentier R, Ouk K, Guidon G, Buda C, Sastre JP, Akaoka H, Sergeeva OA, Yanagisawa M, Ohtsu H, Franco P, Haas HL, Lin JS. Orexin/hypocretin and histamine: distinct roles in the control of wakefulness demonstrated using knock-out mouse models. J Neurosci 2009;29:14423-38. [PMID: 19923277 DOI: 10.1523/JNEUROSCI.2604-09.2009] [Cited by in Crossref: 131] [Cited by in F6Publishing: 86] [Article Influence: 10.1] [Reference Citation Analysis]
|
| 62 |
Galvão MDOL, Sinigaglia-coimbra R, Kawakami SE, Tufik S, Suchecki D. Paradoxical sleep deprivation activates hypothalamic nuclei that regulate food intake and stress response. Psychoneuroendocrinology 2009;34:1176-83. [DOI: 10.1016/j.psyneuen.2009.03.003] [Cited by in Crossref: 55] [Cited by in F6Publishing: 55] [Article Influence: 4.2] [Reference Citation Analysis]
|
| 63 |
Prince CD, Rau AR, Yorgason JT, España RA. Hypocretin/Orexin regulation of dopamine signaling and cocaine self-administration is mediated predominantly by hypocretin receptor 1. ACS Chem Neurosci 2015;6:138-46. [PMID: 25496218 DOI: 10.1021/cn500246j] [Cited by in Crossref: 55] [Cited by in F6Publishing: 48] [Article Influence: 6.9] [Reference Citation Analysis]
|
| 64 |
Nishino S. Narcolepsy. Sleep Medicine Clinics 2006;1:47-61. [DOI: 10.1016/j.jsmc.2005.11.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 65 |
Yaeger JD, Krupp KT, Gale JJ, Summers CH. Counterbalanced microcircuits for Orx1 and Orx2 regulation of stress reactivity. Medicine in Drug Discovery 2020;8:100059. [DOI: 10.1016/j.medidd.2020.100059] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 66 |
Simpson KA, Martin NM, Bloom SR. Hypothalamic regulation of food intake and clinical therapeutic applications. Arq Bras Endocrinol Metabol. 2009;53:120-128. [PMID: 19466203 DOI: 10.1590/S0004-27302009000200002] [Cited by in Crossref: 77] [Cited by in F6Publishing: 30] [Article Influence: 6.4] [Reference Citation Analysis]
|
| 67 |
Richards JK, Simms JA, Steensland P, Taha SA, Borgland SL, Bonci A, Bartlett SE. Inhibition of orexin-1/hypocretin-1 receptors inhibits yohimbine-induced reinstatement of ethanol and sucrose seeking in Long-Evans rats. Psychopharmacology (Berl) 2008;199:109-17. [PMID: 18470506 DOI: 10.1007/s00213-008-1136-5] [Cited by in Crossref: 166] [Cited by in F6Publishing: 178] [Article Influence: 11.9] [Reference Citation Analysis]
|
| 68 |
Perez-Leighton CE, Butterick-Peterson TA, Billington CJ, Kotz CM. Role of orexin receptors in obesity: from cellular to behavioral evidence. Int J Obes (Lond) 2013;37:167-74. [PMID: 22391883 DOI: 10.1038/ijo.2012.30] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 69 |
Prud'homme MJ, Lacroix MC, Badonnel K, Gougis S, Baly C, Salesse R, Caillol M. Nutritional status modulates behavioural and olfactory bulb Fos responses to isoamyl acetate or food odour in rats: roles of orexins and leptin. Neuroscience 2009;162:1287-98. [PMID: 19477242 DOI: 10.1016/j.neuroscience.2009.05.043] [Cited by in Crossref: 56] [Cited by in F6Publishing: 57] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 70 |
Samson WK, Resch ZT. The hypocretin/orexin story. Trends Endocrinol Metab 2000;11:257-62. [PMID: 10920381 DOI: 10.1016/s1043-2760(00)00273-3] [Cited by in Crossref: 36] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 71 |
Naylor E, Aillon DV, Gabbert S, Harmon H, Johnson DA, Wilson GS, Petillo PA. Simultaneous real-time measurement of EEG/EMG and L-glutamate in mice: A biosensor study of neuronal activity during sleep. J Electroanal Chem (Lausanne) 2011;656:106-13. [PMID: 27076812 DOI: 10.1016/j.jelechem.2010.12.031] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 72 |
Burdakov D. Reactive and predictive homeostasis: Roles of orexin/hypocretin neurons. Neuropharmacology 2019;154:61-7. [PMID: 30347195 DOI: 10.1016/j.neuropharm.2018.10.024] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 73 |
Reinscheid RK, Xu Y. Neuropeptide S and Its Receptor: A Newly Deorphanized G Protein–Coupled Receptor System. Neuroscientist 2005;11:532-8. [DOI: 10.1177/1073858405276405] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 5.7] [Reference Citation Analysis]
|
| 74 |
van den Top M, Nolan MF, Lee K, Richardson PJ, Buijs RM, Davies CH, Spanswick D. Orexins induce increased excitability and synchronisation of rat sympathetic preganglionic neurones. J Physiol. 2003;549:809-821. [PMID: 12702746 DOI: 10.1113/jphysiol.2002.033290] [Cited by in Crossref: 78] [Cited by in F6Publishing: 78] [Article Influence: 4.1] [Reference Citation Analysis]
|
| 75 |
Revel FG, Gottowik J, Gatti S, Wettstein JG, Moreau J. Rodent models of insomnia: A review of experimental procedures that induce sleep disturbances. Neuroscience & Biobehavioral Reviews 2009;33:874-99. [DOI: 10.1016/j.neubiorev.2009.03.002] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 76 |
Schreyer S, Büttner-Ennever JA, Tang X, Mustari MJ, Horn AK. Orexin-A inputs onto visuomotor cell groups in the monkey brainstem. Neuroscience 2009;164:629-40. [PMID: 19703526 DOI: 10.1016/j.neuroscience.2009.08.039] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 77 |
Burlet S, Tyler CJ, Leonard CS. Direct and indirect excitation of laterodorsal tegmental neurons by Hypocretin/Orexin peptides: implications for wakefulness and narcolepsy. J Neurosci 2002;22:2862-72. [PMID: 11923451 DOI: 20026234] [Cited by in Crossref: 184] [Article Influence: 9.2] [Reference Citation Analysis]
|
| 78 |
Grafe LA, Eacret D, Luz S, Gotter AL, Renger JJ, Winrow CJ, Bhatnagar S. Orexin 2 receptor regulation of the hypothalamic-pituitary-adrenal (HPA) response to acute and repeated stress. Neuroscience 2017;348:313-23. [PMID: 28257896 DOI: 10.1016/j.neuroscience.2017.02.038] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 5.6] [Reference Citation Analysis]
|
| 79 |
Hunt NJ, Waters KA, Rodriguez ML, Machaalani R. Decreased orexin (hypocretin) immunoreactivity in the hypothalamus and pontine nuclei in sudden infant death syndrome. Acta Neuropathol 2015;130:185-98. [PMID: 25953524 DOI: 10.1007/s00401-015-1437-9] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 80 |
Gotter AL, Winrow CJ, Brunner J, Garson SL, Fox SV, Binns J, Harrell CM, Cui D, Yee KL, Stiteler M, Stevens J, Savitz A, Tannenbaum PL, Tye SJ, McDonald T, Yao L, Kuduk SD, Uslaner J, Coleman PJ, Renger JJ. The duration of sleep promoting efficacy by dual orexin receptor antagonists is dependent upon receptor occupancy threshold. BMC Neurosci 2013;14:90. [PMID: 23981345 DOI: 10.1186/1471-2202-14-90] [Cited by in Crossref: 50] [Cited by in F6Publishing: 49] [Article Influence: 5.6] [Reference Citation Analysis]
|
| 81 |
España RA, Scammell TE. Sleep neurobiology from a clinical perspective. Sleep 2011;34:845-58. [PMID: 21731134 DOI: 10.5665/SLEEP.1112] [Cited by in Crossref: 81] [Cited by in F6Publishing: 63] [Article Influence: 7.4] [Reference Citation Analysis]
|
| 82 |
Cajochen C, Wyatt JK, Czeisler CA, Dijk DJ. Separation of circadian and wake duration-dependent modulation of EEG activation during wakefulness. Neuroscience 2002;114:1047-60. [PMID: 12379258 DOI: 10.1016/s0306-4522(02)00209-9] [Cited by in Crossref: 120] [Cited by in F6Publishing: 53] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 83 |
Ito N, Yabe T, Gamo Y, Nagai T, Oikawa T, Yamada H, Hanawa T. I.c.v. administration of orexin-A induces an antidepressive-like effect through hippocampal cell proliferation. Neuroscience 2008;157:720-32. [DOI: 10.1016/j.neuroscience.2008.09.042] [Cited by in Crossref: 67] [Cited by in F6Publishing: 64] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 84 |
Hervieu G, Cluderay J, Harrison D, Roberts J, Leslie R. Gene expression and protein distribution of the orexin-1 receptor in the rat brain and spinal cord. Neuroscience 2001;103:777-97. [DOI: 10.1016/s0306-4522(01)00033-1] [Cited by in Crossref: 340] [Cited by in F6Publishing: 109] [Article Influence: 16.2] [Reference Citation Analysis]
|
| 85 |
Tkacs NC, Pan Y, Sawhney G, Mann GL, Morrison AR. Hypoglycemia activates arousal-related neurons and increases wake time in adult rats. Physiol Behav 2007;91:240-9. [PMID: 17434543 DOI: 10.1016/j.physbeh.2007.03.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 86 |
Majid H, Hirshkowitz M. Therapeutics of Narcolepsy. Sleep Medicine Clinics 2010;5:659-73. [DOI: 10.1016/j.jsmc.2010.08.007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 87 |
Helena C, Gustafsson JA, Korach K, Pfaff D, Anselmo-Franci JA, Ogawa S. Effects of estrogen receptor alpha and beta gene deletion on estrogenic induction of progesterone receptors in the locus coeruleus in female mice. Endocrine 2009;36:169-77. [PMID: 19551522 DOI: 10.1007/s12020-009-9207-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 88 |
Shirasaka T, Kunitake T, Takasaki M, Kannan H. Neuronal effects of orexins: relevant to sympathetic and cardiovascular functions. Regul Pept 2002;104:91-5. [PMID: 11830282 DOI: 10.1016/s0167-0115(01)00352-4] [Cited by in Crossref: 62] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 89 |
Rodgers RJ, Halford JC, Nunes de Souza RL, Canto de Souza AL, Piper DC, Arch JR, Blundell JE. Dose-response effects of orexin-A on food intake and the behavioural satiety sequence in rats. Regul Pept. 2000;96:71-84. [PMID: 11102655 DOI: 10.1016/S0167-0115(00)00203-2] [Cited by in Crossref: 76] [Cited by in F6Publishing: 29] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 90 |
Galas L, Vaudry H, Braun B, Van Den Pol AN, De Lecea L, Sutcliffe JG, Chartrel N. Immunohistochemical localization and biochemical characterization of hypocretin/orexin-related peptides in the central nervous system of the frogRana ridibunda. J Comp Neurol 2001;429:242-52. [DOI: 10.1002/1096-9861(20000108)429:2<242::aid-cne5>3.0.co;2-z] [Cited by in Crossref: 47] [Cited by in F6Publishing: 9] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 91 |
Murai Y, Akaike T. Orexins cause depolarization via nonselective cationic and K+ channels in isolated locus coeruleus neurons. Neuroscience Research 2005;51:55-65. [DOI: 10.1016/j.neures.2004.09.005] [Cited by in Crossref: 45] [Cited by in F6Publishing: 49] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 92 |
James MH, Campbell EJ, Dayas CV. Role of the Orexin/Hypocretin System in Stress-Related Psychiatric Disorders. Curr Top Behav Neurosci 2017;33:197-219. [PMID: 28083790 DOI: 10.1007/7854_2016_56] [Cited by in Crossref: 55] [Cited by in F6Publishing: 55] [Article Influence: 11.0] [Reference Citation Analysis]
|
| 93 |
Selbach O, Doreulee N, Bohla C, Eriksson KS, Sergeeva OA, Poelchen W, Brown RE, Haas HL. Orexins/hypocretins cause sharp wave- and theta-related synaptic plasticity in the hippocampus via glutamatergic, gabaergic, noradrenergic, and cholinergic signaling. Neuroscience 2004;127:519-28. [PMID: 15262340 DOI: 10.1016/j.neuroscience.2004.05.012] [Cited by in Crossref: 84] [Cited by in F6Publishing: 79] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 94 |
Papolos D, Mattis S, Golshan S, Molay F. Fear of harm, a possible phenotype of pediatric bipolar disorder: a dimensional approach to diagnosis for genotyping psychiatric syndromes. J Affect Disord 2009;118:28-38. [PMID: 19631388 DOI: 10.1016/j.jad.2009.06.016] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 95 |
Berridge CW, España RA, Vittoz NM. Hypocretin/orexin in arousal and stress. Brain Res 2010;1314:91-102. [PMID: 19748490 DOI: 10.1016/j.brainres.2009.09.019] [Cited by in Crossref: 115] [Cited by in F6Publishing: 115] [Article Influence: 8.8] [Reference Citation Analysis]
|
| 96 |
Mieda M, Williams SC, Sinton CM, Richardson JA, Sakurai T, Yanagisawa M. Orexin neurons function in an efferent pathway of a food-entrainable circadian oscillator in eliciting food-anticipatory activity and wakefulness. J Neurosci 2004;24:10493-501. [PMID: 15548664 DOI: 10.1523/JNEUROSCI.3171-04.2004] [Cited by in Crossref: 151] [Cited by in F6Publishing: 63] [Article Influence: 8.9] [Reference Citation Analysis]
|
| 97 |
Smith PM, Samson WK, Ferguson AV. Cardiovascular actions of orexin-A in the rat subfornical organ. J Neuroendocrinol 2007;19:7-13. [PMID: 17184481 DOI: 10.1111/j.1365-2826.2006.01497.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 98 |
Szentirmai É, Kapás L. Nicotinic acid promotes sleep through prostaglandin synthesis in mice. Sci Rep 2019;9:17084. [PMID: 31745228 DOI: 10.1038/s41598-019-53648-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 99 |
Mcgranaghan PA, Piggins HD. Orexin A-like immunoreactivity in the hypothalamus and thalamus of the Syrian hamster (Mesocricetus auratus) and Siberian hamster (Phodopus sungorus), with special reference to circadian structures. Brain Research 2001;904:234-44. [DOI: 10.1016/s0006-8993(01)02463-5] [Cited by in Crossref: 59] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 100 |
Korotkova TM, Sergeeva OA, Ponomarenko AA, Haas HL. Histamine excites noradrenergic neurons in locus coeruleus in rats. Neuropharmacology 2005;49:129-34. [DOI: 10.1016/j.neuropharm.2005.03.001] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 101 |
Sharma R, Sahota P, Thakkar MM. Role of adenosine and the orexinergic perifornical hypothalamus in sleep-promoting effects of ethanol. Sleep 2014;37:525-33. [PMID: 24587575 DOI: 10.5665/sleep.3490] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 102 |
Deng F, Zhang Y, Zhang R, Tang Q, Guo Z, Lv Y, Wang Z, Yang Y. Compromised Dynamic Cerebral Autoregulation in Patients With Central Disorders of Hypersomnolence. Front Neurol 2021;12:634660. [PMID: 33776891 DOI: 10.3389/fneur.2021.634660] [Reference Citation Analysis]
|
| 103 |
Aghajani N, Pourhamzeh M, Azizi H, Semnanian S. Central blockade of orexin type 1 receptors reduces naloxone induced activation of locus coeruleus neurons in morphine dependent rats. Neurosci Lett 2021;755:135909. [PMID: 33892002 DOI: 10.1016/j.neulet.2021.135909] [Reference Citation Analysis]
|
| 104 |
Hagan JJ, Price GW, Jeffrey P, Deeks NJ, Stean T, Piper D, Smith MI, Upton N, Medhurst AD, Middlemiss DN, Riley GJ, Lovell PJ, Bromidge SM, Thomas DR. Characterization of SB-269970-A, a selective 5-HT(7) receptor antagonist. Br J Pharmacol 2000;130:539-48. [PMID: 10821781 DOI: 10.1038/sj.bjp.0703357] [Cited by in Crossref: 216] [Cited by in F6Publishing: 220] [Article Influence: 9.8] [Reference Citation Analysis]
|
| 105 |
Selbach O, Haas HL. Hypocretins: The Timing of Sleep and Waking. Chronobiology International 2009;23:63-70. [DOI: 10.1080/07420520500545961] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 106 |
Latifi B, Adamantidis A, Bassetti C, Schmidt MH. Sleep-Wake Cycling and Energy Conservation: Role of Hypocretin and the Lateral Hypothalamus in Dynamic State-Dependent Resource Optimization. Front Neurol 2018;9:790. [PMID: 30344503 DOI: 10.3389/fneur.2018.00790] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 107 |
Szentirmai E, Kapás L, Sun Y, Smith RG, Krueger JM. Spontaneous sleep and homeostatic sleep regulation in ghrelin knockout mice. Am J Physiol Regul Integr Comp Physiol 2007;293:R510-7. [PMID: 17409264 DOI: 10.1152/ajpregu.00155.2007] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 108 |
Fujiki N, Yoshida Y, Zhang S, Sakurai T, Yanagisawa M, Nishino S. Sex difference in body weight gain and leptin signaling in hypocretin/orexin deficient mouse models. Peptides 2006;27:2326-31. [PMID: 16626839 DOI: 10.1016/j.peptides.2006.03.011] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 109 |
Taheri S, Bloom S. Orexins/hypocretins: waking up the scientific world: Orexins and hypocretins. Clinical Endocrinology 2001;54:421-9. [DOI: 10.1046/j.1365-2265.2001.01247.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 110 |
Teske J, Billington C, Kotz C. Neuropeptidergic Mediators of Spontaneous Physical Activity and Non-Exercise Activity Thermogenesis. Neuroendocrinology 2008;87:71-90. [DOI: 10.1159/000110802] [Cited by in Crossref: 53] [Cited by in F6Publishing: 46] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 111 |
Davimes JG, Alagaili AN, Bennett NC, Mohammed OB, Bhagwandin A, Manger PR, Gravett N. Neurochemical organization and morphology of the sleep related nuclei in the brain of the Arabian oryx, Oryx leucoryx. J Chem Neuroanat 2017;81:53-70. [PMID: 28163217 DOI: 10.1016/j.jchemneu.2017.02.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 112 |
Nixon JP, Kotz CM, Novak CM, Billington CJ, Teske JA. Neuropeptides controlling energy balance: orexins and neuromedins. Handb Exp Pharmacol 2012;:77-109. [PMID: 22249811 DOI: 10.1007/978-3-642-24716-3_4] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 113 |
Domínguez L, Morona R, Joven A, González A, López JM. Immunohistochemical localization of orexins (hypocretins) in the brain of reptiles and its relation to monoaminergic systems. Journal of Chemical Neuroanatomy 2010;39:20-34. [DOI: 10.1016/j.jchemneu.2009.07.007] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 114 |
Burdakov D, Alexopoulos H. Metabolic state signalling through central hypocretin/orexin neurons. J Cell Mol Med 2005;9:795-803. [PMID: 16364191 DOI: 10.1111/j.1582-4934.2005.tb00380.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 115 |
Bårdsen K, Gjerstad MD, Partinen M, Kvivik I, Tjensvoll AB, Ruoff P, Omdal R, Brede C. Considerably Lower Levels of Hypocretin-1 in Cerebrospinal Fluid Is Revealed by a Novel Mass Spectrometry Method Compared with Standard Radioimmunoassay. Anal Chem 2019;91:9323-9. [DOI: 10.1021/acs.analchem.9b02710] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 116 |
Szentirmai E, Kapás L, Krueger JM. Ghrelin microinjection into forebrain sites induces wakefulness and feeding in rats. Am J Physiol Regul Integr Comp Physiol 2007;292:R575-85. [PMID: 16917015 DOI: 10.1152/ajpregu.00448.2006] [Cited by in Crossref: 84] [Cited by in F6Publishing: 85] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 117 |
Finke JB, Deuter CE, Hengesch X, Schächinger H. The time course of pupil dilation evoked by visual sexual stimuli: Exploring the underlying ANS mechanisms. Psychophysiology 2017;54:1444-58. [DOI: 10.1111/psyp.12901] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 118 |
Severs L, Vlemincx E, Ramirez J. The psychophysiology of the sigh: I: The sigh from the physiological perspective. Biological Psychology 2022. [DOI: 10.1016/j.biopsycho.2022.108313] [Reference Citation Analysis]
|
| 119 |
Gatfield J, Brisbare-Roch C, Jenck F, Boss C. Orexin receptor antagonists: a new concept in CNS disorders? ChemMedChem 2010;5:1197-214. [PMID: 20544785 DOI: 10.1002/cmdc.201000132] [Cited by in Crossref: 60] [Cited by in F6Publishing: 56] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 120 |
Dun NJ, Le Dun, S, Chen C, Hwang LL, Kwok EH, Chang J. Orexins: a role in medullary sympathetic outflow. Regulatory Peptides 2000;96:65-70. [DOI: 10.1016/s0167-0115(00)00202-0] [Cited by in Crossref: 70] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 121 |
Urstadt KR, Coop SH, Banuelos BD, Stanley BG. Behaviorally specific versus non-specific suppression of accumbens shell-mediated feeding by ipsilateral versus bilateral inhibition of the lateral hypothalamus. Behav Brain Res 2013;257:230-41. [PMID: 24100119 DOI: 10.1016/j.bbr.2013.09.048] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 122 |
López M, Nogueiras R, Tena-Sempere M, Diéguez C. Orexins (hypocretins) actions on the GHRH/somatostatin-GH axis. Acta Physiol (Oxf) 2010;198:325-34. [PMID: 19769635 DOI: 10.1111/j.1748-1716.2009.02042.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 123 |
Smart D, Haynes AC, Williams G, Arch JR. Orexins and the treatment of obesity. Eur J Pharmacol 2002;440:199-212. [PMID: 12007536 DOI: 10.1016/s0014-2999(02)01429-2] [Cited by in Crossref: 36] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 124 |
Thompson MD, Xhaard H, Sakurai T, Rainero I, Kukkonen JP. OX1 and OX2 orexin/hypocretin receptor pharmacogenetics. Front Neurosci 2014;8:57. [PMID: 24834023 DOI: 10.3389/fnins.2014.00057] [Cited by in Crossref: 34] [Cited by in F6Publishing: 40] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 125 |
Lok R, Smolders KCHJ, Beersma DGM, de Kort YAW. Light, Alertness, and Alerting Effects of White Light: A Literature Overview. J Biol Rhythms 2018;33:589-601. [PMID: 30191746 DOI: 10.1177/0748730418796443] [Cited by in Crossref: 43] [Cited by in F6Publishing: 16] [Article Influence: 10.8] [Reference Citation Analysis]
|
| 126 |
Nishino S, Yoshida Y. History and perspectives of hypocretin/orexin research in sleep medicine. Sleep and Biological Rhythms 2003;1:43-54. [DOI: 10.1046/j.1446-9235.2003.00001.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 127 |
Angelopoulos N, Goula A, Tolis G. Current knowledge in the neurophysiologic modulation of obesity. Metabolism 2005;54:1202-17. [DOI: 10.1016/j.metabol.2005.04.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 128 |
Govindaiah G, Cox CL. Modulation of thalamic neuron excitability by orexins. Neuropharmacology 2006;51:414-25. [PMID: 16713607 DOI: 10.1016/j.neuropharm.2006.03.030] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 129 |
Chang X, Suo L, Xu N, Zhao Y. Orexin-A Stimulates Insulin Secretion Through the Activation of the OX1 Receptor and Mammalian Target of Rapamycin in Rat Insulinoma Cells. Pancreas 2019;48:568-73. [PMID: 30946236 DOI: 10.1097/MPA.0000000000001280] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 130 |
Huang H, Acuna-Goycolea C, Li Y, Cheng HM, Obrietan K, van den Pol AN. Cannabinoids excite hypothalamic melanin-concentrating hormone but inhibit hypocretin/orexin neurons: implications for cannabinoid actions on food intake and cognitive arousal. J Neurosci 2007;27:4870-81. [PMID: 17475795 DOI: 10.1523/JNEUROSCI.0732-07.2007] [Cited by in Crossref: 74] [Cited by in F6Publishing: 29] [Article Influence: 4.9] [Reference Citation Analysis]
|
| 131 |
Strother LC, Srikiatkhachorn A, Supronsinchai W. Targeted Orexin and Hypothalamic Neuropeptides for Migraine. Neurotherapeutics 2018;15:377-90. [PMID: 29442286 DOI: 10.1007/s13311-017-0602-3] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 132 |
Wojciechowicz T, Skrzypski M, Szczepankiewicz D, Hertig I, Kołodziejski PA, Billert M, Strowski MZ, Nowak KW. Original Research: Orexins A and B stimulate proliferation and differentiation of porcine preadipocytes. Exp Biol Med (Maywood) 2016;241:1786-95. [PMID: 27190275 DOI: 10.1177/1535370216649261] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 133 |
Torterolo P, Ramos OV, Sampogna S, Chase MH. Hypocretinergic neurons are activated in conjunction with goal-oriented survival-related motor behaviors. Physiol Behav 2011;104:823-30. [PMID: 21839102 DOI: 10.1016/j.physbeh.2011.07.032] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 134 |
Huang ZL, Qu WM, Li WD, Mochizuki T, Eguchi N, Watanabe T, Urade Y, Hayaishi O. Arousal effect of orexin A depends on activation of the histaminergic system. Proc Natl Acad Sci U S A 2001;98:9965-70. [PMID: 11493714 DOI: 10.1073/pnas.181330998] [Cited by in Crossref: 376] [Cited by in F6Publishing: 336] [Article Influence: 17.9] [Reference Citation Analysis]
|
| 135 |
Lyons DJ, Hellysaz A, Ammari R, Broberger C. Hypocretin/Orexin Peptides Excite Rat Neuroendocrine Dopamine Neurons through Orexin 2 Receptor-Mediated Activation of a Mixed Cation Current. Sci Rep 2017;7:41535. [PMID: 28145492 DOI: 10.1038/srep41535] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 136 |
Hillebrand J, de Wied D, Adan R. Neuropeptides, food intake and body weight regulation: a hypothalamic focus. Peptides 2002;23:2283-306. [DOI: 10.1016/s0196-9781(02)00269-3] [Cited by in Crossref: 202] [Cited by in F6Publishing: 49] [Article Influence: 10.1] [Reference Citation Analysis]
|
| 137 |
Soffin EM, Gill CH, Brough SJ, Jerman JC, Davies CH. Pharmacological characterisation of the orexin receptor subtype mediating postsynaptic excitation in the rat dorsal raphe nucleus. Neuropharmacology. 2004;46:1168-1176. [PMID: 15111023 DOI: 10.1016/j.neuropharm.2004.02.014] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 138 |
Hou RH, Langley RW, Szabadi E, Bradshaw CM. Comparison of diphenhydramine and modafinil on arousal and autonomic functions in healthy volunteers. J Psychopharmacol 2007;21:567-78. [PMID: 17092978 DOI: 10.1177/0269881106071022] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 139 |
Goforth PB, Myers MG. Roles for Orexin/Hypocretin in the Control of Energy Balance and Metabolism. In: Lawrence AJ, de Lecea L, editors. Behavioral Neuroscience of Orexin/Hypocretin. Cham: Springer International Publishing; 2017. pp. 137-56. [DOI: 10.1007/7854_2016_51] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 140 |
Sakurai T, Mieda M. Connectomics of orexin-producing neurons: interface of systems of emotion, energy homeostasis and arousal. Trends Pharmacol Sci 2011;32:451-62. [PMID: 21565412 DOI: 10.1016/j.tips.2011.03.007] [Cited by in Crossref: 139] [Cited by in F6Publishing: 136] [Article Influence: 12.6] [Reference Citation Analysis]
|
| 141 |
Tsuneki H, Sugihara Y, Honda R, Wada T, Sasaoka T, Kimura I. Reduction of blood glucose level by orexins in fasting normal and streptozotocin-diabetic mice. European Journal of Pharmacology 2002;448:245-52. [DOI: 10.1016/s0014-2999(02)01936-2] [Cited by in Crossref: 26] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 142 |
Campbell EJ, Norman A, Bonomo Y, Lawrence AJ. Suvorexant to treat alcohol use disorder and comorbid insomnia: Plan for a phase II trial. Brain Res 2020;1728:146597. [PMID: 31837287 DOI: 10.1016/j.brainres.2019.146597] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 143 |
Prober DA. Discovery of Hypocretin/Orexin Ushers in a New Era of Sleep Research. Trends Neurosci 2018;41:70-2. [PMID: 29405929 DOI: 10.1016/j.tins.2017.11.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 144 |
Zhang J, Li B, Yu L, He YC, Li HZ, Zhu JN, Wang JJ. A role for orexin in central vestibular motor control. Neuron 2011;69:793-804. [PMID: 21338887 DOI: 10.1016/j.neuron.2011.01.026] [Cited by in Crossref: 69] [Cited by in F6Publishing: 71] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 145 |
Morein-Zamir S, Turner DC, Sahakian BJ. A review of the effects of modafinil on cognition in schizophrenia. Schizophr Bull 2007;33:1298-306. [PMID: 17634412 DOI: 10.1093/schbul/sbm090] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 146 |
Koyama Y, Takahashi K, Kodama T, Kayama Y. State-dependent activity of neurons in the perifornical hypothalamic area during sleep and waking. Neuroscience 2003;119:1209-19. [DOI: 10.1016/s0306-4522(03)00173-8] [Cited by in Crossref: 69] [Cited by in F6Publishing: 39] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 147 |
Bjorness TE, Greene RW. Interaction between cocaine use and sleep behavior: A comprehensive review of cocaine's disrupting influence on sleep behavior and sleep disruptions influence on reward seeking. Pharmacol Biochem Behav 2021;206:173194. [PMID: 33940055 DOI: 10.1016/j.pbb.2021.173194] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 148 |
Hening WA, Allen RP, Walters AS, Chokroverty S. Motor Functions and Dysfunctions of Sleep. Sleep Disorders Medicine. Elsevier; 2009. pp. 397-435. [DOI: 10.1016/b978-0-7506-7584-0.00028-8] [Cited by in Crossref: 5] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 149 |
Goadsby PJ, Dodick DW, Almas M, Diener HC, Tfelt-Hansen P, Lipton RB, Parsons B. Treatment-emergent CNS symptoms following triptan therapy are part of the attack. Cephalalgia 2007;27:254-62. [PMID: 17381558 DOI: 10.1111/j.1468-2982.2007.01278.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 150 |
Rachalski A, Alexandre C, Bernard JF, Saurini F, Lesch KP, Hamon M, Adrien J, Fabre V. Altered sleep homeostasis after restraint stress in 5-HTT knock-out male mice: a role for hypocretins. J Neurosci 2009;29:15575-85. [PMID: 20007481 DOI: 10.1523/JNEUROSCI.3138-09.2009] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 151 |
Kane JK, Tanaka H, Parker SL, Yanagisawa M, Li MD. Sensitivity of orexin-A binding to phospholipase C inhibitors, neuropeptide Y, and secretin. Biochem Biophys Res Commun 2000;272:959-65. [PMID: 10860858 DOI: 10.1006/bbrc.2000.2880] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 152 |
Baldo BA, Daniel RA, Berridge CW, Kelley AE. Overlapping distributions of orexin/hypocretin- and dopamine-beta-hydroxylase immunoreactive fibers in rat brain regions mediating arousal, motivation, and stress. J Comp Neurol 2003;464:220-37. [PMID: 12898614 DOI: 10.1002/cne.10783] [Cited by in Crossref: 247] [Cited by in F6Publishing: 253] [Article Influence: 13.0] [Reference Citation Analysis]
|
| 153 |
Graebner AK, Iyer M, Carter ME. Understanding how discrete populations of hypothalamic neurons orchestrate complicated behavioral states. Front Syst Neurosci 2015;9:111. [PMID: 26300745 DOI: 10.3389/fnsys.2015.00111] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 154 |
Lindberg J, Saetre P, Nishino S, Mignot E, Jazin E. Reduced expression of TAC1, PENK and SOCS2 in Hcrtr-2 mutated narcoleptic dog brain. BMC Neurosci 2007;8:34. [PMID: 17521418 DOI: 10.1186/1471-2202-8-34] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 155 |
Bai YJ, Li YH, Zheng XG, Han J, Yang XY, Sui N. Orexin A attenuates unconditioned sexual motivation in male rats. Pharmacol Biochem Behav 2009;91:581-9. [PMID: 18952120 DOI: 10.1016/j.pbb.2008.09.018] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 156 |
Brischoux F, Mainville L, Jones BE. Muscarinic-2 and orexin-2 receptors on GABAergic and other neurons in the rat mesopontine tegmentum and their potential role in sleep-wake state control. J Comp Neurol 2008;510:607-30. [DOI: 10.1002/cne.21803] [Cited by in Crossref: 39] [Cited by in F6Publishing: 44] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 157 |
Tsujino N, Sakurai T. Orexin/hypocretin: a neuropeptide at the interface of sleep, energy homeostasis, and reward system. Pharmacol Rev 2009;61:162-76. [PMID: 19549926 DOI: 10.1124/pr.109.001321] [Cited by in Crossref: 314] [Cited by in F6Publishing: 284] [Article Influence: 26.2] [Reference Citation Analysis]
|
| 158 |
Suzuki H, Yamamoto T. Orexin-B-like immunoreactivity localizes in both luteinizing-hormone-containing cells and melanin-concentrating hormone-containing fibers in the red-bellied piranha (Pygocentrus nattereri) pituitary. Cell Tissue Res 2013;351:175-82. [PMID: 23161098 DOI: 10.1007/s00441-012-1516-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 159 |
Waleh N, Apte-deshpande A, Terao A, Ding J, Kilduff T. Modulation of the promoter region of prepro-hypocretin by α-interferon. Gene 2001;262:123-8. [DOI: 10.1016/s0378-1119(00)00544-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 160 |
Thorpe AJ, Cleary JP, Levine AS, Kotz CM. Centrally administered orexin A increases motivation for sweet pellets in rats. Psychopharmacology (Berl) 2005;182:75-83. [PMID: 16075284 DOI: 10.1007/s00213-005-0040-5] [Cited by in Crossref: 67] [Cited by in F6Publishing: 72] [Article Influence: 3.9] [Reference Citation Analysis]
|
| 161 |
Holland PR. Biology of Neuropeptides: Orexinergic Involvement in Primary Headache Disorders. Headache 2017;57 Suppl 2:76-88. [PMID: 28485849 DOI: 10.1111/head.13078] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 162 |
Satoh S, Matsumura H, Kanbayashi T, Yoshida Y, Urakami T, Nakajima T, Kimura N, Nishino S, Yoneda H. Expression pattern of FOS in orexin neurons during sleep induced by an adenosine A2A receptor agonist. Behavioural Brain Research 2006;170:277-86. [DOI: 10.1016/j.bbr.2006.03.010] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 163 |
Haq IZ, Naidu Y, Reddy P, Chaudhuri KR. Narcolepsy in Parkinson's disease. Expert Rev Neurother 2010;10:879-84. [PMID: 20518604 DOI: 10.1586/ern.10.56] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 164 |
Ishibashi H, Nakahata Y, Eto K, Nabekura J. Excitation of locus coeruleus noradrenergic neurons by thyrotropin-releasing hormone. J Physiol 2009;587:5709-22. [PMID: 19840999 DOI: 10.1113/jphysiol.2009.181420] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 165 |
Mieda M, Hasegawa E, Kisanuki YY, Sinton CM, Yanagisawa M, Sakurai T. Differential roles of orexin receptor-1 and -2 in the regulation of non-REM and REM sleep. J Neurosci 2011;31:6518-26. [PMID: 21525292 DOI: 10.1523/JNEUROSCI.6506-10.2011] [Cited by in Crossref: 134] [Cited by in F6Publishing: 78] [Article Influence: 12.2] [Reference Citation Analysis]
|
| 166 |
de Lecea L, Sutcliffe JG, Fabre V. Hypocretins/orexins as integrators of physiological information: lessons from mutant animals. Neuropeptides 2002;36:85-95. [PMID: 12359500 DOI: 10.1054/npep.2002.0892] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 167 |
Johnson PL, Molosh A, Fitz SD, Truitt WA, Shekhar A. Orexin, stress, and anxiety/panic states. Prog Brain Res 2012;198:133-61. [PMID: 22813973 DOI: 10.1016/B978-0-444-59489-1.00009-4] [Cited by in Crossref: 125] [Cited by in F6Publishing: 69] [Article Influence: 12.5] [Reference Citation Analysis]
|
| 168 |
Bayer L, Serafin M, Eggermann E, Saint-Mleux B, Machard D, Jones BE, Mühlethaler M. Exclusive postsynaptic action of hypocretin-orexin on sublayer 6b cortical neurons. J Neurosci 2004;24:6760-4. [PMID: 15282280 DOI: 10.1523/JNEUROSCI.1783-04.2004] [Cited by in Crossref: 110] [Cited by in F6Publishing: 46] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 169 |
Tafti M, Franken P. Invited Review: Genetic dissection of sleep. Journal of Applied Physiology 2002;92:1339-47. [DOI: 10.1152/japplphysiol.00834.2001] [Cited by in Crossref: 47] [Cited by in F6Publishing: 36] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 170 |
Coborn JE, Lessie RE, Sinton CM, Rance NE, Perez-Leighton CE, Teske JA. Noise-induced sleep disruption increases weight gain and decreases energy metabolism in female rats. Int J Obes (Lond) 2019;43:1759-68. [PMID: 30568267 DOI: 10.1038/s41366-018-0293-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 171 |
Li J, Hu Z, de Lecea L. The hypocretins/orexins: integrators of multiple physiological functions. Br J Pharmacol 2014;171:332-50. [PMID: 24102345 DOI: 10.1111/bph.12415] [Cited by in Crossref: 153] [Cited by in F6Publishing: 141] [Article Influence: 19.1] [Reference Citation Analysis]
|
| 172 |
Cole AG, Stroke IL, Qin L, Hussain Z, Simhadri S, Brescia M, Waksmunski FS, Strohl B, Tellew JE, Williams JP, Saunders J, Appell KC, Henderson I, Webb ML. Synthesis of (3,4-dimethoxyphenoxy)alkylamino acetamides as orexin-2 receptor antagonists. Bioorganic & Medicinal Chemistry Letters 2008;18:5420-3. [DOI: 10.1016/j.bmcl.2008.09.038] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 173 |
Apelbaum A, Perrut A, Chaput M. Orexin A effects on the olfactory bulb spontaneous activity and odor responsiveness in freely breathing rats. Regulatory Peptides 2005;129:49-61. [DOI: 10.1016/j.regpep.2005.01.003] [Cited by in Crossref: 41] [Cited by in F6Publishing: 33] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 174 |
Datta S, Maclean RR. Neurobiological mechanisms for the regulation of mammalian sleep-wake behavior: reinterpretation of historical evidence and inclusion of contemporary cellular and molecular evidence. Neurosci Biobehav Rev 2007;31:775-824. [PMID: 17445891 DOI: 10.1016/j.neubiorev.2007.02.004] [Cited by in Crossref: 194] [Cited by in F6Publishing: 166] [Article Influence: 12.9] [Reference Citation Analysis]
|
| 175 |
Vittoz NM, Berridge CW. Hypocretin/orexin selectively increases dopamine efflux within the prefrontal cortex: involvement of the ventral tegmental area. Neuropsychopharmacology 2006;31:384-95. [PMID: 15988471 DOI: 10.1038/sj.npp.1300807] [Cited by in Crossref: 123] [Cited by in F6Publishing: 126] [Article Influence: 7.7] [Reference Citation Analysis]
|
| 176 |
Li Y, van den Pol AN. Differential target-dependent actions of coexpressed inhibitory dynorphin and excitatory hypocretin/orexin neuropeptides. J Neurosci 2006;26:13037-47. [PMID: 17167093 DOI: 10.1523/JNEUROSCI.3380-06.2006] [Cited by in Crossref: 86] [Cited by in F6Publishing: 59] [Article Influence: 5.7] [Reference Citation Analysis]
|
| 177 |
Kummer M, Neidert SJ, Jöhren O, Dominiak P. Orexin (hypocretin) gene expression in rat ependymal cells: . Neuroreport 2001;12:2117-20. [DOI: 10.1097/00001756-200107200-00015] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 178 |
Lavezzi AM, Ferrero S, Roncati L, Matturri L, Pusiol T. Impaired orexin receptor expression in the Kölliker-Fuse nucleus in sudden infant death syndrome: possible involvement of this nucleus in arousal pathophysiology. Neurol Res 2016;38:706-16. [PMID: 27353953 DOI: 10.1080/01616412.2016.1201632] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 179 |
Matsuki T, Sakurai T. Orexins and Orexin Receptors: From Molecules to Integrative Physiology. In: Civelli O, Zhou Q, editors. Orphan G Protein-Coupled Receptors and Novel Neuropeptides. Berlin: Springer Berlin Heidelberg; 2008. pp. 27-55. [DOI: 10.1007/400_2007_047] [Cited by in Crossref: 51] [Cited by in F6Publishing: 45] [Reference Citation Analysis]
|
| 180 |
Hurley SW, Johnson AK. The role of the lateral hypothalamus and orexin in ingestive behavior: a model for the translation of past experience and sensed deficits into motivated behaviors. Front Syst Neurosci 2014;8:216. [PMID: 25431553 DOI: 10.3389/fnsys.2014.00216] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 181 |
Luppi P, Clément O, Sapin E, Gervasoni D, Peyron C, Léger L, Salvert D, Fort P. The neuronal network responsible for paradoxical sleep and its dysfunctions causing narcolepsy and rapid eye movement (REM) behavior disorder. Sleep Medicine Reviews 2011;15:153-63. [DOI: 10.1016/j.smrv.2010.08.002] [Cited by in Crossref: 176] [Cited by in F6Publishing: 146] [Article Influence: 16.0] [Reference Citation Analysis]
|
| 182 |
Henry BA, Rao A, Ikenasio BA, Mountjoy KG, Tilbrook AJ, Clarke IJ. Differential expression of cocaine- and amphetamine-regulated transcript and agouti related-protein in chronically food-restricted sheep. Brain Research 2001;918:40-50. [DOI: 10.1016/s0006-8993(01)02918-3] [Cited by in Crossref: 38] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 183 |
Suzuki H, Takemoto Y, Yamamoto T. Differential distribution of orexin-A-like and orexin receptor 1 (OX1R)-like immunoreactivities in the Xenopus pituitary. Tissue Cell 2007;39:423-30. [PMID: 17897692 DOI: 10.1016/j.tice.2007.08.001] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 184 |
Kaushik MK, Aritake K, Imanishi A, Kanbayashi T, Ichikawa T, Shimizu T, Urade Y, Yanagisawa M. Continuous intrathecal orexin delivery inhibits cataplexy in a murine model of narcolepsy. Proc Natl Acad Sci U S A 2018;115:6046-51. [PMID: 29784823 DOI: 10.1073/pnas.1722686115] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 185 |
Samson WK, Taylor MM, Follwell M, Ferguson AV. Orexin actions in hypothalamic paraventricular nucleus: physiological consequences and cellular correlates. Regul Pept 2002;104:97-103. [PMID: 11830283 DOI: 10.1016/s0167-0115(01)00353-6] [Cited by in Crossref: 92] [Cited by in F6Publishing: 34] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 186 |
Cannella N, Economidou D, Kallupi M, Stopponi S, Heilig M, Massi M, Ciccocioppo R. Persistent increase of alcohol-seeking evoked by neuropeptide S: an effect mediated by the hypothalamic hypocretin system. Neuropsychopharmacology 2009;34:2125-34. [PMID: 19322167 DOI: 10.1038/npp.2009.37] [Cited by in Crossref: 70] [Cited by in F6Publishing: 73] [Article Influence: 5.4] [Reference Citation Analysis]
|
| 187 |
Telegdy G, Adamik A. The action of orexin A on passive avoidance learning. Involvement of transmitters. Regul Pept 2002;104:105-10. [PMID: 11830284 DOI: 10.1016/s0167-0115(01)00341-x] [Cited by in Crossref: 66] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 188 |
Peyron C, Faraco J, Rogers W, Ripley B, Overeem S, Charnay Y, Nevsimalova S, Aldrich M, Reynolds D, Albin R, Li R, Hungs M, Pedrazzoli M, Padigaru M, Kucherlapati M, Fan J, Maki R, Lammers GJ, Bouras C, Kucherlapati R, Nishino S, Mignot E. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 2000;6:991-7. [PMID: 10973318 DOI: 10.1038/79690] [Cited by in Crossref: 1341] [Cited by in F6Publishing: 1194] [Article Influence: 61.0] [Reference Citation Analysis]
|
| 189 |
Stanley S, Wynne K, McGowan B, Bloom S. Hormonal regulation of food intake. Physiol Rev. 2005;85:1131-1158. [PMID: 16183909 DOI: 10.1152/physrev.00015.2004] [Cited by in Crossref: 240] [Cited by in F6Publishing: 215] [Article Influence: 14.1] [Reference Citation Analysis]
|
| 190 |
Korotkova TM, Eriksson KS, Haas HL, Brown RE. Selective excitation of GABAergic neurons in the substantia nigra of the rat by orexin/hypocretin in vitro. Regul Pept 2002;104:83-9. [PMID: 11830281 DOI: 10.1016/s0167-0115(01)00323-8] [Cited by in Crossref: 62] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 191 |
Summers CH, Yaeger JDW, Staton CD, Arendt DH, Summers TR. Orexin/hypocretin receptor modulation of anxiolytic and antidepressive responses during social stress and decision-making: Potential for therapy. Brain Res 2020;1731:146085. [PMID: 30590027 DOI: 10.1016/j.brainres.2018.12.036] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 192 |
Goadsby P, Charbit A, Andreou A, Akerman S, Holland P. Neurobiology of migraine. Neuroscience 2009;161:327-41. [DOI: 10.1016/j.neuroscience.2009.03.019] [Cited by in Crossref: 260] [Cited by in F6Publishing: 230] [Article Influence: 20.0] [Reference Citation Analysis]
|
| 193 |
Cote-Vélez A, Martínez Báez A, Lezama L, Uribe RM, Joseph-Bravo P, Charli JL. A screen for modulators reveals that orexin-A rapidly stimulates thyrotropin releasing hormone expression and release in hypothalamic cell culture. Neuropeptides 2017;62:11-20. [PMID: 28173961 DOI: 10.1016/j.npep.2017.01.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 194 |
Perez SM, Lodge DJ. Orexin Modulation of VTA Dopamine Neuron Activity: Relevance to Schizophrenia. Int J Neuropsychopharmacol 2021;24:344-53. [PMID: 33587746 DOI: 10.1093/ijnp/pyaa080] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 195 |
Pearson KA, Stephen A, Beck SG, Valentino RJ. Identifying genes in monoamine nuclei that may determine stress vulnerability and depressive behavior in Wistar-Kyoto rats. Neuropsychopharmacology 2006;31:2449-61. [PMID: 16710313 DOI: 10.1038/sj.npp.1301100] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 196 |
Silva JP, von Meyenn F, Howell J, Thorens B, Wolfrum C, Stoffel M. Regulation of adaptive behaviour during fasting by hypothalamic Foxa2. Nature 2009;462:646-50. [PMID: 19956259 DOI: 10.1038/nature08589] [Cited by in Crossref: 53] [Cited by in F6Publishing: 51] [Article Influence: 4.1] [Reference Citation Analysis]
|
| 197 |
Darwinkel A, Stanić D, Booth LC, May CN, Lawrence AJ, Yao ST. Distribution of orexin-1 receptor-green fluorescent protein- (OX1-GFP) expressing neurons in the mouse brain stem and pons: Co-localization with tyrosine hydroxylase and neuronal nitric oxide synthase. Neuroscience 2014;278:253-64. [PMID: 25168728 DOI: 10.1016/j.neuroscience.2014.08.027] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 198 |
John J, Wu MF, Kodama T, Siegel JM. Intravenously administered hypocretin-1 alters brain amino acid release: an in vivo microdialysis study in rats. J Physiol 2003;548:557-62. [PMID: 12626669 DOI: 10.1113/jphysiol.2002.038729] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 199 |
Luppi AI, Spindler LRB, Menon DK, Stamatakis EA. The Inert Brain: Explaining Neural Inertia as Post-anaesthetic Sleep Inertia. Front Neurosci 2021;15:643871. [PMID: 33737863 DOI: 10.3389/fnins.2021.643871] [Reference Citation Analysis]
|
| 200 |
Zeitzer JM, Buckmaster CL, Lyons DM, Mignot E. Locomotor-dependent and -independent components to hypocretin-1 (orexin A) regulation in sleep-wake consolidating monkeys. J Physiol 2004;557:1045-53. [PMID: 15107479 DOI: 10.1113/jphysiol.2004.061606] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 201 |
Prober DA, Rihel J, Onah AA, Sung RJ, Schier AF. Hypocretin/orexin overexpression induces an insomnia-like phenotype in zebrafish. J Neurosci 2006;26:13400-10. [PMID: 17182791 DOI: 10.1523/JNEUROSCI.4332-06.2006] [Cited by in Crossref: 308] [Cited by in F6Publishing: 153] [Article Influence: 20.5] [Reference Citation Analysis]
|
| 202 |
Muehlan C, Vaillant C, Zenklusen I, Kraehenbuehl S, Dingemanse J. Clinical pharmacology, efficacy, and safety of orexin receptor antagonists for the treatment of insomnia disorders. Expert Opinion on Drug Metabolism & Toxicology 2020;16:1063-78. [DOI: 10.1080/17425255.2020.1817380] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 203 |
Novikova NS, Perekrest SV, Shainidze KZ, Korneva EA. Hypothalamic Orexin-Containing Neurons in the Hypothalamus on Exposure to Antigenic and Non-Antigenic Stimuli. Neurosci Behav Physi 2011;41:188-97. [DOI: 10.1007/s11055-011-9399-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 204 |
Nixon J, Smale L. Individual differences in wheel-running rhythms are related to temporal and spatial patterns of activation of orexin A and B cells in a diurnal rodent (arvicanthis niloticus). Neuroscience 2004;127:25-34. [DOI: 10.1016/j.neuroscience.2004.04.052] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 205 |
Kim SW, Lee BI. Metabolic state, neurohormones, and vagal stimulation, not increased serotonin, orchestrate postprandial drowsiness. Bioscience Hypotheses 2009;2:422-7. [DOI: 10.1016/j.bihy.2009.07.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 206 |
Peterfi Z, Obal F, Taishi P, Gardi J, Kacsoh B, Unterman T, Krueger JM. Sleep in spontaneous dwarf rats. Brain Research 2006;1108:133-46. [DOI: 10.1016/j.brainres.2006.06.016] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 207 |
Héricé C, Patel AA, Sakata S. Circuit mechanisms and computational models of REM sleep. Neurosci Res 2019;140:77-92. [PMID: 30118737 DOI: 10.1016/j.neures.2018.08.003] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 208 |
Kordi Jaz E, Moghimi A, Fereidoni M, Asadi S, Shamsizadeh A, Roohbakhsh A. SB-334867, an orexin receptor 1 antagonist, decreased seizure and anxiety in pentylenetetrazol-kindled rats. Fundam Clin Pharmacol 2017;31:201-7. [DOI: 10.1111/fcp.12249] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 209 |
Bettica P, Squassante L, Groeger JA, Gennery B, Winsky-Sommerer R, Dijk DJ. Differential effects of a dual orexin receptor antagonist (SB-649868) and zolpidem on sleep initiation and consolidation, SWS, REM sleep, and EEG power spectra in a model of situational insomnia. Neuropsychopharmacology 2012;37:1224-33. [PMID: 22237311 DOI: 10.1038/npp.2011.310] [Cited by in Crossref: 59] [Cited by in F6Publishing: 59] [Article Influence: 5.9] [Reference Citation Analysis]
|
| 210 |
Betschart C, Hintermann S, Behnke D, Cotesta S, Fendt M, Gee CE, Jacobson LH, Laue G, Ofner S, Chaudhari V, Badiger S, Pandit C, Wagner J, Hoyer D. Identification of a novel series of orexin receptor antagonists with a distinct effect on sleep architecture for the treatment of insomnia. J Med Chem 2013;56:7590-607. [PMID: 23964859 DOI: 10.1021/jm4007627] [Cited by in Crossref: 62] [Cited by in F6Publishing: 55] [Article Influence: 6.9] [Reference Citation Analysis]
|
| 211 |
De la Herrán-Arita AK, Guerra-Crespo M, Drucker-Colín R. Narcolepsy and orexins: an example of progress in sleep research. Front Neurol 2011;2:26. [PMID: 21541306 DOI: 10.3389/fneur.2011.00026] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 212 |
Messina A, De Fusco C, Monda V, Esposito M, Moscatelli F, Valenzano A, Carotenuto M, Viggiano E, Chieffi S, De Luca V, Cibelli G, Monda M, Messina G. Role of the Orexin System on the Hypothalamus-Pituitary-Thyroid Axis. Front Neural Circuits 2016;10:66. [PMID: 27610076 DOI: 10.3389/fncir.2016.00066] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 213 |
Meerabux J, Iwayama Y, Sakurai T, Ohba H, Toyota T, Yamada K, Nagata R, Irukayama-tomobe Y, Shimizu H, Yoshitsugu K, Ohta K, Yoshikawa T. Association of An Orexin 1 Receptor 408Val Variant with Polydipsia–Hyponatremia in Schizophrenic Subjects. Biological Psychiatry 2005;58:401-7. [DOI: 10.1016/j.biopsych.2005.04.015] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 214 |
Mistlberger RE. Circadian regulation of sleep in mammals: Role of the suprachiasmatic nucleus. Brain Research Reviews 2005;49:429-54. [DOI: 10.1016/j.brainresrev.2005.01.005] [Cited by in Crossref: 204] [Cited by in F6Publishing: 173] [Article Influence: 12.0] [Reference Citation Analysis]
|
| 215 |
Bahammam AS, Almushailhi K, Pandi-Perumal SR, Sharif MM. Intermittent fasting during Ramadan: does it affect sleep? J Sleep Res 2014;23:35-43. [PMID: 23937329 DOI: 10.1111/jsr.12076] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 216 |
Haxhiu MA, Rust CF, Brooks C, Kc P. CNS determinants of sleep-related worsening of airway functions: implications for nocturnal asthma. Respir Physiol Neurobiol 2006;151:1-30. [PMID: 16198640 DOI: 10.1016/j.resp.2005.07.009] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 217 |
Luppi PH, Gervasoni D, Verret L, Goutagny R, Peyron C, Salvert D, Leger L, Fort P. Paradoxical (REM) sleep genesis: the switch from an aminergic-cholinergic to a GABAergic-glutamatergic hypothesis. J Physiol Paris 2006;100:271-83. [PMID: 17689057 DOI: 10.1016/j.jphysparis.2007.05.006] [Cited by in Crossref: 121] [Cited by in F6Publishing: 110] [Article Influence: 8.1] [Reference Citation Analysis]
|
| 218 |
Thorpe AJ, Mullett MA, Wang C, Kotz CM. Regional, metabolic, and circadian specificity of lateral hypothalamic orexin A feeding stimulation. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 2003;284:R1409-17. [DOI: 10.1152/ajpregu.00344.2002] [Cited by in Crossref: 59] [Cited by in F6Publishing: 58] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 219 |
Boutrel B. A neuropeptide-centric view of psychostimulant addiction. Br J Pharmacol 2008;154:343-57. [PMID: 18414383 DOI: 10.1038/bjp.2008.133] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 220 |
Ford GK, Al-barazanji KA, Wilson S, Jones DNC, Harbuz MS, Jessop DS. Orexin Expression and Function: Glucocorticoid Manipulation, Stress, and Feeding Studies. Endocrinology 2005;146:3724-31. [DOI: 10.1210/en.2005-0496] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 221 |
Jöhren O, Neidert SJ, Kummer M, Dendorfer A, Dominiak P. Prepro-Orexin and Orexin Receptor mRNAs Are Differentially Expressed in Peripheral Tissues of Male and Female Rats. Endocrinology 2001;142:3324-31. [DOI: 10.1210/endo.142.8.8299] [Cited by in Crossref: 133] [Cited by in F6Publishing: 144] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 222 |
Jöhren O, Neidert SJ, Kummer M, Dominiak P. Sexually dimorphic expression of prepro-orexin mRNA in the rat hypothalamus. Peptides 2002;23:1177-80. [DOI: 10.1016/s0196-9781(02)00052-9] [Cited by in Crossref: 62] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 223 |
Pedrazzoli M, D'almeida V, Martins PJ, Machado RB, Ling L, Nishino S, Tufik S, Mignot E. Increased hypocretin-1 levels in cerebrospinal fluid after REM sleep deprivation. Brain Research 2004;995:1-6. [DOI: 10.1016/j.brainres.2003.09.032] [Cited by in Crossref: 50] [Cited by in F6Publishing: 46] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 224 |
Tanaka S. Transcriptional regulation of the hypocretin/orexin gene. Vitam Horm 2012;89:75-90. [PMID: 22640609 DOI: 10.1016/B978-0-12-394623-2.00005-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 225 |
Sakurai T. Roles of orexins in regulation of feeding and wakefulness: . Neuroreport 2002;13:987-95. [DOI: 10.1097/00001756-200206120-00001] [Cited by in Crossref: 78] [Cited by in F6Publishing: 72] [Article Influence: 3.9] [Reference Citation Analysis]
|
| 226 |
Nicolaidis S. Metabolic mechanism of wakefulness (and hunger) and sleep (and satiety): Role of adenosine triphosphate and hypocretin and other peptides. Metabolism 2006;55:S24-9. [PMID: 16979423 DOI: 10.1016/j.metabol.2006.07.009] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 227 |
Kane JK, Parker SL, Matta SG, Fu Y, Sharp BM, Li MD. Nicotine up-regulates expression of orexin and its receptors in rat brain. Endocrinology 2000;141:3623-9. [PMID: 11014216 DOI: 10.1210/endo.141.10.7707] [Cited by in Crossref: 49] [Cited by in F6Publishing: 63] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 228 |
Mieda M, Sakurai T. Overview of orexin/hypocretin system. Orexin/Hypocretin System. Elsevier; 2012. pp. 5-14. [DOI: 10.1016/b978-0-444-59489-1.00002-1] [Cited by in Crossref: 32] [Cited by in F6Publishing: 8] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 229 |
Bartsch T, Levy MJ, Knight YE, Goadsby PJ. Differential modulation of nociceptive dural input to [hypocretin] orexin A and B receptor activation in the posterior hypothalamic area. Pain 2004;109:367-78. [DOI: 10.1016/j.pain.2004.02.005] [Cited by in Crossref: 204] [Cited by in F6Publishing: 162] [Article Influence: 11.3] [Reference Citation Analysis]
|
| 230 |
Nixon JP, Smale L. A comparative analysis of the distribution of immunoreactive orexin A and B in the brains of nocturnal and diurnal rodents. Behav Brain Funct 2007;3:28. [PMID: 17567902 DOI: 10.1186/1744-9081-3-28] [Cited by in Crossref: 88] [Cited by in F6Publishing: 86] [Article Influence: 5.9] [Reference Citation Analysis]
|
| 231 |
Van Den Pol AN, Patrylo PR, Ghosh PK, Gao X. Lateral hypothalamus: Early developmental expression and response to hypocretin (orexin). J Comp Neurol 2001;433:349-63. [DOI: 10.1002/cne.1144] [Cited by in Crossref: 65] [Cited by in F6Publishing: 65] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 232 |
He Y, Kudo M, Kudo T, Kushikata T, Li E, Hirota K. The Effects of Benzodiazepines on Orexinergic Systems in Rat Cerebrocortical Slices: . Anesthesia & Analgesia 2007;104:338-40. [DOI: 10.1213/01.ane.0000252413.62821.2e] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 233 |
Yamanaka A, Beuckmann CT, Willie JT, Hara J, Tsujino N, Mieda M, Tominaga M, Yagami Ki, Sugiyama F, Goto K, Yanagisawa M, Sakurai T. Hypothalamic orexin neurons regulate arousal according to energy balance in mice. Neuron 2003;38:701-13. [PMID: 12797956 DOI: 10.1016/s0896-6273(03)00331-3] [Cited by in Crossref: 595] [Cited by in F6Publishing: 310] [Article Influence: 31.3] [Reference Citation Analysis]
|
| 234 |
Simpson KA, Bloom SR. Appetite and Hedonism: Gut Hormones and the Brain. Endocrinology and Metabolism Clinics of North America 2010;39:729-43. [DOI: 10.1016/j.ecl.2010.08.001] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 235 |
Samuels ER, Szabadi E. Functional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function part I: principles of functional organisation. Curr Neuropharmacol 2008;6:235-53. [PMID: 19506723 DOI: 10.2174/157015908785777229] [Cited by in Crossref: 389] [Cited by in F6Publishing: 362] [Article Influence: 32.4] [Reference Citation Analysis]
|
| 236 |
Zhang T, Wang M, Pan L, Ding W, Wang J, Yang L, Liu M, Li W, Yan Z. Study of Gene Expression Profiles and Biological Mechanism of Cerebral Palsy Using a Monozygotic Twin Pair. Twin Res Hum Genet 2007;10:496-507. [DOI: 10.1375/twin.10.3.496] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 237 |
Takahashi K, Arihara Z, Suzuki T, Sone M, Kikuchi K, Sasano H, Murakami O, Totsune K. Expression of orexin-A and orexin receptors in the kidney and the presence of orexin-A-like immunoreactivity in human urine. Peptides 2006;27:871-7. [PMID: 16202475 DOI: 10.1016/j.peptides.2005.08.008] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 238 |
Fronczek R, Baumann CR, Lammers GJ, Bassetti CL, Overeem S. Hypocretin/orexin disturbances in neurological disorders. Sleep Medicine Reviews 2009;13:9-22. [DOI: 10.1016/j.smrv.2008.05.002] [Cited by in Crossref: 48] [Cited by in F6Publishing: 35] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 239 |
Hara J, Beuckmann CT, Nambu T, Willie JT, Chemelli RM, Sinton CM, Sugiyama F, Yagami K, Goto K, Yanagisawa M, Sakurai T. Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity. Neuron 2001;30:345-54. [PMID: 11394998 DOI: 10.1016/s0896-6273(01)00293-8] [Cited by in Crossref: 945] [Cited by in F6Publishing: 403] [Article Influence: 45.0] [Reference Citation Analysis]
|
| 240 |
Kiyashchenko LI, Mileykovskiy BY, Maidment N, Lam HA, Wu MF, John J, Peever J, Siegel JM. Release of hypocretin (orexin) during waking and sleep states. J Neurosci 2002;22:5282-6. [PMID: 12097478 DOI: 20026541] [Cited by in Crossref: 224] [Article Influence: 11.2] [Reference Citation Analysis]
|
| 241 |
Székely M, Pétervári E, Balaskó M, Hernádi I, Uzsoki B. Effects of orexins on energy balance and thermoregulation. Regul Pept 2002;104:47-53. [PMID: 11830276 DOI: 10.1016/s0167-0115(01)00348-2] [Cited by in Crossref: 46] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 242 |
Beuckmann CT, Sinton CM, Williams SC, Richardson JA, Hammer RE, Sakurai T, Yanagisawa M. Expression of a poly-glutamine-ataxin-3 transgene in orexin neurons induces narcolepsy-cataplexy in the rat. J Neurosci 2004;24:4469-77. [PMID: 15128861 DOI: 10.1523/JNEUROSCI.5560-03.2004] [Cited by in Crossref: 127] [Cited by in F6Publishing: 57] [Article Influence: 7.1] [Reference Citation Analysis]
|
| 243 |
Puskás N, Papp RS, Gallatz K, Palkovits M. Interactions between orexin-immunoreactive fibers and adrenaline or noradrenaline-expressing neurons of the lower brainstem in rats and mice. Peptides 2010;31:1589-97. [PMID: 20434498 DOI: 10.1016/j.peptides.2010.04.020] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 244 |
Vasquez JH, Borniger JC. Neuroendocrine and Behavioral Consequences of Hyperglycemia in Cancer. Endocrinology 2020;161:bqaa047. [PMID: 32193527 DOI: 10.1210/endocr/bqaa047] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 245 |
van der Ark PD, Golor G, van Nueten L, Nandy P, de Boer P. Multiple daytime administration of the selective orexin-2 receptor antagonist JNJ-42847922 induces somnolence in healthy subjects without residual central effects. J Psychopharmacol 2018;32:1330-40. [DOI: 10.1177/0269881118791521] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 246 |
España RA, Melchior JR, Roberts DC, Jones SR. Hypocretin 1/orexin A in the ventral tegmental area enhances dopamine responses to cocaine and promotes cocaine self-administration. Psychopharmacology (Berl) 2011;214:415-26. [PMID: 20959967 DOI: 10.1007/s00213-010-2048-8] [Cited by in Crossref: 109] [Cited by in F6Publishing: 109] [Article Influence: 9.1] [Reference Citation Analysis]
|
| 247 |
Li S, Franken P, Vassalli A. Bidirectional and context-dependent changes in theta and gamma oscillatory brain activity in noradrenergic cell-specific Hypocretin/Orexin receptor 1-KO mice. Sci Rep 2018;8:15474. [PMID: 30341359 DOI: 10.1038/s41598-018-33069-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 248 |
Yamuy J, Fung SJ, Xi M, Chase MH. Hypocretinergic control of spinal cord motoneurons. J Neurosci 2004;24:5336-45. [PMID: 15190106 DOI: 10.1523/JNEUROSCI.4812-03.2004] [Cited by in Crossref: 58] [Cited by in F6Publishing: 34] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 249 |
Nevárez N, de Lecea L. Hypocretin and the Regulation of Sleep-Wake Transitions. Handbook of Sleep Research. Elsevier; 2019. pp. 89-99. [DOI: 10.1016/b978-0-12-813743-7.00006-2] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 250 |
Wafford KA, Ebert B. Emerging anti-insomnia drugs: tackling sleeplessness and the quality of wake time. Nat Rev Drug Discov 2008;7:530-40. [PMID: 18511929 DOI: 10.1038/nrd2464] [Cited by in Crossref: 71] [Cited by in F6Publishing: 58] [Article Influence: 5.1] [Reference Citation Analysis]
|
| 251 |
Chudasama Y, Robbins TW. Psychopharmacological approaches to modulating attention in the five-choice serial reaction time task: implications for schizophrenia. Psychopharmacology (Berl) 2004;174:86-98. [PMID: 15071717 DOI: 10.1007/s00213-004-1805-y] [Cited by in Crossref: 90] [Cited by in F6Publishing: 95] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 252 |
Katayama S, Shigemi K, Cline MA, Furuse M. Intracerebroventricular injection of orexin-A stimulates monoamine metabolism but not HPA axis in neonatal chicks. Neuroscience Letters 2010;484:157-61. [DOI: 10.1016/j.neulet.2010.08.043] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 253 |
Simmons SJ, Gentile TA. Cocaine abuse and midbrain circuits: Functional anatomy of hypocretin/orexin transmission and therapeutic prospect. Brain Res 2020;1731:146164. [PMID: 30796894 DOI: 10.1016/j.brainres.2019.02.026] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 254 |
Tsujino N, Sakurai T. Role of orexin in modulating arousal, feeding, and motivation. Front Behav Neurosci 2013;7:28. [PMID: 23616752 DOI: 10.3389/fnbeh.2013.00028] [Cited by in Crossref: 135] [Cited by in F6Publishing: 136] [Article Influence: 15.0] [Reference Citation Analysis]
|
| 255 |
Liu X, Zeng J, Zhou A, Theodorsson E, Fahrenkrug J, Reinscheid RK. Molecular fingerprint of neuropeptide S-producing neurons in the mouse brain. J Comp Neurol 2011;519:1847-66. [PMID: 21452230 DOI: 10.1002/cne.22603] [Cited by in Crossref: 47] [Cited by in F6Publishing: 45] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 256 |
Azeez IA, Del Gallo F, Cristino L, Bentivoglio M. Daily Fluctuation of Orexin Neuron Activity and Wiring: The Challenge of "Chronoconnectivity". Front Pharmacol 2018;9:1061. [PMID: 30319410 DOI: 10.3389/fphar.2018.01061] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 257 |
Pekala D, Blasiak T, Raastad M, Lewandowski MH. The influence of orexins on the firing rate and pattern of rat intergeniculate leaflet neurons - electrophysiological and immunohistological studies: Influence of orexins on intergeniculate leaflet. European Journal of Neuroscience 2011;34:1406-18. [DOI: 10.1111/j.1460-9568.2011.07868.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 258 |
Xu YL, Reinscheid RK, Huitron-Resendiz S, Clark SD, Wang Z, Lin SH, Brucher FA, Zeng J, Ly NK, Henriksen SJ. Neuropeptide S: a neuropeptide promoting arousal and anxiolytic-like effects. Neuron. 2004;43:487-497. [PMID: 15312648 DOI: 10.1016/j.neuron.2004.08.005] [Cited by in Crossref: 365] [Cited by in F6Publishing: 364] [Article Influence: 20.3] [Reference Citation Analysis]
|
| 259 |
Liguori C, Mercuri NB, Nuccetelli M, Izzi F, Cordella A, Bernardini S, Placidi F. Obstructive sleep apnea may induce orexinergic system and cerebral β-amyloid metabolism dysregulation: is it a further proof for Alzheimer's disease risk? Sleep Medicine 2019;56:171-6. [DOI: 10.1016/j.sleep.2019.01.003] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 8.3] [Reference Citation Analysis]
|
| 260 |
Takahashi K, Koyama Y, Kayama Y, Yamamoto M. Effects of orexin on the laterodorsal tegmental neurones. Psychiatry Clin Neurosci 2002;56:335-6. [DOI: 10.1046/j.1440-1819.2002.00967.x] [Cited by in Crossref: 53] [Cited by in F6Publishing: 46] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 261 |
Estabrooke IV, McCarthy MT, Ko E, Chou TC, Chemelli RM, Yanagisawa M, Saper CB, Scammell TE. Fos expression in orexin neurons varies with behavioral state. J Neurosci 2001;21:1656-62. [PMID: 11222656 [PMID: 11222656 DOI: 10.1523/jneurosci.21-05-01656.2001] [Cited by in Crossref: 455] [Article Influence: 21.7] [Reference Citation Analysis]
|
| 262 |
Rodgers RJ, Wright FL, Snow NF, Taylor LJ. Orexin-1 receptor antagonism fails to reduce anxiety-like behaviour in either plus-maze-naïve or plus-maze-experienced mice. Behav Brain Res 2013;243:213-9. [PMID: 23333844 DOI: 10.1016/j.bbr.2012.12.064] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 263 |
Jackson KL, Dampney BW, Moretti JL, Stevenson ER, Davern PJ, Carrive P, Head GA. Contribution of Orexin to the Neurogenic Hypertension in BPH/2J Mice. Hypertension 2016;67:959-69. [PMID: 26975709 DOI: 10.1161/HYPERTENSIONAHA.115.07053] [Cited by in Crossref: 28] [Cited by in F6Publishing: 10] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 264 |
Davoudi M, Vijeepallam K, Azizi H, Mirnajafi-Zadeh J, Semnanian S. PKC inhibitor reversed the suppressive effect of orexin-A on IPSCs of locus coeruleus neurons in naloxone-induced morphine withdrawal. J Neural Transm (Vienna) 2019;126:1425-35. [PMID: 31493096 DOI: 10.1007/s00702-019-02064-2] [Reference Citation Analysis]
|
| 265 |
Sasson R, Dearth RK, White RS, Chappell PE, Mellon PL. Orexin A induces GnRH gene expression and secretion from GT1-7 hypothalamic GnRH neurons. Neuroendocrinology 2006;84:353-63. [PMID: 17192702 DOI: 10.1159/000098333] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 266 |
Mesaros A, Koralov SB, Rother E, Wunderlich FT, Ernst MB, Barsh GS, Rajewsky K, Brüning JC. Activation of Stat3 signaling in AgRP neurons promotes locomotor activity. Cell Metab 2008;7:236-48. [PMID: 18316029 DOI: 10.1016/j.cmet.2008.01.007] [Cited by in Crossref: 86] [Cited by in F6Publishing: 86] [Article Influence: 6.1] [Reference Citation Analysis]
|
| 267 |
Ikeno T, Yan L. A comparison of the orexin receptor distribution in the brain between diurnal Nile grass rats (Arvicanthis niloticus) and nocturnal mice (Mus musculus). Brain Res 2018;1690:89-95. [PMID: 29630859 DOI: 10.1016/j.brainres.2018.04.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 268 |
Sutcliffe JG, de Lecea L. The hypocretins: excitatory neuromodulatory peptides for multiple homeostatic systems, including sleep and feeding. J Neurosci Res 2000;62:161-8. [PMID: 11020209 DOI: 10.1002/1097-4547(20001015)62:2<161::AID-JNR1>3.0.CO;2-1] [Cited by in Crossref: 149] [Cited by in F6Publishing: 42] [Article Influence: 6.8] [Reference Citation Analysis]
|
| 269 |
Mondal MS, Nakazato M, Matsukura S. Orexins (hypocretins): novel hypothalamic peptides with divergent functions. Biochem Cell Biol 2000;78:299-305. [DOI: 10.1139/o00-022] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 270 |
Liu M, Min T, Zhang H, Liu Y, Wang Z. Pharmacological Characteristics of Porcine Orexin 2 Receptor and Mutants. Front Endocrinol (Lausanne) 2020;11:132. [PMID: 32296386 DOI: 10.3389/fendo.2020.00132] [Reference Citation Analysis]
|
| 271 |
Shaw JK, Ferris MJ, Locke JL, Brodnik ZD, Jones SR, España RA. Hypocretin/orexin knock-out mice display disrupted behavioral and dopamine responses to cocaine. Addict Biol 2017;22:1695-705. [PMID: 27480648 DOI: 10.1111/adb.12432] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 272 |
Ohkubo T, Boswell T, Lumineau S. Molecular cloning of chicken prepro-orexin cDNA and preferential expression in the chicken hypothalamus. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression 2002;1577:476-80. [DOI: 10.1016/s0167-4781(02)00483-9] [Cited by in Crossref: 46] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 273 |
Bayer L, Eggermann E, Saint-Mleux B, Machard D, Jones BE, Mühlethaler M, Serafin M. Selective action of orexin (hypocretin) on nonspecific thalamocortical projection neurons. J Neurosci 2002;22:7835-9. [PMID: 12223534 [PMID: 12223534 DOI: 10.1523/jneurosci.22-18-07835.2002] [Cited by in Crossref: 107] [Article Influence: 5.4] [Reference Citation Analysis]
|
| 274 |
Torrealba F, Yanagisawa M, Saper CB. Colocalization of orexin a and glutamate immunoreactivity in axon terminals in the tuberomammillary nucleus in rats. Neuroscience 2003;119:1033-44. [PMID: 12831862 DOI: 10.1016/s0306-4522(03)00238-0] [Cited by in Crossref: 134] [Cited by in F6Publishing: 70] [Article Influence: 7.1] [Reference Citation Analysis]
|
| 275 |
Leibowitz SF, Wortley KE. Hypothalamic control of energy balance: different peptides, different functions. Peptides 2004;25:473-504. [PMID: 15134868 DOI: 10.1016/j.peptides.2004.02.006] [Cited by in Crossref: 162] [Cited by in F6Publishing: 155] [Article Influence: 9.5] [Reference Citation Analysis]
|
| 276 |
Watson CJ, Baghdoyan HA, Lydic R. Neuropharmacology of Sleep and Wakefulness: 2012 Update. Sleep Med Clin 2012;7:469-86. [PMID: 23162386 DOI: 10.1016/j.jsmc.2012.06.010] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 277 |
Blasiak A, Gundlach AL, Hess G, Lewandowski MH. Interactions of Circadian Rhythmicity, Stress and Orexigenic Neuropeptide Systems: Implications for Food Intake Control. Front Neurosci 2017;11:127. [PMID: 28373831 DOI: 10.3389/fnins.2017.00127] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 278 |
Nishino S. The hypothalamic peptidergic system, hypocretin/orexin and vigilance control. Neuropeptides 2007;41:117-33. [DOI: 10.1016/j.npep.2007.01.003] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 279 |
Mahoney CE, Brewer JM, Bittman EL. Central control of circadian phase in arousal-promoting neurons. PLoS One 2013;8:e67173. [PMID: 23826226 DOI: 10.1371/journal.pone.0067173] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 280 |
Bocian R, Kazmierska P, Kłos-Wojtczak P, Kowalczyk T, Konopacki J. Orexinergic theta rhythm in the rat hippocampal formation: In vitro and in vivo findings. Hippocampus 2015;25:1393-406. [PMID: 25820995 DOI: 10.1002/hipo.22459] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 281 |
Watson CJ, Baghdoyan HA, Lydic R. Neuropharmacology of Sleep and Wakefulness. Sleep Med Clin 2010;5:513-28. [PMID: 21278831 DOI: 10.1016/j.jsmc.2010.08.003] [Cited by in Crossref: 47] [Cited by in F6Publishing: 34] [Article Influence: 3.9] [Reference Citation Analysis]
|
| 282 |
Eriksson KS, Sergeeva OA, Haas HL, Selbach O. Orexins/hypocretins and aminergic systems. Acta Physiol (Oxf) 2010;198:263-75. [PMID: 19566795 DOI: 10.1111/j.1748-1716.2009.02015.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 283 |
Fujimoto T, Rikimaru K, Fukuda K, Sugimoto H, Masuda K, Ohyabu N, Banno Y, Tokunaga N, Kawamoto T, Tomata Y, Kumagai Y, Iida M, Nagano Y, Yoneyama-hirozane M, Shimizu Y, Sasa K, Ishikawa T, Yukitake H, Ito M, Aoyama K, Matsumoto T. Discovery of TAK-925 as a Potent, Selective, and Brain-Penetrant Orexin 2 Receptor Agonist. ACS Med Chem Lett . [DOI: 10.1021/acsmedchemlett.1c00626] [Reference Citation Analysis]
|
| 284 |
Aston-jones G. Locus Coeruleus, A5 and A7 Noradrenergic Cell Groups. The Rat Nervous System. Elsevier; 2004. pp. 259-94. [DOI: 10.1016/b978-012547638-6/50012-2] [Cited by in Crossref: 40] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 285 |
Franceschini C, Pizza F, Antelmi E, Folli MC, Plazzi G. Narcolepsy treatment: pharmacological and behavioral strategies in adults and children. Sleep Breath 2020;24:615-27. [PMID: 31290083 DOI: 10.1007/s11325-019-01894-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 286 |
Muraki Y, Yamanaka A, Tsujino N, Kilduff TS, Goto K, Sakurai T. Serotonergic regulation of the orexin/hypocretin neurons through the 5-HT1A receptor. J Neurosci 2004;24:7159-66. [PMID: 15306649 DOI: 10.1523/JNEUROSCI.1027-04.2004] [Cited by in Crossref: 127] [Cited by in F6Publishing: 61] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 287 |
Shiba T, Ozu M, Yoshida Y, Mignot E, Nishino S. Hypocretin stimulates [(35)S]GTP gamma S binding in Hcrtr 2-transfected cell lines and in brain homogenate. Biochem Biophys Res Commun 2002;294:615-20. [PMID: 12056812 DOI: 10.1016/S0006-291X(02)00521-1] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 288 |
Brisbare-roch C, Dingemanse J, Koberstein R, Hoever P, Aissaoui H, Flores S, Mueller C, Nayler O, van Gerven J, de Haas SL, Hess P, Qiu C, Buchmann S, Scherz M, Weller T, Fischli W, Clozel M, Jenck F. Promotion of sleep by targeting the orexin system in rats, dogs and humans. Nat Med 2007;13:150-5. [DOI: 10.1038/nm1544] [Cited by in Crossref: 396] [Cited by in F6Publishing: 371] [Article Influence: 26.4] [Reference Citation Analysis]
|
| 289 |
De La Herrán-Arita AK, Zomosa-Signoret VC, Millán-Aldaco DA, Palomero-Rivero M, Guerra-Crespo M, Drucker-Colín R, Vidaltamayo R. Aspects of the narcolepsy-cataplexy syndrome in O/E3-null mutant mice. Neuroscience 2011;183:134-43. [PMID: 21435382 DOI: 10.1016/j.neuroscience.2011.03.029] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 290 |
Zhang JH, Sampogna S, Morales FR, Chase MH. Age-related changes in hypocretin (orexin) immunoreactivity in the cat brainstem. Brain Res 2002;930:206-11. [PMID: 11879811 DOI: 10.1016/s0006-8993(02)02240-0] [Cited by in Crossref: 34] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 291 |
Karasawa H, Yakabi S, Wang L, Taché Y. Orexin-1 receptor mediates the increased food and water intake induced by intracerebroventricular injection of the stable somatostatin pan-agonist, ODT8-SST in rats. Neurosci Lett 2014;576:88-92. [PMID: 24915296 DOI: 10.1016/j.neulet.2014.05.063] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 292 |
Gravett N, Bhagwandin A, Fuxe K, Manger PR. Distribution of orexin-A immunoreactive neurons and their terminal networks in the brain of the rock hyrax, Procavia capensis. J Chem Neuroanat 2011;41:86-96. [PMID: 21126575 DOI: 10.1016/j.jchemneu.2010.11.005] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 293 |
Overeem S, Kok SW, Lammers GJ, Vein AA, Frölich M, Meinders AE, Roelfsema F, Pijl H. Somatotropic axis in hypocretin-deficient narcoleptic humans: altered circadian distribution of GH-secretory events. Am J Physiol Endocrinol Metab 2003;284:E641-7. [PMID: 12453828 DOI: 10.1152/ajpendo.00421.2002] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 294 |
Nishino S, Mignot E. Wake-Promoting Medications: Basic Mechanisms and Pharmacology. Principles and Practice of Sleep Medicine. Elsevier; 2005. pp. 468-83. [DOI: 10.1016/b0-72-160797-7/50045-8] [Cited by in Crossref: 7] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 295 |
Hirota K, Kushikata T, Kudo M, Kudo T, Lambert DG, Matsuki A. Orexin A and B evoke noradrenaline release from rat cerebrocortical slices. Br J Pharmacol 2001;134:1461-6. [PMID: 11724752 DOI: 10.1038/sj.bjp.0704409] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 296 |
Sakurai T, Yanagisawa M, Mieda M. Rodent Models of Human Narcolepsy-cataplexy. In: de Lecea L, Sutcliffe JG, editors. Hypocretins. Boston: Springer US; 2005. pp. 27-38. [DOI: 10.1007/0-387-25446-3_3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 297 |
Martin G, Fabre V, Siggins GR, de Lecea L. Interaction of the hypocretins with neurotransmitters in the nucleus accumbens. Regul Pept 2002;104:111-7. [PMID: 11830285 DOI: 10.1016/s0167-0115(01)00354-8] [Cited by in Crossref: 63] [Cited by in F6Publishing: 22] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 298 |
Beuckmann CT, Ueno T, Nakagawa M, Suzuki M, Akasofu S. Preclinical in vivo characterization of lemborexant (E2006), a novel dual orexin receptor antagonist for sleep/wake regulation. Sleep 2019;42:zsz076. [PMID: 30923834 DOI: 10.1093/sleep/zsz076] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 299 |
Cannella N, Kallupi M, Ruggeri B, Ciccocioppo R, Ubaldi M. The role of the neuropeptide S system in addiction: focus on its interaction with the CRF and hypocretin/orexin neurotransmission. Prog Neurobiol 2013;100:48-59. [PMID: 23041581 DOI: 10.1016/j.pneurobio.2012.09.005] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 300 |
Takahashi K, Wang QP, Guan JL, Kayama Y, Shioda S, Koyama Y. State-dependent effects of orexins on the serotonergic dorsal raphe neurons in the rat. Regul Pept 2005;126:43-7. [PMID: 15620412 DOI: 10.1016/j.regpep.2004.08.009] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 301 |
Kirchgessner AL. Orexins in the brain-gut axis. Endocr Rev. 2002;23:1-15. [PMID: 11844742 DOI: 10.1210/edrv.23.1.0454] [Cited by in Crossref: 70] [Cited by in F6Publishing: 63] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 302 |
Mehta R, Singh A, Mallick BN. Disciplined sleep for healthy living: Role of noradrenaline. World J Neurol 2017; 7(1): 6-23 [DOI: 10.5316/wjn.v7.i1.6] [Cited by in CrossRef: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 303 |
Surendran S, Campbell GA, Tyring SK, Matalon K, McDonald JD, Matalon R. High levels of orexin A in the brain of the mouse model for phenylketonuria: possible role of orexin A in hyperactivity seen in children with PKU. Neurochem Res 2003;28:1891-4. [PMID: 14649732 DOI: 10.1023/a:1026184127689] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 304 |
Karnani MM, Schöne C, Bracey EF, González JA, Viskaitis P, Li HT, Adamantidis A, Burdakov D. Role of spontaneous and sensory orexin network dynamics in rapid locomotion initiation. Prog Neurobiol 2020;187:101771. [PMID: 32058043 DOI: 10.1016/j.pneurobio.2020.101771] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 305 |
Ito M. Functional roles of neuropeptides in cerebellar circuits. Neuroscience 2009;162:666-72. [PMID: 19361475 DOI: 10.1016/j.neuroscience.2009.01.019] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 306 |
Papuć E, Stelmasiak Z, Grieb P, Paweł G, Rejdak K. CSF hypocretin-1 concentrations correlate with the level of fatigue in multiple sclerosis patients. Neurosci Lett 2010;474:9-12. [PMID: 20193740 DOI: 10.1016/j.neulet.2010.02.062] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 307 |
Nishino S, Ripley B, Overeem S, Nevsimalova S, Lammers GJ, Vankova J, Okun M, Rogers W, Brooks S, Mignot E. Low cerebrospinal fluid hypocretin (Orexin) and altered energy homeostasis in human narcolepsy. Ann Neurol 2001;50:381-8. [PMID: 11558795 DOI: 10.1002/ana.1130] [Cited by in Crossref: 308] [Cited by in F6Publishing: 261] [Article Influence: 14.7] [Reference Citation Analysis]
|
| 308 |
Kotz C, Nixon J, Butterick T, Perez-Leighton C, Teske J, Billington C. Brain orexin promotes obesity resistance. Ann N Y Acad Sci 2012;1264:72-86. [PMID: 22803681 DOI: 10.1111/j.1749-6632.2012.06585.x] [Cited by in Crossref: 58] [Cited by in F6Publishing: 49] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 309 |
Zhu L, Onaka T, Sakurai T, Yada T. Activation of orexin neurones after noxious but not conditioned fear stimuli in rats. Neuroreport 2002;13:1351-3. [PMID: 12151801 DOI: 10.1097/00001756-200207190-00027] [Cited by in Crossref: 49] [Cited by in F6Publishing: 42] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 310 |
Mohammed M, Ootsuka Y, Yanagisawa M, Blessing W. Reduced brown adipose tissue thermogenesis during environmental interactions in transgenic rats with ataxin-3-mediated ablation of hypothalamic orexin neurons. Am J Physiol Regul Integr Comp Physiol 2014;307:R978-89. [PMID: 25324552 DOI: 10.1152/ajpregu.00260.2014] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 311 |
Chen X, Chen L, Du Y. Orexin-A increases the firing activity of hippocampal CA1 neurons through orexin-1 receptors: Orexin-A in Hippocampal CA1 Neurons. Journal of Neuroscience Research 2017;95:1415-26. [DOI: 10.1002/jnr.23975] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 312 |
Weinhold SL, Göder R, Baier PC. Pathway and Effect of Intranasal Orexin. In: Sakurai T, Pandi-perumal S, Monti JM, editors. Orexin and Sleep. Cham: Springer International Publishing; 2015. pp. 339-51. [DOI: 10.1007/978-3-319-23078-8_18] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 313 |
Xu R, Wang Q, Yan M, Hernandez M, Gong C, Boon WC, Murata Y, Ueta Y, Chen C. Orexin-A augments voltage-gated Ca2+ currents and synergistically increases growth hormone (GH) secretion with GH-releasing hormone in primary cultured ovine somatotropes. Endocrinology 2002;143:4609-19. [PMID: 12446588 DOI: 10.1210/en.2002-220506] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 314 |
Bernard R, Lydic R, Baghdoyan HA. Hypocretin-1 activates G proteins in arousal-related brainstem nuclei of rat. Neuroreport 2002;13:447-50. [PMID: 11930158 DOI: 10.1097/00001756-200203250-00017] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 315 |
Huang H, Ghosh P, van den Pol AN. Prefrontal cortex-projecting glutamatergic thalamic paraventricular nucleus-excited by hypocretin: a feedforward circuit that may enhance cognitive arousal. J Neurophysiol 2006;95:1656-68. [PMID: 16492946 DOI: 10.1152/jn.00927.2005] [Cited by in Crossref: 109] [Cited by in F6Publishing: 99] [Article Influence: 6.8] [Reference Citation Analysis]
|
| 316 |
Li Y, van den Pol AN. Direct and indirect inhibition by catecholamines of hypocretin/orexin neurons. J Neurosci 2005;25:173-83. [PMID: 15634779 DOI: 10.1523/JNEUROSCI.4015-04.2005] [Cited by in Crossref: 76] [Cited by in F6Publishing: 41] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 317 |
Heinonen MV, Purhonen AK, Mäkelä KA, Herzig KH. Functions of orexins in peripheral tissues. Acta Physiol (Oxf) 2008;192:471-85. [PMID: 18294339 DOI: 10.1111/j.1748-1716.2008.01836.x] [Cited by in Crossref: 125] [Cited by in F6Publishing: 115] [Article Influence: 8.9] [Reference Citation Analysis]
|
| 318 |
Ambati A, Luo G, Pradhan E, Louis J, Lin L, Leib RD, Ollila HM, Poiret T, Adams C, Mignot E. Mass Spectrometric Characterization of Narcolepsy-Associated Pandemic 2009 Influenza Vaccines. Vaccines (Basel) 2020;8:E630. [PMID: 33142956 DOI: 10.3390/vaccines8040630] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 319 |
Valatx JL. Disorders of consciousness: anatomical and physiological mechanisms. Adv Tech Stand Neurosurg 2004;29:3-22. [PMID: 15035335 DOI: 10.1007/978-3-7091-0558-0_1] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 320 |
van den Pol AN, Ghosh PK, Liu RJ, Li Y, Aghajanian GK, Gao XB. Hypocretin (orexin) enhances neuron activity and cell synchrony in developing mouse GFP-expressing locus coeruleus. J Physiol 2002;541:169-85. [PMID: 12015428 DOI: 10.1113/jphysiol.2002.017426] [Cited by in Crossref: 117] [Cited by in F6Publishing: 109] [Article Influence: 5.9] [Reference Citation Analysis]
|
| 321 |
Barb CR, Matteri RL. Orexin-B modulates luteinizing hormone and growth hormone secretion from porcine pituitary cells in culture. Domest Anim Endocrinol 2005;28:331-7. [PMID: 15760673 DOI: 10.1016/j.domaniend.2004.09.005] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 322 |
Suzuki H, Hashimoto H, Kawasaki M, Watanabe M, Otsubo H, Ishikura T, Fujihara H, Ohnishi H, Onuma E, Yamada-Okabe H, Takuwa Y, Ogata E, Nakamura T, Ueta Y. Similar changes of hypothalamic feeding-regulating peptides mRNAs and plasma leptin levels in PTHrP-, LIF-secreting tumors-induced cachectic rats and adjuvant arthritic rats. Int J Cancer 2011;128:2215-23. [PMID: 20602340 DOI: 10.1002/ijc.25535] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 323 |
Yamanaka A, Tsujino N, Funahashi H, Honda K, Guan JL, Wang QP, Tominaga M, Goto K, Shioda S, Sakurai T. Orexins activate histaminergic neurons via the orexin 2 receptor. Biochem Biophys Res Commun 2002;290:1237-45. [PMID: 11811995 DOI: 10.1006/bbrc.2001.6318] [Cited by in Crossref: 201] [Cited by in F6Publishing: 188] [Article Influence: 10.1] [Reference Citation Analysis]
|
| 324 |
Bian H, Huang L, Li B, Hu Q, Liang X, Tang J, Zhang JH. The arousal effect of hyperbaric oxygen through orexin/hypocretin an upregulation on ketamine/ethanol-induced unconsciousness in male rats. J Neurosci Res 2020;98:201-11. [PMID: 30895638 DOI: 10.1002/jnr.24414] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 325 |
Sakurai T. Roles of orexin/hypocretin in regulation of sleep/wakefulness and energy homeostasis. Sleep Med Rev 2005;9:231-41. [PMID: 15961331 DOI: 10.1016/j.smrv.2004.07.007] [Cited by in Crossref: 196] [Cited by in F6Publishing: 172] [Article Influence: 11.5] [Reference Citation Analysis]
|
| 326 |
Stoyanova II. Ghrelin: a link between ageing, metabolism and neurodegenerative disorders. Neurobiol Dis 2014;72 Pt A:72-83. [PMID: 25173805 DOI: 10.1016/j.nbd.2014.08.026] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 327 |
Rodgers R, Ishii Y, Halford J, Blundell J. Orexins and appetite regulation. Neuropeptides 2002;36:303-25. [DOI: 10.1016/s0143-4179(02)00085-9] [Cited by in Crossref: 118] [Cited by in F6Publishing: 27] [Article Influence: 5.9] [Reference Citation Analysis]
|
| 328 |
Girault EM, Foppen E, Ackermans MT, Fliers E, Kalsbeek A. Central administration of an orexin receptor 1 antagonist prevents the stimulatory effect of Olanzapine on endogenous glucose production. Brain Research 2013;1527:238-45. [DOI: 10.1016/j.brainres.2013.06.034] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 329 |
Obukuro K, Nobunaga M, Takigawa M, Morioka H, Hisatsune A, Isohama Y, Shimokawa H, Tsutsui M, Katsuki H. Nitric oxide mediates selective degeneration of hypothalamic orexin neurons through dysfunction of protein disulfide isomerase. J Neurosci 2013;33:12557-68. [PMID: 23904594 DOI: 10.1523/JNEUROSCI.0595-13.2013] [Cited by in Crossref: 40] [Cited by in F6Publishing: 18] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 330 |
Ahmadi-Soleimani SM, Azizi H, Abbasi-Mazar A. Intermittent REM sleep deprivation attenuates the development of morphine tolerance and dependence in male rats. Neurosci Lett 2021;748:135735. [PMID: 33592307 DOI: 10.1016/j.neulet.2021.135735] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 331 |
Luppi P, Fort P. Neurochemistry of sleep. Sleep Disorders. Elsevier; 2011. pp. 173-90. [DOI: 10.1016/b978-0-444-52006-7.00011-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 332 |
Jerath R, Harden K, Crawford M, Barnes VA, Jensen M. Role of cardiorespiratory synchronization and sleep physiology: effects on membrane potential in the restorative functions of sleep. Sleep Medicine 2014;15:279-88. [DOI: 10.1016/j.sleep.2013.10.017] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 333 |
Abbott SM, Videnovic A. Chronic sleep disturbance and neural injury: links to neurodegenerative disease. Nat Sci Sleep 2016;8:55-61. [PMID: 26869817 DOI: 10.2147/NSS.S78947] [Cited by in Crossref: 12] [Cited by in F6Publishing: 24] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 334 |
Kukkonen JP, Holmqvist T, Ammoun S, Åkerman KEO. Functions of the orexinergic/hypocretinergic system. American Journal of Physiology-Cell Physiology 2002;283:C1567-91. [DOI: 10.1152/ajpcell.00055.2002] [Cited by in Crossref: 200] [Cited by in F6Publishing: 188] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 335 |
Teske JA, Levine AS, Kuskowski M, Levine JA, Kotz CM. Elevated hypothalamic orexin signaling, sensitivity to orexin A, and spontaneous physical activity in obesity-resistant rats. Am J Physiol Regul Integr Comp Physiol 2006;291:R889-99. [PMID: 16763079 DOI: 10.1152/ajpregu.00536.2005] [Cited by in Crossref: 79] [Cited by in F6Publishing: 80] [Article Influence: 4.9] [Reference Citation Analysis]
|
| 336 |
Peever JH, Lai YY, Siegel JM. Excitatory effects of hypocretin-1 (orexin-A) in the trigeminal motor nucleus are reversed by NMDA antagonism. J Neurophysiol 2003;89:2591-600. [PMID: 12611960 DOI: 10.1152/jn.00968.2002] [Cited by in Crossref: 60] [Cited by in F6Publishing: 71] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 337 |
Eggermann E, Bayer L, Serafin M, Saint-Mleux B, Bernheim L, Machard D, Jones BE, Mühlethaler M. The wake-promoting hypocretin-orexin neurons are in an intrinsic state of membrane depolarization. J Neurosci 2003;23:1557-62. [PMID: 12629156 [PMID: 12629156 DOI: 10.1523/jneurosci.23-05-01557.2003] [Cited by in Crossref: 113] [Article Influence: 5.9] [Reference Citation Analysis]
|
| 338 |
Boutrel B, Kenny PJ, Markou A, Koob GF. Hypocretin and Brain Reward Function. In: de Lecea L, Sutcliffe JG, editors. Hypocretins. Boston: Springer US; 2005. pp. 317-26. [DOI: 10.1007/0-387-25446-3_21] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 339 |
da Silva ES, dos Santos TV, Hoeller AA, dos Santos TS, Pereira GV, Meneghelli C, Penzlin AI, dos Santos MM, Faria MS, Paschoalini MA, Marino-neto J. Behavioral and metabolic effects of central injections of orexins/hypocretins in pigeons (Columba livia). Regulatory Peptides 2008;147:9-18. [DOI: 10.1016/j.regpep.2007.12.003] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 340 |
Irving E, Harrison D, Babbs A, Mayes A, Campbell C, Hunter A, Upton N, Parsons A. Increased cortical expression of the orexin-1 receptor following permanent middle cerebral artery occlusion in the rat. Neuroscience Letters 2002;324:53-6. [DOI: 10.1016/s0304-3940(02)00176-3] [Cited by in Crossref: 28] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 341 |
Samson WK, Taylor MM, Ferguson AV. Non-sleep effects of hypocretin/orexin. Sleep Med Rev 2005;9:243-52. [PMID: 16036174 DOI: 10.1016/j.smrv.2004.07.006] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 342 |
Kagerer SM, Jöhren O. Interactions of orexins/hypocretins with adrenocortical functions. Acta Physiol (Oxf) 2010;198:361-71. [PMID: 19719797 DOI: 10.1111/j.1748-1716.2009.02034.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 343 |
Karnani MM, Apergis-Schoute J, Adamantidis A, Jensen LT, de Lecea L, Fugger L, Burdakov D. Activation of central orexin/hypocretin neurons by dietary amino acids. Neuron 2011;72:616-29. [PMID: 22099463 DOI: 10.1016/j.neuron.2011.08.027] [Cited by in Crossref: 99] [Cited by in F6Publishing: 93] [Article Influence: 9.9] [Reference Citation Analysis]
|
| 344 |
Dehkordi O, Rose JE, Dávila-García MI, Millis RM, Mirzaei SA, Manaye KF, Jayam-Trouth A. Neuroanatomical Relationships between Orexin/Hypocretin-Containing Neurons/Nerve Fibers and Nicotine-Induced c-Fos-Activated Cells of the Reward-Addiction Neurocircuitry. J Alcohol Drug Depend 2017;5:273. [PMID: 29038792 DOI: 10.4172/2329-6488.1000273] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 345 |
Nishino S, Mignot E. Narcolepsy and cataplexy. Sleep Disorders. Elsevier; 2011. pp. 783-814. [DOI: 10.1016/b978-0-444-52007-4.00007-2] [Cited by in Crossref: 32] [Cited by in F6Publishing: 9] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 346 |
Kiwaki K, Kotz CM, Wang C, Lanningham-Foster L, Levine JA. Orexin A (hypocretin 1) injected into hypothalamic paraventricular nucleus and spontaneous physical activity in rats. Am J Physiol Endocrinol Metab 2004;286:E551-9. [PMID: 14656716 DOI: 10.1152/ajpendo.00126.2003] [Cited by in Crossref: 105] [Cited by in F6Publishing: 98] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 347 |
Teske JA, Perez-Leighton CE, Billington CJ, Kotz CM. Role of the locus coeruleus in enhanced orexin A-induced spontaneous physical activity in obesity-resistant rats. Am J Physiol Regul Integr Comp Physiol 2013;305:R1337-45. [PMID: 24089383 DOI: 10.1152/ajpregu.00229.2013] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 348 |
Meye FJ, Adan RA. Feelings about food: the ventral tegmental area in food reward and emotional eating. Trends Pharmacol Sci 2014;35:31-40. [PMID: 24332673 DOI: 10.1016/j.tips.2013.11.003] [Cited by in Crossref: 85] [Cited by in F6Publishing: 81] [Article Influence: 9.4] [Reference Citation Analysis]
|
| 349 |
Smith KL, Patterson M, Dhillo WS, Patel SR, Semjonous NM, Gardiner JV, Ghatei MA, Bloom SR. Neuropeptide S stimulates the hypothalamo-pituitary-adrenal axis and inhibits food intake. Endocrinology 2006;147:3510-8. [PMID: 16574794 DOI: 10.1210/en.2005-1280] [Cited by in Crossref: 138] [Cited by in F6Publishing: 141] [Article Influence: 8.6] [Reference Citation Analysis]
|
| 350 |
Narita M, Nagumo Y, Hashimoto S, Narita M, Khotib J, Miyatake M, Sakurai T, Yanagisawa M, Nakamachi T, Shioda S, Suzuki T. Direct involvement of orexinergic systems in the activation of the mesolimbic dopamine pathway and related behaviors induced by morphine. J Neurosci 2006;26:398-405. [PMID: 16407535 DOI: 10.1523/JNEUROSCI.2761-05.2006] [Cited by in Crossref: 357] [Cited by in F6Publishing: 172] [Article Influence: 22.3] [Reference Citation Analysis]
|
| 351 |
Taheri S, Sunter D, Dakin C, Moyes S, Seal L, Gardiner J, Rossi M, Ghatei M, Bloom S. Diurnal variation in orexin A immunoreactivity and prepro-orexin mRNA in the rat central nervous system. Neuroscience Letters 2000;279:109-12. [DOI: 10.1016/s0304-3940(99)00955-6] [Cited by in Crossref: 122] [Cited by in F6Publishing: 37] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 352 |
Huesa G, van den Pol AN, Finger TE. Differential distribution of hypocretin (orexin) and melanin-concentrating hormone in the goldfish brain. J Comp Neurol 2005;488:476-91. [PMID: 15973685 DOI: 10.1002/cne.20610] [Cited by in Crossref: 77] [Cited by in F6Publishing: 73] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 353 |
Rasmussen K, Hsu MA, Yang Y. The orexin-1 receptor antagonist SB-334867 blocks the effects of antipsychotics on the activity of A9 and A10 dopamine neurons: implications for antipsychotic therapy. Neuropsychopharmacology 2007;32:786-92. [PMID: 17063151 DOI: 10.1038/sj.npp.1301239] [Cited by in Crossref: 40] [Cited by in F6Publishing: 33] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 354 |
Xia J, Chen X, Song C, Ye J, Yu Z, Hu Z. Postsynaptic excitation of prefrontal cortical pyramidal neurons by hypocretin-1/orexin A through the inhibition of potassium currents. J Neurosci Res 2005;82:729-36. [PMID: 16247802 DOI: 10.1002/jnr.20667] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 355 |
Ahmadi-soleimani SM, Azizi H, Gompf HS, Semnanian S. Role of orexin type-1 receptors in paragiganto-coerulear modulation of opioid withdrawal and tolerance: A site specific focus. Neuropharmacology 2017;126:25-37. [DOI: 10.1016/j.neuropharm.2017.08.024] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 7.8] [Reference Citation Analysis]
|
| 356 |
Mieda M, Willie JT, Hara J, Sinton CM, Sakurai T, Yanagisawa M. Orexin peptides prevent cataplexy and improve wakefulness in an orexin neuron-ablated model of narcolepsy in mice. Proc Natl Acad Sci U S A 2004;101:4649-54. [PMID: 15070772 DOI: 10.1073/pnas.0400590101] [Cited by in Crossref: 217] [Cited by in F6Publishing: 193] [Article Influence: 12.1] [Reference Citation Analysis]
|
| 357 |
Schmeichel BE, Berridge CW. Amphetamine acts within the lateral hypothalamic area to elicit affectively neutral arousal and reinstate drug-seeking. Int J Neuropsychopharmacol 2014;17:63-75. [PMID: 23895988 DOI: 10.1017/S1461145713000734] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 358 |
Cluderay JE, Harrison DC, Hervieu GJ. Protein distribution of the orexin-2 receptor in the rat central nervous system. Regul Pept 2002;104:131-44. [PMID: 11830288 DOI: 10.1016/s0167-0115(01)00357-3] [Cited by in Crossref: 198] [Cited by in F6Publishing: 65] [Article Influence: 9.9] [Reference Citation Analysis]
|
| 359 |
Simpson KA, Martin NM, Bloom SR. Hypothalamic regulation of appetite. Expert Review of Endocrinology & Metabolism 2014;3:577-92. [DOI: 10.1586/17446651.3.5.577] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 360 |
Álvarez-Crespo M, Martínez-Sánchez N, Ruíz-Pino F, Garcia-Lavandeira M, Alvarez CV, Tena-Sempere M, Nogueiras R, Diéguez C, López M. The orexigenic effect of orexin-A revisited: dependence of an intact growth hormone axis. Endocrinology 2013;154:3589-98. [PMID: 23861376 DOI: 10.1210/en.2013-1251] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 361 |
Doane DF, Lawson MA, Meade JR, Kotz CM, Beverly JL. Orexin-induced feeding requires NMDA receptor activation in the perifornical region of the lateral hypothalamus. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 2007;293:R1022-6. [DOI: 10.1152/ajpregu.00282.2007] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 362 |
Ferguson AV, Samson WK. The orexin/hypocretin system: a critical regulator of neuroendocrine and autonomic function. Frontiers in Neuroendocrinology 2003;24:141-50. [DOI: 10.1016/s0091-3022(03)00028-1] [Cited by in Crossref: 133] [Cited by in F6Publishing: 38] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 363 |
España RA, Baldo BA, Kelley AE, Berridge CW. Wake-promoting and sleep-suppressing actions of hypocretin (orexin): basal forebrain sites of action. Neuroscience 2001;106:699-715. [PMID: 11682157 DOI: 10.1016/s0306-4522(01)00319-0] [Cited by in Crossref: 218] [Cited by in F6Publishing: 95] [Article Influence: 10.9] [Reference Citation Analysis]
|
| 364 |
Collier DA. News in Brief. Mol Psychiatry 2000;5:9-10. [DOI: 10.1038/sj.mp.4000715] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 365 |
Bateman JT, Saunders SE, Levitt ES. Understanding and countering opioid-induced respiratory depression. Br J Pharmacol 2021. [PMID: 34089181 DOI: 10.1111/bph.15580] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 366 |
Sakurai T. Reverse pharmacology of orexin: from an orphan GPCR to integrative physiology. Regulatory Peptides 2005;126:3-10. [DOI: 10.1016/j.regpep.2004.08.006] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 367 |
Kourosh-arami M, Javan M, Semnanian S. Inhibition of orexin receptor 1 contributes to the development of morphine dependence via attenuation of cAMP response element-binding protein and phospholipase Cβ3. Journal of Chemical Neuroanatomy 2020;108:101801. [DOI: 10.1016/j.jchemneu.2020.101801] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 368 |
Katayama S, Hamasu K, Shigemi K, Cline M, Furuse M. Intracerebroventricular injection of orexin-A, but not orexin-B, induces arousal of layer-type neonatal chicks. Comparative Biochemistry and Physiology Part A: Molecular & Integrative Physiology 2010;157:132-5. [DOI: 10.1016/j.cbpa.2010.05.018] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 369 |
Volgin DV, Lu JW, Stettner GM, Mann GL, Ross RJ, Morrison AR, Kubin L. Time- and behavioral state-dependent changes in posterior hypothalamic GABAA receptors contribute to the regulation of sleep. PLoS One 2014;9:e86545. [PMID: 24466145 DOI: 10.1371/journal.pone.0086545] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 370 |
Simmons SJ, Martorana R, Philogene-Khalid H, Tran FH, Gentile TA, Xu X, Su S, Rawls SM, Muschamp JW. Role of hypocretin/orexin receptor blockade on drug-taking and ultrasonic vocalizations (USVs) associated with low-effort self-administration of cathinone-derived 3,4-methylenedioxypyrovalerone (MDPV) in rats. Psychopharmacology (Berl) 2017;234:3207-15. [PMID: 28786030 DOI: 10.1007/s00213-017-4709-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 371 |
Sasaki K, Suzuki M, Mieda M, Tsujino N, Roth B, Sakurai T. Pharmacogenetic modulation of orexin neurons alters sleep/wakefulness states in mice. PLoS One 2011;6:e20360. [PMID: 21647372 DOI: 10.1371/journal.pone.0020360] [Cited by in Crossref: 152] [Cited by in F6Publishing: 157] [Article Influence: 13.8] [Reference Citation Analysis]
|
| 372 |
Imperatore R, Palomba L, Cristino L. Role of Orexin-A in Hypertension and Obesity. Curr Hypertens Rep 2017;19. [DOI: 10.1007/s11906-017-0729-y] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 373 |
Branch AF, Navidi W, Tabuchi S, Terao A, Yamanaka A, Scammell TE, Diniz Behn C. Progressive Loss of the Orexin Neurons Reveals Dual Effects on Wakefulness. Sleep 2016;39:369-77. [PMID: 26446125 DOI: 10.5665/sleep.5446] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 374 |
de Lecea L. Optogenetic control of hypocretin (orexin) neurons and arousal circuits. Curr Top Behav Neurosci 2015;25:367-78. [PMID: 25502546 DOI: 10.1007/7854_2014_364] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 375 |
Asakawa A, Inui A, Inui T, Katsuura G, Fujino MA, Kasuga M. Orexin reverses cholecystokinin-induced reduction in feeding. Diabetes Obes Metab. 2002;4:399-401. [PMID: 12406038 DOI: 10.1046/j.1463-1326.2002.00234.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 376 |
Gompf H, Chen J, Sun Y, Yanagisawa M, Aston-Jones G, Kelz MB. Halothane-induced hypnosis is not accompanied by inactivation of orexinergic output in rodents. Anesthesiology 2009;111:1001-9. [PMID: 19809293 DOI: 10.1097/ALN.0b013e3181b764b3] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 377 |
Kawashima M, Tamiya G, Oka A, Hohjoh H, Juji T, Ebisawa T, Honda Y, Inoko H, Tokunaga K. Genomewide association analysis of human narcolepsy and a new resistance gene. Am J Hum Genet 2006;79:252-63. [PMID: 16826516 DOI: 10.1086/505539] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 378 |
López JM, Sanz-Morello B, González A. Organization of the orexin/hypocretin system in the brain of two basal actinopterygian fishes, the cladistians Polypterus senegalus and Erpetoichthys calabaricus. Peptides 2014;61:23-37. [PMID: 25169954 DOI: 10.1016/j.peptides.2014.08.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 379 |
Xia J, Chen X, Cheng S, Hu Z. Mechanisms of orexin A-evoked changes of intracellular calcium in primary cultured cortical neurons: . NeuroReport 2005;16:783-6. [DOI: 10.1097/00001756-200505120-00025] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 380 |
Cutler DJ, Morris R, Evans ML, Leslie RA, Arch JR, Williams G. Orexin-A immunoreactive neurons in the rat hypothalamus do not contain neuronal nitric oxide synthase (nNOS). Peptides 2001;22:123-8. [DOI: 10.1016/s0196-9781(00)00364-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 1] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 381 |
Weinhold SL, Seeck-Hirschner M, Nowak A, Hallschmid M, Göder R, Baier PC. The effect of intranasal orexin-A (hypocretin-1) on sleep, wakefulness and attention in narcolepsy with cataplexy. Behav Brain Res 2014;262:8-13. [PMID: 24406723 DOI: 10.1016/j.bbr.2013.12.045] [Cited by in Crossref: 60] [Cited by in F6Publishing: 61] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 382 |
Alam MN, Gong H, Alam T, Jaganath R, McGinty D, Szymusiak R. Sleep-waking discharge patterns of neurons recorded in the rat perifornical lateral hypothalamic area. J Physiol. 2002;538:619-631. [PMID: 11790824 DOI: 10.1113/jphysiol.2001.012888] [Cited by in Crossref: 129] [Cited by in F6Publishing: 119] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 383 |
Li Y, Gao X, Sakurai T, van den Pol AN. Hypocretin/Orexin Excites Hypocretin Neurons via a Local Glutamate Neuron—A Potential Mechanism for Orchestrating the Hypothalamic Arousal System. Neuron 2002;36:1169-81. [DOI: 10.1016/s0896-6273(02)01132-7] [Cited by in Crossref: 300] [Cited by in F6Publishing: 162] [Article Influence: 15.0] [Reference Citation Analysis]
|
| 384 |
Keating GL, Kuhar MJ, Bliwise DL, Rye DB. Wake promoting effects of cocaine and amphetamine-regulated transcript (CART). Neuropeptides 2010;44:241-6. [PMID: 20116848 DOI: 10.1016/j.npep.2009.12.013] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 385 |
Imperatore R, Cristino L. Role of Orexin-B/Orexin 2 receptor in myocardial protection. Clinical Science 2019;133:853-7. [DOI: 10.1042/cs20181036] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 386 |
De la Herrán-arita AK, Drucker-colín R. Models for narcolepsy with cataplexy drug discovery. Expert Opinion on Drug Discovery 2012;7:155-64. [DOI: 10.1517/17460441.2012.651454] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 387 |
Ahnaou A, Drinkenburg W. Neuropeptide-S Evoked Arousal with Electroencephalogram Slow-Wave Compensatory Drive in Rats. Neuropsychobiology 2012;65:195-205. [DOI: 10.1159/000336998] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 388 |
Reinscheid RK, Xu Y. Neuropeptide S as a novel arousal promoting peptide transmitter: NPS produces arousal and anxiolysis. FEBS Journal 2005;272:5689-93. [DOI: 10.1111/j.1742-4658.2005.04982.x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 389 |
Otake K, Kin K, Nakamura Y. Fos expression in afferents to the rat midline thalamus following immobilization stress. Neurosci Res 2002;43:269-82. [PMID: 12103445 DOI: 10.1016/s0168-0102(02)00042-1] [Cited by in Crossref: 48] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 390 |
Gao XB, Hermes G. Neural plasticity in hypocretin neurons: the basis of hypocretinergic regulation of physiological and behavioral functions in animals. Front Syst Neurosci 2015;9:142. [PMID: 26539086 DOI: 10.3389/fnsys.2015.00142] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 391 |
Del Cid-Pellitero E, Jones BE. Immunohistochemical evidence for synaptic release of GABA from melanin-concentrating hormone containing varicosities in the locus coeruleus. Neuroscience 2012;223:269-76. [PMID: 22890079 DOI: 10.1016/j.neuroscience.2012.07.072] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 392 |
Igarashi N, Tatsumi K, Nakamura A, Sakao S, Takiguchi Y, Nishikawa T, Kuriyama T. Plasma orexin-A levels in obstructive sleep apnea-hypopnea syndrome. Chest 2003;124:1381-5. [PMID: 14555569 DOI: 10.1378/chest.124.4.1381] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 393 |
Godden KE, Landry JP, Slepneva N, Migues PV, Pompeiano M. Early expression of hypocretin/orexin in the chick embryo brain. PLoS One 2014;9:e106977. [PMID: 25188307 DOI: 10.1371/journal.pone.0106977] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 394 |
Yang C, Zhang L, Hao H, Ran M, Li J, Dong H. Serotonergic neurons in the dorsal raphe nucleus mediate the arousal-promoting effect of orexin during isoflurane anesthesia in male rats. Neuropeptides 2019;75:25-33. [DOI: 10.1016/j.npep.2019.03.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 395 |
Goadsby PJ. Can we Develop Neurally Acting Drugs for the Treatment of Migraine? Nat Rev Drug Discov 2005;4:741-50. [DOI: 10.1038/nrd1822] [Cited by in Crossref: 52] [Cited by in F6Publishing: 41] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 396 |
España RA, Oleson EB, Locke JL, Brookshire BR, Roberts DC, Jones SR. The hypocretin-orexin system regulates cocaine self-administration via actions on the mesolimbic dopamine system. Eur J Neurosci 2010;31:336-48. [PMID: 20039943 DOI: 10.1111/j.1460-9568.2009.07065.x] [Cited by in Crossref: 165] [Cited by in F6Publishing: 162] [Article Influence: 12.7] [Reference Citation Analysis]
|
| 397 |
Wang J, Osaka T, Inoue S. Orexin-A-sensitive site for energy expenditure localized in the arcuate nucleus of the hypothalamus. Brain Research 2003;971:128-34. [DOI: 10.1016/s0006-8993(03)02437-5] [Cited by in Crossref: 28] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 398 |
Sandsmark DK, Elliott JE, Lim MM. Sleep-Wake Disturbances After Traumatic Brain Injury: Synthesis of Human and Animal Studies. Sleep 2017;40. [PMID: 28329120 DOI: 10.1093/sleep/zsx044] [Cited by in Crossref: 32] [Cited by in F6Publishing: 47] [Article Influence: 6.4] [Reference Citation Analysis]
|
| 399 |
Ishibashi M, Takano S, Yanagida H, Takatsuna M, Nakajima K, Oomura Y, Wayner MJ, Sasaki K. Effects of orexins/hypocretins on neuronal activity in the paraventricular nucleus of the thalamus in rats in vitro. Peptides 2005;26:471-81. [PMID: 15652654 DOI: 10.1016/j.peptides.2004.10.014] [Cited by in Crossref: 69] [Cited by in F6Publishing: 68] [Article Influence: 4.1] [Reference Citation Analysis]
|
| 400 |
de Lecea L, Huerta R. Hypocretin (orexin) regulation of sleep-to-wake transitions. Front Pharmacol. 2014;5:16. [PMID: 24575043 DOI: 10.3389/fphar.2014.00016] [Cited by in Crossref: 68] [Cited by in F6Publishing: 69] [Article Influence: 8.5] [Reference Citation Analysis]
|
| 401 |
Grafe LA, Bhatnagar S. Orexins and stress. Front Neuroendocrinol 2018;51:132-45. [PMID: 29932958 DOI: 10.1016/j.yfrne.2018.06.003] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 8.5] [Reference Citation Analysis]
|
| 402 |
Sato-suzuki I, Kita I, Seki Y, Oguri M, Arita H. Cortical arousal induced by microinjection of orexins into the paraventricular nucleus of the rat. Behavioural Brain Research 2002;128:169-77. [DOI: 10.1016/s0166-4328(01)00307-2] [Cited by in Crossref: 39] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 403 |
Moorman DE. The hypocretin/orexin system as a target for excessive motivation in alcohol use disorders. Psychopharmacology (Berl) 2018;235:1663-80. [PMID: 29508004 DOI: 10.1007/s00213-018-4871-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 404 |
González JA, Jensen LT, Iordanidou P, Strom M, Fugger L, Burdakov D. Inhibitory Interplay between Orexin Neurons and Eating. Curr Biol 2016;26:2486-91. [PMID: 27546579 DOI: 10.1016/j.cub.2016.07.013] [Cited by in Crossref: 63] [Cited by in F6Publishing: 50] [Article Influence: 10.5] [Reference Citation Analysis]
|
| 405 |
Bernstein DL, Badve PS, Barson JR, Bass CE, España RA. Hypocretin receptor 1 knockdown in the ventral tegmental area attenuates mesolimbic dopamine signaling and reduces motivation for cocaine. Addict Biol 2018;23:1032-45. [PMID: 28971565 DOI: 10.1111/adb.12553] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 406 |
Davis SF, Williams KW, Xu W, Glatzer NR, Smith BN. Selective enhancement of synaptic inhibition by hypocretin (orexin) in rat vagal motor neurons: implications for autonomic regulation. J Neurosci 2003;23:3844-54. [PMID: 12736355 [PMID: 12736355 DOI: 10.1523/jneurosci.23-09-03844.2003] [Cited by in Crossref: 63] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 407 |
Patton DF, Mistlberger RE. Circadian adaptations to meal timing: neuroendocrine mechanisms. Front Neurosci. 2013;7:185. [PMID: 24133410 DOI: 10.3389/fnins.2013.00185] [Cited by in Crossref: 100] [Cited by in F6Publishing: 96] [Article Influence: 11.1] [Reference Citation Analysis]
|
| 408 |
Aston-Jones G, Chen S, Zhu Y, Oshinsky ML. A neural circuit for circadian regulation of arousal. Nat Neurosci 2001;4:732-8. [PMID: 11426230 DOI: 10.1038/89522] [Cited by in Crossref: 396] [Cited by in F6Publishing: 365] [Article Influence: 18.9] [Reference Citation Analysis]
|
| 409 |
Mintz EM, van den Pol AN, Casano AA, Albers H. Distribution of hypocretin-(orexin) immunoreactivity in the central nervous system of Syrian hamsters (Mesocricetus auratus). Journal of Chemical Neuroanatomy 2001;21:225-38. [DOI: 10.1016/s0891-0618(01)00111-9] [Cited by in Crossref: 73] [Cited by in F6Publishing: 19] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 410 |
Stoyanova II, Rutten WL, le Feber J. Orexin-A and orexin-B during the postnatal development of the rat brain. Cell Mol Neurobiol 2010;30:81-9. [PMID: 19633949 DOI: 10.1007/s10571-009-9433-z] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 411 |
Chase MH. A unified survival theory of the functioning of the hypocretinergic system. J Appl Physiol (1985) 2013;115:954-71. [PMID: 23640599 DOI: 10.1152/japplphysiol.00700.2012] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 412 |
Koob GF, Colrain IM. Alcohol use disorder and sleep disturbances: a feed-forward allostatic framework. Neuropsychopharmacology 2020;45:141-65. [PMID: 31234199 DOI: 10.1038/s41386-019-0446-0] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 12.3] [Reference Citation Analysis]
|
| 413 |
Kallupi M, Cannella N, Economidou D, Ubaldi M, Ruggeri B, Weiss F, Massi M, Marugan J, Heilig M, Bonnavion P, de Lecea L, Ciccocioppo R. Neuropeptide S facilitates cue-induced relapse to cocaine seeking through activation of the hypothalamic hypocretin system. Proc Natl Acad Sci U S A 2010;107:19567-72. [PMID: 20974945 DOI: 10.1073/pnas.1004100107] [Cited by in Crossref: 64] [Cited by in F6Publishing: 64] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 414 |
Ortega JE, Katner J, Davis R, Wade M, Nisenbaum L, Nomikos GG, Svensson KA, Perry KW. Modulation of neurotransmitter release in orexin/hypocretin-2 receptor knockout mice: a microdialysis study. J Neurosci Res 2012;90:588-96. [PMID: 22038504 DOI: 10.1002/jnr.22781] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 415 |
Franks NP, Zecharia AY. Sleep and general anesthesia. Can J Anaesth 2011;58:139-48. [PMID: 21170623 DOI: 10.1007/s12630-010-9420-3] [Cited by in Crossref: 56] [Cited by in F6Publishing: 54] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 416 |
Kim AK, Brown RM, Lawrence AJ. The role of orexins/hypocretins in alcohol use and abuse: an appetitive-reward relationship. Front Behav Neurosci 2012;6:78. [PMID: 23189046 DOI: 10.3389/fnbeh.2012.00078] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 417 |
Yamanaka A, Muraki Y, Ichiki K, Tsujino N, Kilduff TS, Goto K, Sakurai T. Orexin neurons are directly and indirectly regulated by catecholamines in a complex manner. J Neurophysiol 2006;96:284-98. [PMID: 16611835 DOI: 10.1152/jn.01361.2005] [Cited by in Crossref: 79] [Cited by in F6Publishing: 80] [Article Influence: 4.9] [Reference Citation Analysis]
|
| 418 |
Mochizuki T, Klerman EB, Sakurai T, Scammell TE. Elevated body temperature during sleep in orexin knockout mice. Am J Physiol Regul Integr Comp Physiol 2006;291:R533-40. [PMID: 16556901 DOI: 10.1152/ajpregu.00887.2005] [Cited by in Crossref: 56] [Cited by in F6Publishing: 54] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 419 |
Inutsuka A, Yamashita A, Chowdhury S, Nakai J, Ohkura M, Taguchi T, Yamanaka A. The integrative role of orexin/hypocretin neurons in nociceptive perception and analgesic regulation. Sci Rep 2016;6:29480. [PMID: 27385517 DOI: 10.1038/srep29480] [Cited by in Crossref: 62] [Cited by in F6Publishing: 55] [Article Influence: 10.3] [Reference Citation Analysis]
|
| 420 |
Toyama S, Shimoyama N, Tagaito Y, Nagase H, Saitoh T, Yanagisawa M, Shimoyama M. Nonpeptide Orexin-2 Receptor Agonist Attenuates Morphine-induced Sedative Effects in Rats. Anesthesiology 2018;128:992-1003. [PMID: 29521652 DOI: 10.1097/ALN.0000000000002161] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 421 |
Shimizu S, Takenoshita N, Inagawa Y, Tsugawa A, Hirose D, Kaneko Y, Ogawa Y, Serisawa S, Sakurai S, Hirao K, Kanetaka H, Kanbayashi T, Imanishi A, Sakurai H, Hanyu H. Positive Association Between Cognitive Function and Cerebrospinal Fluid Orexin A Levels in Alzheimer’s Disease. JAD 2020;73:117-23. [DOI: 10.3233/jad-190958] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 422 |
Higuchi S, Usui A, Murasaki M, Matsushita S, Nishioka N, Yoshino A, Matsui T, Muraoka H, Ishizuka Y, Kanba S, Sakurai T. Plasma orexin-A is lower in patients with narcolepsy. Neurosci Lett 2002;318:61-4. [PMID: 11796186 DOI: 10.1016/s0304-3940(01)02476-4] [Cited by in Crossref: 63] [Cited by in F6Publishing: 9] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 423 |
Franceschini C, Pizza F, Cavalli F, Plazzi G. A practical guide to the pharmacological and behavioral therapy of Narcolepsy. Neurotherapeutics 2021;18:6-19. [PMID: 33886090 DOI: 10.1007/s13311-021-01051-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 424 |
Darker JG, Porter RA, Eggleston DS, Smart D, Brough SJ, Sabido-david C, Jerman JC. Structure–activity analysis of truncated orexin-A analogues at the orexin-1 receptor. Bioorganic & Medicinal Chemistry Letters 2001;11:737-40. [DOI: 10.1016/s0960-894x(01)00043-9] [Cited by in Crossref: 49] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 425 |
Baier PC, Hallschmid M, Seeck-Hirschner M, Weinhold SL, Burkert S, Diessner N, Göder R, Aldenhoff JB, Hinze-Selch D. Effects of intranasal hypocretin-1 (orexin A) on sleep in narcolepsy with cataplexy. Sleep Med 2011;12:941-6. [PMID: 22036605 DOI: 10.1016/j.sleep.2011.06.015] [Cited by in Crossref: 64] [Cited by in F6Publishing: 59] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 426 |
Bonert VS, Melmed S. Growth Hormone. The Pituitary. Elsevier; 2017. pp. 85-127. [DOI: 10.1016/b978-0-12-804169-7.00004-0] [Cited by in Crossref: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 427 |
Fadel J, Deutch A. Anatomical substrates of orexin–dopamine interactions: lateral hypothalamic projections to the ventral tegmental area. Neuroscience 2002;111:379-87. [DOI: 10.1016/s0306-4522(02)00017-9] [Cited by in Crossref: 346] [Cited by in F6Publishing: 171] [Article Influence: 17.3] [Reference Citation Analysis]
|
| 428 |
Kawada Y, Ueno S, Asayama K, Tsutsui M, Utsunomiya K, Toyohira Y, Morisada N, Tanaka K, Shirahata A, Yanagihara N. Stimulation of catecholamine synthesis by orexin-A in bovine adrenal medullary cells through orexin receptor 1. Biochem Pharmacol. 2003;66:141-147. [PMID: 12818374 DOI: 10.1016/S0006-2952(03)00236-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 429 |
Thakkar MM, Winston S, McCarley RW. Orexin neurons of the hypothalamus express adenosine A1 receptors. Brain Res 2002;944:190-4. [PMID: 12106679 DOI: 10.1016/s0006-8993(02)02873-1] [Cited by in Crossref: 47] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 430 |
Langmead CJ, Jerman JC, Brough SJ, Scott C, Porter RA, Herdon HJ. Characterisation of the binding of [3H]-SB-674042, a novel nonpeptide antagonist, to the human orexin-1 receptor. Br J Pharmacol 2004;141:340-6. [PMID: 14691055 DOI: 10.1038/sj.bjp.0705610] [Cited by in Crossref: 110] [Cited by in F6Publishing: 94] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 431 |
Farr SA, Banks WA, Kumar VB, Morley JE. Orexin-A-induced feeding is dependent on nitric oxide. Peptides 2005;26:759-65. [DOI: 10.1016/j.peptides.2004.12.004] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 432 |
Blanco-Centurion C, Gerashchenko D, Salin-Pascual RJ, Shiromani PJ. Effects of hypocretin2-saporin and antidopamine-beta-hydroxylase-saporin neurotoxic lesions of the dorsolateral pons on sleep and muscle tone. Eur J Neurosci 2004;19:2741-52. [PMID: 15147308 DOI: 10.1111/j.0953-816X.2004.03366.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 433 |
Rosenwasser AM. Functional neuroanatomy of sleep and circadian rhythms. Brain Res Rev 2009;61:281-306. [PMID: 19695288 DOI: 10.1016/j.brainresrev.2009.08.001] [Cited by in Crossref: 67] [Cited by in F6Publishing: 46] [Article Influence: 5.2] [Reference Citation Analysis]
|
| 434 |
Emamzadeh FN, Surguchov A. Parkinson's Disease: Biomarkers, Treatment, and Risk Factors. Front Neurosci 2018;12:612. [PMID: 30214392 DOI: 10.3389/fnins.2018.00612] [Cited by in Crossref: 129] [Cited by in F6Publishing: 101] [Article Influence: 32.3] [Reference Citation Analysis]
|
| 435 |
Zeitzer JM, Buckmaster CL, Landolt HP, Lyons DM, Mignot E. Modafinil and γ-hydroxybutyrate have sleep state-specific pharmacological actions on hypocretin-1 physiology in a primate model of human sleep. Behav Pharmacol 2009;20:643-52. [PMID: 19752724 DOI: 10.1097/FBP.0b013e328331b9db] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 436 |
Muroya S, Uramura K, Sakurai T, Takigawa M, Yada T. Lowering glucose concentrations increases cytosolic Ca2+ in orexin neurons of the rat lateral hypothalamus. Neuroscience Letters 2001;309:165-8. [DOI: 10.1016/s0304-3940(01)02053-5] [Cited by in Crossref: 52] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 437 |
Matzeu A, Martin-Fardon R. Targeting the Orexin System for Prescription Opioid Use Disorder. Brain Sci 2020;10:E226. [PMID: 32290110 DOI: 10.3390/brainsci10040226] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 438 |
Parsons MP, Li S, Kirouac GJ. Functional and anatomical connection between the paraventricular nucleus of the thalamus and dopamine fibers of the nucleus accumbens. J Comp Neurol 2007;500:1050-63. [PMID: 17183538 DOI: 10.1002/cne.21224] [Cited by in Crossref: 96] [Cited by in F6Publishing: 97] [Article Influence: 6.4] [Reference Citation Analysis]
|
| 439 |
Li JX, Yoshida T, Monk KJ, Katz DB. Lateral hypothalamus contains two types of palatability-related taste responses with distinct dynamics. J Neurosci 2013;33:9462-73. [PMID: 23719813 DOI: 10.1523/JNEUROSCI.3935-12.2013] [Cited by in Crossref: 40] [Cited by in F6Publishing: 27] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 440 |
Duncan MJ, Franklin KM, Peng X, Yun C, Legan SJ. Circadian rhythm disruption by a novel running wheel: roles of exercise and arousal in blockade of the luteinizing hormone surge. Physiol Behav 2014;131:7-16. [PMID: 24727338 DOI: 10.1016/j.physbeh.2014.04.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 441 |
Xue Y, Yang YT, Liu HY, Chen WF, Chen AQ, Sheng Q, Chen XY, Wang Y, Chen H, Liu HX, Pang YY, Chen L. Orexin-A increases the activity of globus pallidus neurons in both normal and parkinsonian rats. Eur J Neurosci 2016;44:2247-57. [PMID: 27336845 DOI: 10.1111/ejn.13323] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 442 |
Milbank E, López M. Orexins/Hypocretins: Key Regulators of Energy Homeostasis. Front Endocrinol (Lausanne) 2019;10:830. [PMID: 31920958 DOI: 10.3389/fendo.2019.00830] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 443 |
Atkin T, Comai S, Gobbi G. Drugs for Insomnia beyond Benzodiazepines: Pharmacology, Clinical Applications, and Discovery. Pharmacol Rev 2018;70:197-245. [PMID: 29487083 DOI: 10.1124/pr.117.014381] [Cited by in Crossref: 89] [Cited by in F6Publishing: 57] [Article Influence: 22.3] [Reference Citation Analysis]
|
| 444 |
Dugovic C, Shelton JE, Aluisio LE, Fraser IC, Jiang X, Sutton SW, Bonaventure P, Yun S, Li X, Lord B, Dvorak CA, Carruthers NI, Lovenberg TW. Blockade of orexin-1 receptors attenuates orexin-2 receptor antagonism-induced sleep promotion in the rat. J Pharmacol Exp Ther 2009;330:142-51. [PMID: 19363060 DOI: 10.1124/jpet.109.152009] [Cited by in Crossref: 150] [Cited by in F6Publishing: 154] [Article Influence: 11.5] [Reference Citation Analysis]
|
| 445 |
García-Brito S, Aldavert-Vera L, Huguet G, Kádár E, Segura-Torres P. Orexin-1 receptor blockade differentially affects spatial and visual discrimination memory facilitation by intracranial self-stimulation. Neurobiol Learn Mem 2020;169:107188. [PMID: 32061874 DOI: 10.1016/j.nlm.2020.107188] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 446 |
Surendran S, Rady PL, Szucs S, Michals-matalon K, Tyring SK, Matalon R. High level of orexin A observed in the phenylketonuria mouse brain is due to the abnormal expression of prepro-orexin. Biochemical and Biophysical Research Communications 2004;317:522-6. [DOI: 10.1016/j.bbrc.2004.03.079] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 447 |
Yoshida Y, Fujiki N, Nakajima T, Ripley B, Matsumura H, Yoneda H, Mignot E, Nishino S. Fluctuation of extracellular hypocretin-1 (orexin A) levels in the rat in relation to the light-dark cycle and sleep-wake activities: Hypocretin release during the sleep-wake cycle. European Journal of Neuroscience 2001;14:1075-81. [DOI: 10.1046/j.0953-816x.2001.01725.x] [Cited by in Crossref: 304] [Cited by in F6Publishing: 278] [Article Influence: 14.5] [Reference Citation Analysis]
|
| 448 |
Inocente CO, Gustin MP, Lavault S, Guignard-Perret A, Raoux A, Christol N, Gerard D, Dauvilliers Y, Reimão R, Bat-Pitault F, Lin JS, Arnulf I, Lecendreux M, Franco P. Depressive feelings in children with narcolepsy. Sleep Med 2014;15:309-14. [PMID: 24503472 DOI: 10.1016/j.sleep.2013.08.798] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 449 |
Scammell TE, Estabrooke IV, McCarthy MT, Chemelli RM, Yanagisawa M, Miller MS, Saper CB. Hypothalamic arousal regions are activated during modafinil-induced wakefulness. J Neurosci 2000;20:8620-8. [PMID: 11069971 [PMID: 11069971 DOI: 10.1523/jneurosci.20-22-08620.2000] [Cited by in Crossref: 321] [Article Influence: 15.3] [Reference Citation Analysis]
|
| 450 |
Gottschalk MG, Richter J, Ziegler C, Schiele MA, Mann J, Geiger MJ, Schartner C, Homola GA, Alpers GW, Büchel C, Fehm L, Fydrich T, Gerlach AL, Gloster AT, Helbig-Lang S, Kalisch R, Kircher T, Lang T, Lonsdorf TB, Pané-Farré CA, Ströhle A, Weber H, Zwanzger P, Arolt V, Romanos M, Wittchen HU, Hamm A, Pauli P, Reif A, Deckert J, Neufang S, Höfler M, Domschke K. Orexin in the anxiety spectrum: association of a HCRTR1 polymorphism with panic disorder/agoraphobia, CBT treatment response and fear-related intermediate phenotypes. Transl Psychiatry 2019;9:75. [PMID: 30718541 DOI: 10.1038/s41398-019-0415-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 451 |
Aksu K, Güven SF, Aksu F, Ciftci B, Ciftci TU, Aksaray S, Şipit T, Peker Y. Obstructive Sleep Apnoea, Cigarette Smoking and Plasma Orexin-A in a Sleep Clinic Cohort. J Int Med Res 2009;37:331-40. [DOI: 10.1177/147323000903700207] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 452 |
Nakamura T, Uramura K, Nambu T, Yada T, Goto K, Yanagisawa M, Sakurai T. Orexin-induced hyperlocomotion and stereotypy are mediated by the dopaminergic system. Brain Res. 2000;873:181-187. [PMID: 10915829 DOI: 10.1016/S0006-8993(00)02555-5] [Cited by in Crossref: 231] [Cited by in F6Publishing: 73] [Article Influence: 10.5] [Reference Citation Analysis]
|
| 453 |
Mavanji V, Perez-Leighton CE, Kotz CM, Billington CJ, Parthasarathy S, Sinton CM, Teske JA. Promotion of Wakefulness and Energy Expenditure by Orexin-A in the Ventrolateral Preoptic Area. Sleep 2015;38:1361-70. [PMID: 25845696 DOI: 10.5665/sleep.4970] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.9] [Reference Citation Analysis]
|
| 454 |
Mobarakeh JI, Takahashi K, Sakurada S, Nishino S, Watanabe H, Kato M, Naghdi N, Yanai K. Enhanced antinociception by intracerebroventricularly administered orexin A in histamine H1 or H2 receptor gene knockout mice. Pain 2005;118:254-62. [DOI: 10.1016/j.pain.2005.08.024] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 455 |
Eriksson KS, Sergeeva OA, Selbach O, Haas HL. Orexin (hypocretin)/dynorphin neurons control GABAergic inputs to tuberomammillary neurons. Eur J Neurosci 2004;19:1278-84. [PMID: 15016085 DOI: 10.1111/j.1460-9568.2004.03243.x] [Cited by in Crossref: 76] [Cited by in F6Publishing: 75] [Article Influence: 4.2] [Reference Citation Analysis]
|
| 456 |
Jalal B. The neuropharmacology of sleep paralysis hallucinations: serotonin 2A activation and a novel therapeutic drug. Psychopharmacology (Berl) 2018;235:3083-91. [PMID: 30288594 DOI: 10.1007/s00213-018-5042-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 457 |
Arihara Z, Takahashi K, Murakami O, Totsune K, Sone M, Satoh F, Ito S, Mouri T. Immunoreactive orexin-A in human plasma. Peptides. 2001;22:139-142. [PMID: 11179609 DOI: 10.1016/S0196-9781(00)00369-7] [Cited by in Crossref: 75] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 458 |
Bingham S, Davey PT, Babbs AJ, Irving EA, Sammons MJ, Wyles M, Jeffrey P, Cutler L, Riba I, Johns A, Porter RA, Upton N, Hunter AJ, Parsons AA. Orexin-A, an hypothalamic peptide with analgesic properties. Pain 2001;92:81-90. [PMID: 11323129 DOI: 10.1016/s0304-3959(00)00470-x] [Cited by in Crossref: 193] [Cited by in F6Publishing: 46] [Article Influence: 9.2] [Reference Citation Analysis]
|
| 459 |
Teske JA, Billington CJ, Kotz CM. Hypocretin/orexin and energy expenditure. Acta Physiol (Oxf) 2010;198:303-12. [PMID: 20070282 DOI: 10.1111/j.1748-1716.2010.02075.x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 39] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 460 |
Parsons MP, Hirasawa M. ATP-sensitive potassium channel-mediated lactate effect on orexin neurons: implications for brain energetics during arousal. J Neurosci 2010;30:8061-70. [PMID: 20554857 DOI: 10.1523/JNEUROSCI.5741-09.2010] [Cited by in Crossref: 75] [Cited by in F6Publishing: 46] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 461 |
Tsunematsu T, Tabuchi S, Tanaka KF, Boyden ES, Tominaga M, Yamanaka A. Long-lasting silencing of orexin/hypocretin neurons using archaerhodopsin induces slow-wave sleep in mice. Behav Brain Res 2013;255:64-74. [PMID: 23707248 DOI: 10.1016/j.bbr.2013.05.021] [Cited by in Crossref: 71] [Cited by in F6Publishing: 72] [Article Influence: 7.9] [Reference Citation Analysis]
|
| 462 |
Sharf R, Sarhan M, Brayton CE, Guarnieri DJ, Taylor JR, DiLeone RJ. Orexin signaling via the orexin 1 receptor mediates operant responding for food reinforcement. Biol Psychiatry 2010;67:753-60. [PMID: 20189166 DOI: 10.1016/j.biopsych.2009.12.035] [Cited by in Crossref: 74] [Cited by in F6Publishing: 71] [Article Influence: 6.2] [Reference Citation Analysis]
|
| 463 |
Fabris C, Cozzi B, Hay-schmidt A, Naver B, Møller M. Demonstration of an orexinergic central innervation of the pineal gland of the pig: Orexinergic System in the Pig Brain. J Comp Neurol 2004;471:113-27. [DOI: 10.1002/cne.20007] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 464 |
Jöhren O, Brüggemann N, Dendorfer A, Dominiak P. Gonadal Steroids Differentially Regulate the Messenger Ribonucleic Acid Expression of Pituitary Orexin Type 1 Receptors and Adrenal Orexin Type 2 Receptors. Endocrinology 2003;144:1219-25. [DOI: 10.1210/en.2002-0030] [Cited by in Crossref: 49] [Cited by in F6Publishing: 46] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 465 |
van den Pol AN. Physiological Characteristics of Hypocretin/Orexin Neurons. In: de Lecea L, Sutcliffe JG, editors. Hypocretins. Boston: Springer US; 2005. pp. 123-36. [DOI: 10.1007/0-387-25446-3_8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 466 |
Arihara Z, Takahashi K, Murakami O, Totsune K, Sone M, Satoh F, Ito S, Hayashi Y, Sasano H, Mouri T. Orexin-A in the human brain and tumor tissues of ganglioneuroblastoma and neuroblastoma. Peptides 2000;21:565-70. [DOI: 10.1016/s0196-9781(00)00184-4] [Cited by in Crossref: 38] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 467 |
Bonnavion P, Jackson AC, Carter ME, de Lecea L. Antagonistic interplay between hypocretin and leptin in the lateral hypothalamus regulates stress responses. Nat Commun 2015;6:6266. [PMID: 25695914 DOI: 10.1038/ncomms7266] [Cited by in Crossref: 91] [Cited by in F6Publishing: 86] [Article Influence: 13.0] [Reference Citation Analysis]
|
| 468 |
Volkoff H. Sleep and Orexins in Nonmammalian Vertebrates. Sleep Hormones. Elsevier; 2012. pp. 315-39. [DOI: 10.1016/b978-0-12-394623-2.00017-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 469 |
Marcus JN, Aschkenasi CJ, Lee CE, Chemelli RM, Saper CB, Yanagisawa M, Elmquist JK. Differential expression of orexin receptors 1 and 2 in the rat brain. J Comp Neurol. 2001;435:6-25. [PMID: 11370008 DOI: 10.1002/cne.1190] [Cited by in Crossref: 1089] [Cited by in F6Publishing: 1066] [Article Influence: 51.9] [Reference Citation Analysis]
|
| 470 |
Brodnik ZD, Bernstein DL, Prince CD, España RA. Hypocretin receptor 1 blockade preferentially reduces high effort responding for cocaine without promoting sleep. Behav Brain Res 2015;291:377-84. [PMID: 26049058 DOI: 10.1016/j.bbr.2015.05.051] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 471 |
Gartlon J, Szekeres P, Pullen M, Sarau HM, Aiyar N, Shabon U, Michalovich D, Steplewski K, Ellis C, Elshourbagy N, Duxon M, Ashmeade TE, Harrison DC, Murdock P, Wilson S, Ennaceur A, Atkins A, Heidbreder C, Hagan JJ, Hunter AJ, Jones DN. Localisation of NMU1R and NMU2R in human and rat central nervous system and effects of neuromedin-U following central administration in rats. Psychopharmacology (Berl) 2004;177:1-14. [PMID: 15205870 DOI: 10.1007/s00213-004-1918-3] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 472 |
Kok SW, Roelfsema F, Overeem S, Lammers GJ, Frölich M, Meinders AE, Pijl H. Pulsatile LH release is diminished, whereas FSH secretion is normal, in hypocretin-deficient narcoleptic men. Am J Physiol Endocrinol Metab 2004;287:E630-6. [PMID: 15172887 DOI: 10.1152/ajpendo.00060.2004] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 473 |
Zhao P, You Y, Wang Z, Zhou Y, Chai G, Yan G, Jin Z, Wang Q, Sun H. Orexin A peptidergic system: comparative sleep behavior, morphology and population in brains between wild type and Alzheimer’s disease mice. Brain Struct Funct. [DOI: 10.1007/s00429-021-02447-w] [Reference Citation Analysis]
|
| 474 |
Pan L, Qi R, Wang J, Zhou W, Liu J, Cai Y. Evidence for a Role of Orexin/Hypocretin System in Vestibular Lesion-Induced Locomotor Abnormalities in Rats. Front Neurosci 2016;10:355. [PMID: 27507932 DOI: 10.3389/fnins.2016.00355] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 475 |
Nixon JP, Smale L. Orexin fibers form appositions with Fos expressing neuropeptide-Y cells in the grass rat intergeniculate leaflet. Brain Research 2005;1053:33-7. [DOI: 10.1016/j.brainres.2005.06.043] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 476 |
Eggermann E, Serafin M, Bayer L, Machard D, Saint-Mleux B, Jones BE, Mühlethaler M. Orexins/hypocretins excite basal forebrain cholinergic neurones. Neuroscience 2001;108:177-81. [PMID: 11734353 DOI: 10.1016/s0306-4522(01)00512-7] [Cited by in Crossref: 200] [Cited by in F6Publishing: 83] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 477 |
Fujisawa S, Komatsubara M, Ogura-Ochi K, Tsukamoto-Yamauchi N, Toma K, Inagaki K, Wada J, Otsuka F. Orexin A modulates prolactin production by regulating BMP-4 activity in rat pituitary lactotorope cells. Peptides 2019;113:35-40. [PMID: 30721716 DOI: 10.1016/j.peptides.2019.01.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 478 |
Brown JA, Woodworth HL, Leinninger GM. To ingest or rest? Specialized roles of lateral hypothalamic area neurons in coordinating energy balance. Front Syst Neurosci 2015;9:9. [PMID: 25741247 DOI: 10.3389/fnsys.2015.00009] [Cited by in Crossref: 47] [Cited by in F6Publishing: 51] [Article Influence: 6.7] [Reference Citation Analysis]
|
| 479 |
Di Giovanni G, Chagraoui A, Puginier E, Galati S, De Deurwaerdère P. Reciprocal interaction between monoaminergic systems and the pedunculopontine nucleus: Implication in the mechanism of L-DOPA. Neurobiol Dis 2019;128:9-18. [PMID: 30149181 DOI: 10.1016/j.nbd.2018.08.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 480 |
Harthoorn LF, Sane A, Nethe M, Van Heerikhuize JJ. Multi-transcriptional profiling of melanin-concentrating hormone and orexin-containing neurons. Cell Mol Neurobiol. 2005;25:1209-1223. [PMID: 16388333 DOI: 10.1007/s10571-005-8184-8] [Cited by in Crossref: 69] [Cited by in F6Publishing: 75] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 481 |
Boutrel B, Kenny PJ, Specio SE, Martin-Fardon R, Markou A, Koob GF, de Lecea L. Role for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior. Proc Natl Acad Sci U S A 2005;102:19168-73. [PMID: 16357203 DOI: 10.1073/pnas.0507480102] [Cited by in Crossref: 354] [Cited by in F6Publishing: 361] [Article Influence: 20.8] [Reference Citation Analysis]
|
| 482 |
Bernard R, Lydic R, Baghdoyan HA. Hypocretin-1 causes G protein activation and increases ACh release in rat pons. Eur J Neurosci 2003;18:1775-85. [PMID: 14622212 DOI: 10.1046/j.1460-9568.2003.02905.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 483 |
Roch C, Bergamini G, Steiner MA, Clozel M. Nonclinical pharmacology of daridorexant: a new dual orexin receptor antagonist for the treatment of insomnia. Psychopharmacology (Berl) 2021;238:2693-708. [PMID: 34415378 DOI: 10.1007/s00213-021-05954-0] [Reference Citation Analysis]
|
| 484 |
Jia X, Yan J, Xia J, Xiong J, Wang T, Chen Y, Qi A, Yang N, Fan S, Ye J, Hu Z. Arousal effects of orexin A on acute alcohol intoxication-induced coma in rats. Neuropharmacology 2012;62:775-83. [PMID: 21924278 DOI: 10.1016/j.neuropharm.2011.08.047] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 485 |
Mavanji V, Billington CJ, Kotz CM, Teske JA. Sleep and obesity: a focus on animal models. Neurosci Biobehav Rev 2012;36:1015-29. [PMID: 22266350 DOI: 10.1016/j.neubiorev.2012.01.001] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 486 |
Morshedi MM, Meredith GE. Repeated amphetamine administration induces Fos in prefrontal cortical neurons that project to the lateral hypothalamus but not the nucleus accumbens or basolateral amygdala. Psychopharmacology (Berl) 2008;197:179-89. [PMID: 18080115 DOI: 10.1007/s00213-007-1021-7] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 487 |
Ferry B. The orexinergic system influences conditioned odor aversion learning in the rat: a theory on the processes and hypothesis on the circuit involved. Front Behav Neurosci 2014;8:164. [PMID: 24834041 DOI: 10.3389/fnbeh.2014.00164] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 488 |
Conrad KL, Davis AR, Silberman Y, Sheffler DJ, Shields AD, Saleh SA, Sen N, Matthies HJ, Javitch JA, Lindsley CW, Winder DG. Yohimbine depresses excitatory transmission in BNST and impairs extinction of cocaine place preference through orexin-dependent, norepinephrine-independent processes. Neuropsychopharmacology 2012;37:2253-66. [PMID: 22617356 DOI: 10.1038/npp.2012.76] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 489 |
Tang F, Lane S, Korsak A, Paton JF, Gourine AV, Kasparov S, Teschemacher AG. Lactate-mediated glia-neuronal signalling in the mammalian brain. Nat Commun 2014;5:3284. [PMID: 24518663 DOI: 10.1038/ncomms4284] [Cited by in Crossref: 181] [Cited by in F6Publishing: 191] [Article Influence: 25.9] [Reference Citation Analysis]
|
| 490 |
Steiner MA, Sciarretta C, Brisbare-Roch C, Strasser DS, Studer R, Jenck F. Examining the role of endogenous orexins in hypothalamus-pituitary-adrenal axis endocrine function using transient dual orexin receptor antagonism in the rat. Psychoneuroendocrinology 2013;38:560-71. [PMID: 22917622 DOI: 10.1016/j.psyneuen.2012.07.016] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 491 |
Lang M, Söll RM, Dürrenberger F, Dautzenberg FM, Beck-sickinger AG. Structure−Activity Studies of Orexin A and Orexin B at the Human Orexin 1 and Orexin 2 Receptors Led to Orexin 2 Receptor Selective and Orexin 1 Receptor Preferring Ligands. J Med Chem 2004;47:1153-60. [DOI: 10.1021/jm030982t] [Cited by in Crossref: 52] [Cited by in F6Publishing: 47] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 492 |
Suzuki H, Kubo Y, Yamamoto T. Orexin-A immunoreactive cells and fibers in the central nervous system of the axolotl brain and their association with tyrosine hydroxylase and serotonin immunoreactive somata. Journal of Chemical Neuroanatomy 2008;35:295-305. [DOI: 10.1016/j.jchemneu.2008.02.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 493 |
Saper CB, Chou TC, Scammell TE. The sleep switch: hypothalamic control of sleep and wakefulness. Trends in Neurosciences 2001;24:726-31. [DOI: 10.1016/s0166-2236(00)02002-6] [Cited by in Crossref: 1023] [Cited by in F6Publishing: 326] [Article Influence: 48.7] [Reference Citation Analysis]
|
| 494 |
Sun H, Kennedy WP, Wilbraham D, Lewis N, Calder N, Li X, Ma J, Yee KL, Ermlich S, Mangin E, Lines C, Rosen L, Chodakewitz J, Murphy GM. Effects of suvorexant, an orexin receptor antagonist, on sleep parameters as measured by polysomnography in healthy men. Sleep 2013;36:259-67. [PMID: 23372274 DOI: 10.5665/sleep.2386] [Cited by in Crossref: 11] [Cited by in F6Publishing: 48] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 495 |
Novak CM, Albers H. Localization of hypocretin-like immunoreactivity in the brain of the diurnal rodent, Arvicanthis niloticus. Journal of Chemical Neuroanatomy 2002;23:49-58. [DOI: 10.1016/s0891-0618(01)00144-2] [Cited by in Crossref: 26] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 496 |
Diniz GB, Candido PL, Klein MO, Alvisi RD, Presse F, Nahon J, Felicio LF, Bittencourt JC. The weaning period promotes alterations in the orexin neuronal population of rats in a suckling-dependent manner. Brain Struct Funct 2018;223:3739-55. [DOI: 10.1007/s00429-018-1723-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 497 |
Corcoran AE, Richerson GB, Harris MB. Functional link between the hypocretin and serotonin systems in the neural control of breathing and central chemosensitivity. J Neurophysiol 2015;114:381-9. [PMID: 25878157 DOI: 10.1152/jn.00870.2013] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 498 |
Matsuzaki I, Sakurai T, Kunii K, Nakamura T, Yanagisawa M, Goto K. Involvement of the serotonergic system in orexin-induced behavioral alterations in rats. Regul Pept 2002;104:119-23. [PMID: 11830286 DOI: 10.1016/s0167-0115(01)00355-x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 499 |
Hunt NJ, Waters KA, Machaalani R. Orexin receptors in the developing piglet hypothalamus, and effects of nicotine and intermittent hypercapnic hypoxia exposures. Brain Res 2013;1508:73-82. [PMID: 23500635 DOI: 10.1016/j.brainres.2013.03.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 500 |
Martins PJ, D'Almeida V, Pedrazzoli M, Lin L, Mignot E, Tufik S. Increased hypocretin-1 (orexin-a) levels in cerebrospinal fluid of rats after short-term forced activity. Regul Pept 2004;117:155-8. [PMID: 14749034 DOI: 10.1016/j.regpep.2003.10.003] [Cited by in Crossref: 68] [Cited by in F6Publishing: 63] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 501 |
Tang H, Zhu Q, Li W, Qin S, Gong Y, Wang H, Shioda S, Li S, Huang J, Liu B, Fang Y, Liu Y, Wang S, Guo Y, Xia Q, Guo Y, Xu Z. Neurophysiology and Treatment of Disorders of Consciousness Induced by Traumatic Brain Injury: Orexin Signaling as a Potential Therapeutic Target. Curr Pharm Des 2019;25:4208-20. [PMID: 31663471 DOI: 10.2174/1381612825666191029101830] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 502 |
Wu M, Zhang Z, Leranth C, Xu C, van den Pol AN, Alreja M. Hypocretin increases impulse flow in the septohippocampal GABAergic pathway: implications for arousal via a mechanism of hippocampal disinhibition. J Neurosci 2002;22:7754-65. [PMID: 12196599 [PMID: 12196599 DOI: 10.1523/jneurosci.22-17-07754.2002] [Cited by in Crossref: 83] [Article Influence: 4.2] [Reference Citation Analysis]
|
| 503 |
Torterolo P, Chase MH. The hypocretins (orexins) mediate the "phasic" components of REM sleep: A new hypothesis. Sleep Sci 2014;7:19-29. [PMID: 26483897 DOI: 10.1016/j.slsci.2014.07.021] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 504 |
Kim J, Nakajima K, Oomura Y, Wayner MJ, Sasaki K. Orexin-A and ghrelin depolarize the same pedunculopontine tegmental neurons in rats: An in vitro study. Peptides 2009;30:1328-35. [DOI: 10.1016/j.peptides.2009.03.015] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 505 |
Guillaumin MCC, Burdakov D. Neuropeptides as Primary Mediators of Brain Circuit Connectivity. Front Neurosci 2021;15:644313. [PMID: 33776641 DOI: 10.3389/fnins.2021.644313] [Reference Citation Analysis]
|
| 506 |
Shahid IZ, Rahman AA, Pilowsky PM. Orexin and Central Regulation of Cardiorespiratory System. Sleep Hormones. Elsevier; 2012. pp. 159-84. [DOI: 10.1016/b978-0-12-394623-2.00009-3] [Cited by in Crossref: 27] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 507 |
Ferrucci M, Limanaqi F, Ryskalin L, Biagioni F, Busceti CL, Fornai F. The Effects of Amphetamine and Methamphetamine on the Release of Norepinephrine, Dopamine and Acetylcholine From the Brainstem Reticular Formation. Front Neuroanat 2019;13:48. [PMID: 31133823 DOI: 10.3389/fnana.2019.00048] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 508 |
Kaminski T, Smolinska N. Expression of orexin receptors in the pituitary. Vitam Horm 2012;89:61-73. [PMID: 22640608 DOI: 10.1016/B978-0-12-394623-2.00004-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 509 |
Kotz CM, Teske JA, Billington CJ. Neuroregulation of nonexercise activity thermogenesis and obesity resistance. Am J Physiol Regul Integr Comp Physiol 2008;294:R699-710. [PMID: 18160530 DOI: 10.1152/ajpregu.00095.2007] [Cited by in Crossref: 58] [Cited by in F6Publishing: 55] [Article Influence: 3.9] [Reference Citation Analysis]
|
| 510 |
Inagawa Y, Shimizu S, Takenoshita N, Tsugawa A, Hirose D, Kanbayashi T, Imanishi A, Sakurai H, Hanyu H, Kanetaka H, Hirao K. Association between cerebrospinal fluid Orexin A level and severity of rapid eye movement sleep behaviour disorder in dementia with Lewy bodies. Psychogeriatrics 2021;21:128-30. [PMID: 33145889 DOI: 10.1111/psyg.12618] [Reference Citation Analysis]
|
| 511 |
Alexandre C, Andermann ML, Scammell TE. Control of arousal by the orexin neurons. Curr Opin Neurobiol 2013;23:752-9. [PMID: 23683477 DOI: 10.1016/j.conb.2013.04.008] [Cited by in Crossref: 72] [Cited by in F6Publishing: 74] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 512 |
Saper CB, Fuller PM, Pedersen NP, Lu J, Scammell TE. Sleep state switching. Neuron 2010;68:1023-42. [PMID: 21172606 DOI: 10.1016/j.neuron.2010.11.032] [Cited by in Crossref: 775] [Cited by in F6Publishing: 639] [Article Influence: 70.5] [Reference Citation Analysis]
|
| 513 |
Smale L, Nunez AA, Schwartz MD. Rhythms in a diurnal brain. Biological Rhythm Research 2008;39:305-18. [DOI: 10.1080/09291010701682666] [Cited by in Crossref: 34] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 514 |
Schwartz MD, Kilduff TS. The Neurobiology of Sleep and Wakefulness. Psychiatr Clin North Am 2015;38:615-44. [PMID: 26600100 DOI: 10.1016/j.psc.2015.07.002] [Cited by in Crossref: 83] [Cited by in F6Publishing: 70] [Article Influence: 11.9] [Reference Citation Analysis]
|
| 515 |
Liguori C, Mercuri NB, Nuccetelli M, Izzi F, Bernardini S, Placidi F, Ferini-strambi L. Cerebrospinal Fluid Orexin Levels and Nocturnal Sleep Disruption in Alzheimer’s Disease Patients Showing Neuropsychiatric Symptoms. JAD 2018;66:993-9. [DOI: 10.3233/jad-180769] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 516 |
Enrique Martínez-rodríguez J, Iranzo Á, Santamaría J. Narcolepsia. Medicina Clínica 2002;119:749-54. [DOI: 10.1016/s0025-7753(02)73563-x] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 517 |
Fujiki N, Yoshida Y, Ripley B, Honda K, Mignot E, Nishino S. Changes in CSF hypocretin-1 (orexin A) levels in rats across 24 hours and in response to food deprivation. Neuroreport 2001;12:993-7. [PMID: 11303775 DOI: 10.1097/00001756-200104170-00026] [Cited by in Crossref: 150] [Cited by in F6Publishing: 139] [Article Influence: 7.1] [Reference Citation Analysis]
|
| 518 |
Schmidt FM, Arendt E, Steinmetzer A, Bruegel M, Kratzsch J, Strauß M, Baum P, Hegerl U, Schönknecht P. CSF-hypocretin-1 levels in patients with major depressive disorder compared to healthy controls. Psychiatry Research 2011;190:240-3. [DOI: 10.1016/j.psychres.2011.06.004] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 519 |
Keenan RJ, Oberrauch S, Bron R, Nowell CJ, Challis LM, Hoyer D, Jacobson LH. Decreased Orexin Receptor 1 mRNA Expression in the Locus Coeruleus in Both Tau Transgenic rTg4510 and Tau Knockout Mice and Accompanying Ascending Arousal System Tau Invasion in rTg4510. J Alzheimers Dis 2021;79:693-708. [PMID: 33361602 DOI: 10.3233/JAD-201177] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 520 |
Kukkonen JP. Physiology of the orexinergic/hypocretinergic system: a revisit in 2012. Am J Physiol Cell Physiol 2013;304:C2-32. [PMID: 23034387 DOI: 10.1152/ajpcell.00227.2012] [Cited by in Crossref: 93] [Cited by in F6Publishing: 91] [Article Influence: 9.3] [Reference Citation Analysis]
|
| 521 |
Scammell TE. Wakefulness: an eye-opening perspective on orexin neurons. Curr Biol 2001;11:R769-71. [PMID: 11591333 DOI: 10.1016/s0960-9822(01)00466-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 522 |
Tortorella S, Rodrigo-Angulo ML, Núñez A, Garzón M. Synaptic interactions between perifornical lateral hypothalamic area, locus coeruleus nucleus and the oral pontine reticular nucleus are implicated in the stage succession during sleep-wakefulness cycle. Front Neurosci 2013;7:216. [PMID: 24311996 DOI: 10.3389/fnins.2013.00216] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 523 |
Bertucci JI, Blanco AM, Sundarrajan L, Rajeswari JJ, Velasco C, Unniappan S. Nutrient Regulation of Endocrine Factors Influencing Feeding and Growth in Fish. Front Endocrinol (Lausanne) 2019;10:83. [PMID: 30873115 DOI: 10.3389/fendo.2019.00083] [Cited by in Crossref: 30] [Cited by in F6Publishing: 16] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 524 |
Amador A, Wang Y, Banerjee S, Kameneka TM, Solt LA, Burris TP. Pharmacological and Genetic Modulation of REV-ERB Activity and Expression Affects Orexigenic Gene Expression. PLoS One 2016;11:e0151014. [PMID: 26963516 DOI: 10.1371/journal.pone.0151014] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 525 |
Mehta R, Khanday MA, Mallick BN. REM sleep loss associated changes in orexin-A levels in discrete brain areas in rats. Neurosci Lett 2015;590:62-7. [PMID: 25637698 DOI: 10.1016/j.neulet.2015.01.067] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 526 |
Miller JK, Miller BR, O'Neil DA, Yuste R. An increase in spontaneous activity mediates visual habituation. Cell Rep 2022;39:110751. [PMID: 35476991 DOI: 10.1016/j.celrep.2022.110751] [Reference Citation Analysis]
|
| 527 |
Mieda M, Tsujino N, Sakurai T. Differential roles of orexin receptors in the regulation of sleep/wakefulness. Front Endocrinol (Lausanne) 2013;4:57. [PMID: 23730297 DOI: 10.3389/fendo.2013.00057] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 528 |
Pałasz A, Lapray D, Peyron C, Rojczyk-Gołębiewska E, Skowronek R, Markowski G, Czajkowska B, Krzystanek M, Wiaderkiewicz R. Dual orexin receptor antagonists - promising agents in the treatment of sleep disorders. Int J Neuropsychopharmacol 2014;17:157-68. [PMID: 23702225 DOI: 10.1017/S1461145713000552] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 529 |
Cid-pellitero ED, Garzón M. Hypocretin1/OrexinA-containing axons innervate locus coeruleus neurons that project to the Rat medial prefrontal cortex. Implication in the sleep-wakefulness cycle and cortical activation. Synapse 2011;65:843-57. [DOI: 10.1002/syn.20912] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 530 |
Bhagwandin A, Fuxe K, Bennett NC, Manger PR. Distribution of orexinergic neurons and their terminal networks in the brains of two species of African mole rats. Journal of Chemical Neuroanatomy 2011;41:32-42. [DOI: 10.1016/j.jchemneu.2010.11.002] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 531 |
Bettica P, Squassante L, Zamuner S, Nucci G, Danker-Hopfe H, Ratti E. The orexin antagonist SB-649868 promotes and maintains sleep in men with primary insomnia. Sleep 2012;35:1097-104. [PMID: 22851805 DOI: 10.5665/sleep.1996] [Cited by in Crossref: 52] [Cited by in F6Publishing: 58] [Article Influence: 5.2] [Reference Citation Analysis]
|
| 532 |
Young JK, Wu M, Manaye KF, Kc P, Allard JS, Mack SO, Haxhiu MA. Orexin stimulates breathing via medullary and spinal pathways. Journal of Applied Physiology 2005;98:1387-95. [DOI: 10.1152/japplphysiol.00914.2004] [Cited by in Crossref: 106] [Cited by in F6Publishing: 98] [Article Influence: 6.2] [Reference Citation Analysis]
|
| 533 |
Levin BE. Central regulation of energy homeostasis intelligent design: how to build the perfect survivor. Obesity (Silver Spring) 2006;14 Suppl 5:192S-6S. [PMID: 17021365 DOI: 10.1038/oby.2006.307] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 534 |
López M, Tena-sempere M, García-caballero T, Señarís R, Diéguez C. Hypocretins in Endocrine Regulation. In: de Lecea L, Sutcliffe JG, editors. Hypocretins. Boston: Springer US; 2005. pp. 395-423. [DOI: 10.1007/0-387-25446-3_27] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 535 |
Wang JB, Murata T, Narita K, Honda K, Higuchi T. Variation in the expression of orexin and orexin receptors in the rat hypothalamus during the estrous cycle, pregnancy, parturition, and lactation. Endocrine 2003;22:127-34. [PMID: 14665716 DOI: 10.1385/ENDO:22:2:127] [Cited by in Crossref: 26] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 536 |
Sakurai T. Orexin and Orexin Receptors. In: de Lecea L, Sutcliffe JG, editors. Hypocretins. Boston: Springer US; 2005. pp. 13-23. [DOI: 10.1007/0-387-25446-3_2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 537 |
Duva MA, Tomkins EM, Moranda L, Kaplan R, Sukhaseum A, Bernardo JP, Stanley B. Regional differences in feeding and other behaviors elicited by N-methyl-d-aspartic acid in the rodent hypothalamus: a reverse microdialysis mapping study. Brain Research 2002;925:141-7. [DOI: 10.1016/s0006-8993(01)03269-3] [Cited by in Crossref: 29] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 538 |
España RA, Plahn S, Berridge CW. Circadian-dependent and circadian-independent behavioral actions of hypocretin/orexin. Brain Res. 2002;943:224-236. [PMID: 12101045 DOI: 10.1016/S0006-8993(02)02653-7] [Cited by in Crossref: 73] [Cited by in F6Publishing: 31] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 539 |
Poli F, Plazzi G, Di Dalmazi G, Ribichini D, Vicennati V, Pizza F, Mignot E, Montagna P, Pasquali R, Pagotto U. Body mass index-independent metabolic alterations in narcolepsy with cataplexy. Sleep 2009;32:1491-7. [PMID: 19928388 DOI: 10.1093/sleep/32.11.1491] [Cited by in Crossref: 75] [Cited by in F6Publishing: 68] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 540 |
Pérez-morales M, De La Herrán-arita AK, Méndez-díaz M, Ruiz-contreras AE, Drucker-colín R, Prospéro-garcía O. 2-AG into the lateral hypothalamus increases REM sleep and cFos expression in melanin concentrating hormone neurons in rats. Pharmacology Biochemistry and Behavior 2013;108:1-7. [DOI: 10.1016/j.pbb.2013.04.006] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 541 |
Ohno K, Sakurai T. Orexin neuronal circuitry: role in the regulation of sleep and wakefulness. Front Neuroendocrinol 2008;29:70-87. [PMID: 17910982 DOI: 10.1016/j.yfrne.2007.08.001] [Cited by in Crossref: 178] [Cited by in F6Publishing: 162] [Article Influence: 11.9] [Reference Citation Analysis]
|
| 542 |
Dye TJ, Simakajornboon N. Narcolepsy in Children: Sleep disorders in children, A rapidly evolving field seeking consensus. Pediatr Pulmonol 2021. [PMID: 34021733 DOI: 10.1002/ppul.25512] [Reference Citation Analysis]
|
| 543 |
Baumann CR, Bassetti CL. Hypocretins (orexins) and sleep–wake disorders. The Lancet Neurology 2005;4:673-82. [DOI: 10.1016/s1474-4422(05)70196-4] [Cited by in Crossref: 102] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 544 |
Osorio RS, Ducca EL, Wohlleber ME, Tanzi EB, Gumb T, Twumasi A, Tweardy S, Lewis C, Fischer E, Koushyk V, Cuartero-Toledo M, Sheikh MO, Pirraglia E, Zetterberg H, Blennow K, Lu SE, Mosconi L, Glodzik L, Schuetz S, Varga AW, Ayappa I, Rapoport DM, de Leon MJ. Orexin-A is Associated with Increases in Cerebrospinal Fluid Phosphorylated-Tau in Cognitively Normal Elderly Subjects. Sleep 2016;39:1253-60. [PMID: 26951396 DOI: 10.5665/sleep.5846] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 545 |
Nollet M, Gaillard P, Minier F, Tanti A, Belzung C, Leman S. Activation of orexin neurons in dorsomedial/perifornical hypothalamus and antidepressant reversal in a rodent model of depression. Neuropharmacology 2011;61:336-46. [PMID: 21530551 DOI: 10.1016/j.neuropharm.2011.04.022] [Cited by in Crossref: 70] [Cited by in F6Publishing: 69] [Article Influence: 6.4] [Reference Citation Analysis]
|
| 546 |
Sharf R, Sarhan M, Dileone RJ. Role of orexin/hypocretin in dependence and addiction. Brain Res 2010;1314:130-8. [PMID: 19699189 DOI: 10.1016/j.brainres.2009.08.028] [Cited by in Crossref: 73] [Cited by in F6Publishing: 72] [Article Influence: 5.6] [Reference Citation Analysis]
|
| 547 |
Russell SH, Kim MS, Small CJ, Abbott CR, Morgan DGA, Taheri S, Murphy KG, Todd JF, Ghatei MA, Bloom SR. Central Administration of Orexin A Suppresses Basal and Domperidone Stimulated Plasma Prolactin: Orexin suppresses domperidone stimulated prolactin. Journal of Neuroendocrinology 2000;12:1213-8. [DOI: 10.1046/j.1365-2826.2000.00582.x] [Cited by in Crossref: 54] [Cited by in F6Publishing: 48] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 548 |
Ursin R. Serotonin and sleep. Sleep Medicine Reviews 2002;6:55-67. [DOI: 10.1053/smrv.2001.0174] [Cited by in Crossref: 191] [Cited by in F6Publishing: 151] [Article Influence: 9.6] [Reference Citation Analysis]
|
| 549 |
Bourgin P, Huitrón-Résendiz S, Spier AD, Fabre V, Morte B, Criado JR, Sutcliffe JG, Henriksen SJ, de Lecea L. Hypocretin-1 modulates rapid eye movement sleep through activation of locus coeruleus neurons. J Neurosci 2000;20:7760-5. [PMID: 11027239 [PMID: 11027239 DOI: 10.1523/jneurosci.20-20-07760.2000] [Cited by in Crossref: 347] [Article Influence: 16.5] [Reference Citation Analysis]
|
| 550 |
Tose R, Kushikata T, Yoshida H, Kudo M, Furukawa K, Ueno S, Hirota K. Interaction between orexinergic neurons and NMDA receptors in the control of locus coeruleus-cerebrocortical noradrenergic activity of the rat. Brain Res 2009;1250:81-7. [PMID: 19007758 DOI: 10.1016/j.brainres.2008.10.041] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 551 |
Briggs C, Hirasawa M, Semba K. Sleep Deprivation Distinctly Alters Glutamate Transporter 1 Apposition and Excitatory Transmission to Orexin and MCH Neurons. J Neurosci 2018;38:2505-18. [PMID: 29431649 DOI: 10.1523/JNEUROSCI.2179-17.2018] [Cited by in Crossref: 19] [Cited by in F6Publishing: 10] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 552 |
Xu Q, Wang DR, Dong H, Chen L, Lu J, Lazarus M, Cherasse Y, Chen GH, Qu WM, Huang ZL. Medial Parabrachial Nucleus Is Essential in Controlling Wakefulness in Rats. Front Neurosci 2021;15:645877. [PMID: 33841086 DOI: 10.3389/fnins.2021.645877] [Reference Citation Analysis]
|
| 553 |
Martins PJ, Marques MS, Tufik S, D'Almeida V. Orexin activation precedes increased NPY expression, hyperphagia, and metabolic changes in response to sleep deprivation. Am J Physiol Endocrinol Metab 2010;298:E726-34. [PMID: 20051529 DOI: 10.1152/ajpendo.00660.2009] [Cited by in Crossref: 61] [Cited by in F6Publishing: 60] [Article Influence: 5.1] [Reference Citation Analysis]
|
| 554 |
Hoang QV, Bajic D, Yanagisawa M, Nakajima S, Nakajima Y. Effects of orexin (hypocretin) on GIRK channels. J Neurophysiol 2003;90:693-702. [PMID: 12702704 DOI: 10.1152/jn.00001.2003] [Cited by in Crossref: 63] [Cited by in F6Publishing: 59] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 555 |
Maehara S, Furukawa J, Ota T. Orexin 2 receptor is involved in orexin A-induced hyperlocomotion in rats. Pharmacol Rep 2019;71:1147-50. [PMID: 31655279 DOI: 10.1016/j.pharep.2019.06.018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 556 |
Kotz CM, Teske JA, Levine JA, Wang C. Feeding and activity induced by orexin A in the lateral hypothalamus in rats. Regul Pept 2002;104:27-32. [PMID: 11830273 DOI: 10.1016/s0167-0115(01)00346-9] [Cited by in Crossref: 124] [Cited by in F6Publishing: 48] [Article Influence: 6.2] [Reference Citation Analysis]
|
| 557 |
Jöhren O, Gremmels JA, Qadri F, Dendorfer A, Dominiak P. Adrenal expression of orexin receptor subtypes is differentially regulated in experimental streptozotocin induced type-1 diabetes. Peptides 2006;27:2764-9. [DOI: 10.1016/j.peptides.2006.05.008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 558 |
Davoudi M, Azizi H, Mirnajafi-zadeh J, Semnanian S. Decrease of inhibitory synaptic currents of locus coeruleus neurons via orexin type 1 receptors in the context of naloxone-induced morphine withdrawal. J Physiol Sci 2019;69:281-93. [DOI: 10.1007/s12576-018-0645-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 559 |
Mohammad-pour Kargar H, Azizi H, Mirnajafi-zadeh J, Ali Reza M, Semnanian S. Microinjection of orexin-A into the rat locus coeruleus nucleus induces analgesia via cannabinoid type-1 receptors. Brain Research 2015;1624:424-32. [DOI: 10.1016/j.brainres.2015.07.050] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 560 |
Hsu TM, Hahn JD, Konanur VR, Noble EE, Suarez AN, Thai J, Nakamoto EM, Kanoski SE. Hippocampus ghrelin signaling mediates appetite through lateral hypothalamic orexin pathways. Elife 2015;4:e11190. [PMID: 26745307 DOI: 10.7554/eLife.11190] [Cited by in Crossref: 61] [Cited by in F6Publishing: 36] [Article Influence: 8.7] [Reference Citation Analysis]
|
| 561 |
Ghaemi-jandabi M, Azizi H, Ahmadi-soleimani SM, Semnanian S. Intracoerulear microinjection of orexin-A induces morphine withdrawal-like signs in rats. Brain Research Bulletin 2017;130:107-11. [DOI: 10.1016/j.brainresbull.2017.01.010] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 4.2] [Reference Citation Analysis]
|
| 562 |
Yoshimichi G, Yoshimatsu H, Masaki T, Sakata T. Orexin-A regulates body temperature in coordination with arousal status. Exp Biol Med (Maywood) 2001;226:468-76. [PMID: 11393177 DOI: 10.1177/153537020122600513] [Cited by in Crossref: 98] [Cited by in F6Publishing: 96] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 563 |
Fenzl T, Romanowski CP, Flachskamm C, Deussing JM, Kimura M. Wake-promoting effects of orexin: Its independent actions against the background of an impaired corticotropine-releasing hormone receptor system. Behav Brain Res 2011;222:43-50. [PMID: 21420442 DOI: 10.1016/j.bbr.2011.03.026] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 564 |
Baumann CR, Bassetti CL. Hypocretins (orexins): clinical impact of the discovery of a neurotransmitter. Sleep Medicine Reviews 2005;9:253-68. [DOI: 10.1016/j.smrv.2005.01.005] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 565 |
Matsuura W, Nakamoto K, Tokuyama S. Involvement of descending pain control system regulated by orexin receptor signaling in the induction of central post-stroke pain in mice. Eur J Pharmacol 2020;874:173029. [PMID: 32084419 DOI: 10.1016/j.ejphar.2020.173029] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 566 |
Sakamoto F, Yamada S, Ueta Y. Centrally administered orexin-A activates corticotropin-releasing factor-containing neurons in the hypothalamic paraventricular nucleus and central amygdaloid nucleus of rats: possible involvement of central orexins on stress-activated central CRF neurons. Regul Pept 2004;118:183-91. [PMID: 15003835 DOI: 10.1016/j.regpep.2003.12.014] [Cited by in Crossref: 121] [Cited by in F6Publishing: 115] [Article Influence: 7.1] [Reference Citation Analysis]
|
| 567 |
Shono K, Yamamoto T. Orexin-2 receptors inhibit primary afferent fiber-evoked responses of ventral roots in the neonatal rat isolated spinal cord. Brain Research 2008;1218:97-102. [DOI: 10.1016/j.brainres.2008.04.016] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 568 |
Chung S, Civelli O. Orphan neuropeptides. Neuropeptides 2006;40:233-43. [DOI: 10.1016/j.npep.2006.04.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 569 |
Ripley B, Fujiki N, Okura M, Mignot E, Nishino S. Hypocretin levels in sporadic and familial cases of canine narcolepsy. Neurobiol Dis 2001;8:525-34. [PMID: 11442359 DOI: 10.1006/nbdi.2001.0389] [Cited by in Crossref: 125] [Cited by in F6Publishing: 94] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 570 |
Wu MF, John J, Maidment N, Lam HA, Siegel JM. Hypocretin release in normal and narcoleptic dogs after food and sleep deprivation, eating, and movement. Am J Physiol Regul Integr Comp Physiol 2002;283:R1079-86. [PMID: 12376401 DOI: 10.1152/ajpregu.00207.2002] [Cited by in Crossref: 87] [Cited by in F6Publishing: 90] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 571 |
Kodama T, Kimura M. Arousal effects of orexin-A correlate with GLU release from the locus coeruleus in rats. Peptides 2002;23:1673-81. [DOI: 10.1016/s0196-9781(02)00109-2] [Cited by in Crossref: 35] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 572 |
Iyer M, Essner RA, Klingenberg B, Carter ME. Identification of discrete, intermingled hypocretin neuronal populations. J Comp Neurol 2018;526:2937-54. [PMID: 30019757 DOI: 10.1002/cne.24490] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 573 |
Zhang J, Sampogna S, Morales FR, Chase MH. Distribution of hypocretin (orexin) immunoreactivity in the feline pons and medulla. Brain Research 2004;995:205-17. [DOI: 10.1016/j.brainres.2003.10.004] [Cited by in Crossref: 47] [Cited by in F6Publishing: 42] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 574 |
Kumamoto E. Cellular Mechanisms for Antinociception Produced by Oxytocin and Orexins in the Rat Spinal Lamina II-Comparison with Those of Other Endogenous Pain Modulators. Pharmaceuticals (Basel) 2019;12:E136. [PMID: 31527474 DOI: 10.3390/ph12030136] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 575 |
Berridge CW, Waterhouse BD. The locus coeruleus-noradrenergic system: modulation of behavioral state and state-dependent cognitive processes. Brain Res Brain Res Rev 2003;42:33-84. [PMID: 12668290 DOI: 10.1016/s0165-0173(03)00143-7] [Cited by in Crossref: 1455] [Cited by in F6Publishing: 690] [Article Influence: 76.6] [Reference Citation Analysis]
|
| 576 |
Nishino S, Fujiki N. Neuropeptides as possible targets in sleep disorders. Expert Opin Ther Targets 2007;11:37-59. [PMID: 17150033 DOI: 10.1517/14728222.11.1.37] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 577 |
Becchetti A. Neuronal nicotinic receptors in sleep-related epilepsy: studies in integrative biology. ISRN Biochem 2012;2012:262941. [PMID: 25969754 DOI: 10.5402/2012/262941] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 578 |
Teske JA, Mavanji V. Energy expenditure: role of orexin. Vitam Horm 2012;89:91-109. [PMID: 22640610 DOI: 10.1016/B978-0-12-394623-2.00006-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 579 |
Haas HL, Lin J. Waking with the hypothalamus. Pflugers Arch - Eur J Physiol 2012;463:31-42. [DOI: 10.1007/s00424-011-0996-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 580 |
Choudhary RC, Khanday MA, Mitra A, Mallick BN. Perifornical orexinergic neurons modulate REM sleep by influencing locus coeruleus neurons in rats. Neuroscience. 2014;279:33-43. [PMID: 25168734 DOI: 10.1016/j.neuroscience.2014.08.017] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 581 |
Coborn JE, DePorter DP, Mavanji V, Sinton CM, Kotz CM, Billington CJ, Teske JA. Role of orexin-A in the ventrolateral preoptic area on components of total energy expenditure. Int J Obes (Lond) 2017;41:1256-62. [PMID: 28392556 DOI: 10.1038/ijo.2017.92] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 582 |
Russell SH, Small CJ, Dakin CL, Abbott CR, Morgan DGA, Ghatei MA, Bloom SR. The Central Effects of Orexin-A in the Hypothalamic-Pituitary-Adrenal Axis In Vivo and In Vitro in Male Rats: Effects of central orexin-A on CRF, ACTH and corticosterone release. Journal of Neuroendocrinology 2001;13:561-6. [DOI: 10.1046/j.1365-2826.2001.00672.x] [Cited by in Crossref: 87] [Cited by in F6Publishing: 80] [Article Influence: 4.1] [Reference Citation Analysis]
|
| 583 |
Dileone RJ, Georgescu D, Nestler EJ. Lateral hypothalamic neuropeptides in reward and drug addiction. Life Sciences 2003;73:759-68. [DOI: 10.1016/s0024-3205(03)00408-9] [Cited by in Crossref: 143] [Cited by in F6Publishing: 95] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 584 |
Georgescu D, Zachariou V, Barrot M, Mieda M, Willie JT, Eisch AJ, Yanagisawa M, Nestler EJ, DiLeone RJ. Involvement of the lateral hypothalamic peptide orexin in morphine dependence and withdrawal. J Neurosci 2003;23:3106-11. [PMID: 12716916 [PMID: 12716916 DOI: 10.1523/jneurosci.23-08-03106.2003] [Cited by in Crossref: 250] [Article Influence: 13.2] [Reference Citation Analysis]
|
| 585 |
Pace-Schott EF, Hobson JA. The neurobiology of sleep: genetics, cellular physiology and subcortical networks. Nat Rev Neurosci. 2002;3:591-605. [PMID: 12154361 DOI: 10.1038/nrn895] [Cited by in Crossref: 546] [Cited by in F6Publishing: 473] [Article Influence: 27.3] [Reference Citation Analysis]
|
| 586 |
Semjonous NM, Smith KL, Parkinson JR, Gunner DJ, Liu YL, Murphy KG, Ghatei MA, Bloom SR, Small CJ. Coordinated changes in energy intake and expenditure following hypothalamic administration of neuropeptides involved in energy balance. Int J Obes (Lond) 2009;33:775-85. [PMID: 19488048 DOI: 10.1038/ijo.2009.96] [Cited by in Crossref: 58] [Cited by in F6Publishing: 59] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 587 |
Pasumarthi RK, Fadel J. Activation of orexin/hypocretin projections to basal forebrain and paraventricular thalamus by acute nicotine. Brain Res Bull 2008;77:367-73. [PMID: 18950690 DOI: 10.1016/j.brainresbull.2008.09.014] [Cited by in Crossref: 51] [Cited by in F6Publishing: 51] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 588 |
Ferry B, Duchamp-Viret P. The orexin component of fasting triggers memory processes underlying conditioned food selection in the rat. Learn Mem 2014;21:185-9. [PMID: 24634353 DOI: 10.1101/lm.033688.113] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 589 |
Ahmadi-soleimani SM, Mianbandi V, Azizi H, Azhdari-zarmehri H, Ghaemi-jandabi M, Abbasi-mazar A, Mohajer Y, Darana SP. Coregulation of sleep-pain physiological interplay by orexin system: An unprecedented review. Behavioural Brain Research 2020;391:112650. [DOI: 10.1016/j.bbr.2020.112650] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 590 |
España RA, Valentino RJ, Berridge CW. Fos immunoreactivity in hypocretin-synthesizing and hypocretin-1 receptor-expressing neurons: effects of diurnal and nocturnal spontaneous waking, stress and hypocretin-1 administration. Neuroscience 2003;121:201-17. [PMID: 12946712 DOI: 10.1016/s0306-4522(03)00334-8] [Cited by in Crossref: 114] [Cited by in F6Publishing: 45] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 591 |
Yoshida Y, Fujiki N, Maki RA, Schwarz D, Nishino S. Differential kinetics of hypocretins in the cerebrospinal fluid after intracerebroventricular administration in rats. Neurosci Lett 2003;346:182-6. [PMID: 12853114 DOI: 10.1016/s0304-3940(03)00571-8] [Cited by in Crossref: 31] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 592 |
Peleg-Raibstein D, Burdakov D. Do orexin/hypocretin neurons signal stress or reward? Peptides 2021;145:170629. [PMID: 34416308 DOI: 10.1016/j.peptides.2021.170629] [Reference Citation Analysis]
|
| 593 |
Hoever P, Dorffner G, Beneš H, Penzel T, Danker-Hopfe H, Barbanoj MJ, Pillar G, Saletu B, Polo O, Kunz D, Zeitlhofer J, Berg S, Partinen M, Bassetti CL, Högl B, Ebrahim IO, Holsboer-Trachsler E, Bengtsson H, Peker Y, Hemmeter UM, Chiossi E, Hajak G, Dingemanse J. Orexin receptor antagonism, a new sleep-enabling paradigm: a proof-of-concept clinical trial. Clin Pharmacol Ther 2012;91:975-85. [PMID: 22549286 DOI: 10.1038/clpt.2011.370] [Cited by in Crossref: 93] [Cited by in F6Publishing: 88] [Article Influence: 9.3] [Reference Citation Analysis]
|
| 594 |
Gotter AL, Webber AL, Coleman PJ, Renger JJ, Winrow CJ. International Union of Basic and Clinical Pharmacology. LXXXVI. Orexin Receptor Function, Nomenclature and Pharmacology. Pharmacol Rev 2012;64:389-420. [DOI: 10.1124/pr.111.005546] [Cited by in Crossref: 114] [Cited by in F6Publishing: 107] [Article Influence: 11.4] [Reference Citation Analysis]
|
| 595 |
Mieda M, Sakurai T. Orexin (hypocretin) receptor agonists and antagonists for treatment of sleep disorders. Rationale for development and current status. CNS Drugs 2013;27:83-90. [PMID: 23359095 DOI: 10.1007/s40263-012-0036-8] [Cited by in Crossref: 62] [Cited by in F6Publishing: 62] [Article Influence: 6.9] [Reference Citation Analysis]
|
| 596 |
Smith PM, Connolly BC, Ferguson AV. Microinjection of orexin into the rat nucleus tractus solitarius causes increases in blood pressure. Brain Res 2002;950:261-7. [PMID: 12231252 DOI: 10.1016/s0006-8993(02)03048-2] [Cited by in Crossref: 65] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 597 |
Li FW, Deurveilher S, Semba K. Behavioural and neuronal activation after microinjections of AMPA and NMDA into the perifornical lateral hypothalamus in rats. Behav Brain Res 2011;224:376-86. [PMID: 21723327 DOI: 10.1016/j.bbr.2011.06.021] [Cited by in Crossref: 7] [Cited by in F6Publishing: 17] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 598 |
Assan D, Mustapha UF, Chen H, Li Z, Peng Y, Li G. The Roles of Neuropeptide Y (Npy) and Peptide YY (Pyy) in Teleost Food Intake: A Mini Review. Life (Basel) 2021;11:547. [PMID: 34200824 DOI: 10.3390/life11060547] [Reference Citation Analysis]
|
| 599 |
Stiasny-kolster K, Mignot E, Ling L, Möller J, Cassel W, Oertel W. CSF hypocretin-1 levels in restless legs syndrome. Neurology 2003;61:1426-9. [DOI: 10.1212/01.wnl.0000094196.50155.38] [Cited by in Crossref: 20] [Cited by in F6Publishing: 1] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 600 |
Sakurai T. The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness. Nat Rev Neurosci 2007;8:171-81. [DOI: 10.1038/nrn2092] [Cited by in Crossref: 763] [Cited by in F6Publishing: 716] [Article Influence: 50.9] [Reference Citation Analysis]
|
| 601 |
Xi M, Fung SJ, Yamuy J, Morales FR, Chase MH. Induction of Active (REM) Sleep and Motor Inhibition by Hypocretin in the Nucleus Pontis Oralis of the Cat. Journal of Neurophysiology 2002;87:2880-8. [DOI: 10.1152/jn.2002.87.6.2880] [Cited by in Crossref: 47] [Cited by in F6Publishing: 45] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 602 |
Winsky-Sommerer R, Yamanaka A, Diano S, Borok E, Roberts AJ, Sakurai T, Kilduff TS, Horvath TL, de Lecea L. Interaction between the corticotropin-releasing factor system and hypocretins (orexins): a novel circuit mediating stress response. J Neurosci 2004;24:11439-48. [PMID: 15601950 DOI: 10.1523/JNEUROSCI.3459-04.2004] [Cited by in Crossref: 288] [Cited by in F6Publishing: 148] [Article Influence: 16.9] [Reference Citation Analysis]
|
| 603 |
Lawrence AJ, Cowen MS, Yang HJ, Chen F, Oldfield B. The orexin system regulates alcohol-seeking in rats. Br J Pharmacol 2006;148:752-9. [PMID: 16751790 DOI: 10.1038/sj.bjp.0706789] [Cited by in Crossref: 283] [Cited by in F6Publishing: 279] [Article Influence: 17.7] [Reference Citation Analysis]
|
| 604 |
Singh AK, Mahlios J, Mignot E. Genetic association, seasonal infections and autoimmune basis of narcolepsy. J Autoimmun 2013;43:26-31. [PMID: 23497937 DOI: 10.1016/j.jaut.2013.02.003] [Cited by in Crossref: 66] [Cited by in F6Publishing: 56] [Article Influence: 7.3] [Reference Citation Analysis]
|
| 605 |
Fatemi I, Shamsizadeh A, Ayoobi F, Taghipour Z, Sanati MH, Roohbakhsh A, Motevalian M. Role of orexin-A in experimental autoimmune encephalomyelitis. J Neuroimmunol 2016;291:101-9. [PMID: 26857503 DOI: 10.1016/j.jneuroim.2016.01.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 606 |
Ikeda M, Hirono M, Sugiyama T, Moriya T, Ikeda-Sagara M, Eguchi N, Urade Y, Yoshioka T. Phospholipase C-beta4 is essential for the progression of the normal sleep sequence and ultradian body temperature rhythms in mice. PLoS One 2009;4:e7737. [PMID: 19898623 DOI: 10.1371/journal.pone.0007737] [Reference Citation Analysis]
|
| 607 |
Di Sebastiano AR, Yong-Yow S, Wagner L, Lehman MN, Coolen LM. Orexin mediates initiation of sexual behavior in sexually naive male rats, but is not critical for sexual performance. Horm Behav 2010;58:397-404. [PMID: 20541554 DOI: 10.1016/j.yhbeh.2010.06.004] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 608 |
Sakurai T. Orexin: a link between energy homeostasis and adaptive behaviour. Curr Opin Clin Nutr Metab Care. 2003;6:353-360. [PMID: 12806206 DOI: 10.1097/00075197-200307000-00001] [Cited by in Crossref: 70] [Cited by in F6Publishing: 44] [Article Influence: 3.9] [Reference Citation Analysis]
|
| 609 |
Chen Q, de Lecea L, Hu Z, Gao D. The hypocretin/orexin system: an increasingly important role in neuropsychiatry. Med Res Rev 2015;35:152-97. [PMID: 25044006 DOI: 10.1002/med.21326] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 610 |
Liu YP, Tung CS, Lin YL, Chuang CH. Wake-promoting agent modafinil worsened attentional performance following REM sleep deprivation in a young-adult rat model of 5-choice serial reaction time task. Psychopharmacology (Berl) 2011;213:155-66. [PMID: 20865249 DOI: 10.1007/s00213-010-2019-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 611 |
Wang C, Fujita T, Kumamoto E. Orexin B Modulates Spontaneous Excitatory and Inhibitory Transmission in Lamina II Neurons of Adult Rat Spinal Cord. Neuroscience 2018;383:114-28. [PMID: 29752983 DOI: 10.1016/j.neuroscience.2018.04.048] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 612 |
Deadwyler SA, Porrino L, Siegel JM, Hampson RE. Systemic and nasal delivery of orexin-A (Hypocretin-1) reduces the effects of sleep deprivation on cognitive performance in nonhuman primates. J Neurosci 2007;27:14239-47. [PMID: 18160631 DOI: 10.1523/JNEUROSCI.3878-07.2007] [Cited by in Crossref: 186] [Cited by in F6Publishing: 78] [Article Influence: 13.3] [Reference Citation Analysis]
|
| 613 |
Chrobok L, Palus-Chramiec K, Chrzanowska A, Kepczynski M, Lewandowski MH. Multiple excitatory actions of orexins upon thalamo-cortical neurons in dorsal lateral geniculate nucleus - implications for vision modulation by arousal. Sci Rep 2017;7:7713. [PMID: 28794459 DOI: 10.1038/s41598-017-08202-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 614 |
Katzman MA, Katzman MP. Neurobiology of the Orexin System and Its Potential Role in the Regulation of Hedonic Tone. Brain Sciences 2022;12:150. [DOI: 10.3390/brainsci12020150] [Reference Citation Analysis]
|
| 615 |
Kilduff TS, Peyron C. The hypocretin/orexin ligand–receptor system: implications for sleep and sleep disorders. Trends in Neurosciences 2000;23:359-65. [DOI: 10.1016/s0166-2236(00)01594-0] [Cited by in Crossref: 306] [Cited by in F6Publishing: 83] [Article Influence: 13.9] [Reference Citation Analysis]
|
| 616 |
Lin JS, Anaclet C, Sergeeva OA, Haas HL. The waking brain: an update. Cell Mol Life Sci 2011;68:2499-512. [PMID: 21318261 DOI: 10.1007/s00018-011-0631-8] [Cited by in Crossref: 77] [Cited by in F6Publishing: 65] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 617 |
Sterling ME, Chang GQ, Karatayev O, Chang SY, Leibowitz SF. Effects of embryonic ethanol exposure at low doses on neuronal development, voluntary ethanol consumption and related behaviors in larval and adult zebrafish: Role of hypothalamic orexigenic peptides. Behav Brain Res 2016;304:125-38. [PMID: 26778786 DOI: 10.1016/j.bbr.2016.01.013] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 618 |
Ross JA, Van Bockstaele EJ. The Locus Coeruleus- Norepinephrine System in Stress and Arousal: Unraveling Historical, Current, and Future Perspectives. Front Psychiatry 2020;11:601519. [PMID: 33584368 DOI: 10.3389/fpsyt.2020.601519] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 619 |
Eacret D, Grafe LA, Dobkin J, Gotter AL, Renger JJ, Winrow CJ, Bhatnagar S. Orexin signaling during social defeat stress influences subsequent social interaction behaviour and recognition memory. Behavioural Brain Research 2019;356:444-52. [DOI: 10.1016/j.bbr.2018.05.032] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 620 |
Linehan V, Fang LZ, Parsons MP, Hirasawa M. High-fat diet induces time-dependent synaptic plasticity of the lateral hypothalamus. Mol Metab 2020;36:100977. [PMID: 32277924 DOI: 10.1016/j.molmet.2020.100977] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 621 |
Bettica P, Nucci G, Pyke C, Squassante L, Zamuner S, Ratti E, Gomeni R, Alexander R. Phase I studies on the safety, tolerability, pharmacokinetics and pharmacodynamics of SB-649868, a novel dual orexin receptor antagonist. J Psychopharmacol 2012;26:1058-70. [PMID: 21730017 DOI: 10.1177/0269881111408954] [Cited by in Crossref: 42] [Cited by in F6Publishing: 47] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 622 |
López M, Seoane LM, Tovar S, Nogueiras R, Diéguez C, Señarís R. Orexin-A regulates growth hormone-releasing hormone mRNA content in a nucleus-specific manner and somatostatin mRNA content in a growth hormone-dependent fashion in the rat hypothalamus. Eur J Neurosci 2004;19:2080-8. [PMID: 15090035 DOI: 10.1111/j.0953-816X.2004.03318.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 623 |
Volkoff H, Peter RE. Effects of CART peptides on food consumption, feeding and associated behaviors in the goldfish, Carassius auratus: actions on neuropeptide Y- and orexin A-induced feeding. Brain Research 2000;887:125-33. [DOI: 10.1016/s0006-8993(00)03001-8] [Cited by in Crossref: 112] [Cited by in F6Publishing: 17] [Article Influence: 5.1] [Reference Citation Analysis]
|
| 624 |
Rowe RK, Harrison JL, Morrison HW, Subbian V, Murphy SM, Lifshitz J. Acute Post-Traumatic Sleep May Define Vulnerability to a Second Traumatic Brain Injury in Mice. J Neurotrauma 2019;36:1318-34. [PMID: 30398389 DOI: 10.1089/neu.2018.5980] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
|
| 625 |
España RA, Berridge CW, Gammie SC. Diurnal levels of Fos immunoreactivity are elevated within hypocretin neurons in lactating mice. Peptides 2004;25:1927-34. [PMID: 15501524 DOI: 10.1016/j.peptides.2004.06.006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 626 |
Shirasaka T, Miyahara S, Kunitake T, Jin QH, Kato K, Takasaki M, Kannan H. Orexin depolarizes rat hypothalamic paraventricular nucleus neurons. Am J Physiol Regul Integr Comp Physiol 2001;281:R1114-8. [PMID: 11557617 DOI: 10.1152/ajpregu.2001.281.4.R1114] [Cited by in Crossref: 51] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 627 |
Chen C, Xu R. The In Vitro Regulation of Growth Hormone Secretion by Orexins. ENDO 2003;22:57-66. [DOI: 10.1385/endo:22:1:57] [Cited by in Crossref: 14] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 628 |
Tritos NA, Mastaitis JW, Kokkotou E, Maratos-flier E. Characterization of melanin concentrating hormone and preproorexin expression in the murine hypothalamus. Brain Research 2001;895:160-6. [DOI: 10.1016/s0006-8993(01)02066-2] [Cited by in Crossref: 75] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 629 |
Tran D, Bonaventure P, Hack M, Mirzadegan T, Dvorak C, Letavic M, Carruthers N, Lovenberg T, Sutton SW. Chimeric, mutant orexin receptors show key interactions between orexin receptors, peptides and antagonists. European Journal of Pharmacology 2011;667:120-8. [DOI: 10.1016/j.ejphar.2011.05.074] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 630 |
Acuna-Goycolea C, van den Pol A. Glucagon-like peptide 1 excites hypocretin/orexin neurons by direct and indirect mechanisms: implications for viscera-mediated arousal. J Neurosci 2004;24:8141-52. [PMID: 15371515 DOI: 10.1523/JNEUROSCI.1607-04.2004] [Cited by in Crossref: 78] [Cited by in F6Publishing: 48] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 631 |
Shigemoto Y, Fujii Y, Shinomiya K, Kamei C. Participation of histaminergic H1 and noradrenergic α1 receptors in orexin A-induced wakefulness in rats. Brain Research 2004;1023:121-5. [DOI: 10.1016/j.brainres.2004.07.031] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 632 |
Hunsley MS, Curtis WR, Palmiter RD. Behavioral and sleep/wake characteristics of mice lacking norepinephrine and hypocretin. Genes Brain Behav 2006;5:451-7. [DOI: 10.1111/j.1601-183x.2005.00179.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 633 |
Szentirmai É. Central but not systemic administration of ghrelin induces wakefulness in mice. PLoS One 2012;7:e41172. [PMID: 22815958 DOI: 10.1371/journal.pone.0041172] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 634 |
Sharma R, Sahota P, Thakkar MM. Melatonin promotes sleep in mice by inhibiting orexin neurons in the perifornical lateral hypothalamus. J Pineal Res 2018;65:e12498. [DOI: 10.1111/jpi.12498] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 635 |
Seigneur E, de Lecea L. Hypocretin (Orexin) Replacement Therapies. Medicine in Drug Discovery 2020;8:100070. [DOI: 10.1016/j.medidd.2020.100070] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 636 |
Hooshmand B, Azizi H, Ahmadi-soleimani SM, Semnanian S. Synergistic effect of orexin-glutamate co-administration on spontaneous discharge rate of locus coeruleus neurons in morphine-dependent rats. Neuroscience Letters 2019;706:12-7. [DOI: 10.1016/j.neulet.2019.04.060] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 637 |
Okamura N, Reinscheid RK. Neuropeptide S: A novel modulator of stress and arousal: Review. Stress 2009;10:221-6. [DOI: 10.1080/10253890701248673] [Cited by in Crossref: 53] [Cited by in F6Publishing: 53] [Article Influence: 4.1] [Reference Citation Analysis]
|
| 638 |
Wright KP, Lowry CA, Lebourgeois MK. Circadian and wakefulness-sleep modulation of cognition in humans. Front Mol Neurosci 2012;5:50. [PMID: 22529774 DOI: 10.3389/fnmol.2012.00050] [Cited by in Crossref: 82] [Cited by in F6Publishing: 84] [Article Influence: 8.2] [Reference Citation Analysis]
|
| 639 |
Sakurai T. Roles of orexins in the regulation of feeding and arousal. Sleep Medicine 2002;3:S3-9. [DOI: 10.1016/s1389-9457(02)00156-9] [Cited by in Crossref: 21] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 640 |
Brundin L, Petersén Å, Björkqvist M, Träskman-bendz L. Orexin and psychiatric symptoms in suicide attempters. Journal of Affective Disorders 2007;100:259-63. [DOI: 10.1016/j.jad.2006.10.019] [Cited by in Crossref: 51] [Cited by in F6Publishing: 46] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 641 |
Herring WJ, Roth T, Krystal AD, Michelson D. Orexin receptor antagonists for the treatment of insomnia and potential treatment of other neuropsychiatric indications. J Sleep Res 2018;28. [DOI: 10.1111/jsr.12782] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 642 |
González JA, Jensen LT, Fugger L, Burdakov D. Convergent inputs from electrically and topographically distinct orexin cells to locus coeruleus and ventral tegmental area. Eur J Neurosci 2012;35:1426-32. [PMID: 22507526 DOI: 10.1111/j.1460-9568.2012.08057.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 37] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 643 |
Li SB, de Lecea L. The hypocretin (orexin) system: from a neural circuitry perspective. Neuropharmacology 2020;167:107993. [PMID: 32135427 DOI: 10.1016/j.neuropharm.2020.107993] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 14.5] [Reference Citation Analysis]
|
| 644 |
Diniz Behn CG, Kopell N, Brown EN, Mochizuki T, Scammell TE. Delayed orexin signaling consolidates wakefulness and sleep: physiology and modeling. J Neurophysiol 2008;99:3090-103. [PMID: 18417630 DOI: 10.1152/jn.01243.2007] [Cited by in Crossref: 51] [Cited by in F6Publishing: 47] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 645 |
Brown RE, Sergeeva OA, Eriksson KS, Haas HL. Convergent excitation of dorsal raphe serotonin neurons by multiple arousal systems (orexin/hypocretin, histamine and noradrenaline). J Neurosci 2002;22:8850-9. [PMID: 12388591 [PMID: 12388591 DOI: 10.1523/jneurosci.22-20-08850.2002] [Cited by in Crossref: 228] [Article Influence: 11.4] [Reference Citation Analysis]
|
| 646 |
León-domínguez U, Vela-bueno A, Froufé-torres M, León-carrión J. A chronometric functional sub-network in the thalamo-cortical system regulates the flow of neural information necessary for conscious cognitive processes. Neuropsychologia 2013;51:1336-49. [DOI: 10.1016/j.neuropsychologia.2013.03.012] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 647 |
D'Anna KL, Gammie SC. Hypocretin-1 dose-dependently modulates maternal behaviour in mice. J Neuroendocrinol 2006;18:553-66. [PMID: 16867176 DOI: 10.1111/j.1365-2826.2006.01448.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 648 |
Kilduff TS, De Lecea L. Mapping of the mRNAs for the hypocretin/orexin and melanin-concentrating hormone receptors: Networks of overlapping peptide systems. J Comp Neurol 2001;435:1-5. [DOI: 10.1002/cne.1189] [Cited by in Crossref: 62] [Cited by in F6Publishing: 56] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 649 |
Niu J, Yokota S, Tsumori T, Qin Y, Yasui Y. Glutamatergic lateral parabrachial neurons innervate orexin-containing hypothalamic neurons in the rat. Brain Research 2010;1358:110-22. [DOI: 10.1016/j.brainres.2010.08.056] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 650 |
Berisha A, Shutkind K, Borniger JC. Sleep Disruption and Cancer: Chicken or the Egg? Front Neurosci 2022;16:856235. [DOI: 10.3389/fnins.2022.856235] [Reference Citation Analysis]
|
| 651 |
Grossberg AJ, Zhu X, Leinninger GM, Levasseur PR, Braun TP, Myers MG Jr, Marks DL. Inflammation-induced lethargy is mediated by suppression of orexin neuron activity. J Neurosci 2011;31:11376-86. [PMID: 21813697 DOI: 10.1523/JNEUROSCI.2311-11.2011] [Cited by in Crossref: 85] [Cited by in F6Publishing: 60] [Article Influence: 7.7] [Reference Citation Analysis]
|
| 652 |
Matsuo E, Mochizuki A, Nakayama K, Nakamura S, Yamamoto T, Shioda S, Sakurai T, Yanagisawa M, Shiuchi T, Minokoshi Y, Inoue T. Decreased Intake of Sucrose Solutions in Orexin Knockout Mice. J Mol Neurosci 2011;43:217-24. [DOI: 10.1007/s12031-010-9475-1] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 653 |
Schwartz MD, Smale L. Individual differences in rhythms of behavioral sleep and its neural substrates in Nile grass rats. J Biol Rhythms 2005;20:526-37. [PMID: 16275771 DOI: 10.1177/0748730405280924] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 654 |
Suchecki D, Antunes J, Tufik S. Palatable solutions during paradoxical sleep deprivation: reduction of hypothalamic-pituitary-adrenal axis activity and lack of effect on energy imbalance. J Neuroendocrinol 2003;15:815-21. [PMID: 12899675 DOI: 10.1046/j.1365-2826.2003.01067.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 655 |
Kok SW, Roelfsema F, Overeem S, Lammers GJ, Frölich M, Meinders AE, Pijl H. Altered setting of the pituitary-thyroid ensemble in hypocretin-deficient narcoleptic men. Am J Physiol Endocrinol Metab 2005;288:E892-9. [PMID: 15625087 DOI: 10.1152/ajpendo.00327.2004] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 656 |
Ishizuka T, Murotani T, Yamatodani A. Action of Modafinil Through Histaminergic and Orexinergic Neurons. Sleep Hormones. Elsevier; 2012. pp. 259-78. [DOI: 10.1016/b978-0-12-394623-2.00014-7] [Cited by in Crossref: 23] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 657 |
Dickinson H, Walker DW, Castillo-melendez M. Onset of feeding at birth—Perinatal development of the hypothalamic mechanisms that induce appetite and feeding in the newborn. Neuroscience Letters 2008;436:1-6. [DOI: 10.1016/j.neulet.2007.12.043] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 658 |
Holland PR. Headache and sleep: shared pathophysiological mechanisms. Cephalalgia 2014;34:725-44. [PMID: 25053747 DOI: 10.1177/0333102414541687] [Cited by in Crossref: 62] [Cited by in F6Publishing: 52] [Article Influence: 7.8] [Reference Citation Analysis]
|
| 659 |
Singh C, Oikonomou G, Prober DA. Norepinephrine is required to promote wakefulness and for hypocretin-induced arousal in zebrafish. Elife 2015;4:e07000. [PMID: 26374985 DOI: 10.7554/eLife.07000] [Cited by in Crossref: 61] [Cited by in F6Publishing: 40] [Article Influence: 8.7] [Reference Citation Analysis]
|
| 660 |
Brunton PJ, Russell JA. Hypothalamic-pituitary-adrenal responses to centrally administered orexin-A are suppressed in pregnant rats. J Neuroendocrinol 2003;15:633-7. [PMID: 12787047 DOI: 10.1046/j.1365-2826.2003.01045.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 661 |
Berteotti C, Liguori C, Pace M. Dysregulation of the orexin/hypocretin system is not limited to narcolepsy but has far-reaching implications for neurological disorders. Eur J Neurosci 2021;53:1136-54. [PMID: 33290595 DOI: 10.1111/ejn.15077] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 662 |
Nishino S. Hypothalamus, hypocretins/orexin, and vigilance control. Sleep Disorders. Elsevier; 2011. pp. 765-82. [DOI: 10.1016/b978-0-444-52007-4.00006-0] [Cited by in Crossref: 19] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 663 |
Huang H, Xu Y, van den Pol AN. Nicotine excites hypothalamic arcuate anorexigenic proopiomelanocortin neurons and orexigenic neuropeptide Y neurons: similarities and differences. J Neurophysiol 2011;106:1191-202. [PMID: 21653710 DOI: 10.1152/jn.00740.2010] [Cited by in Crossref: 44] [Cited by in F6Publishing: 49] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 664 |
Gompf HS, Aston-Jones G. Role of orexin input in the diurnal rhythm of locus coeruleus impulse activity. Brain Res 2008;1224:43-52. [PMID: 18614159 DOI: 10.1016/j.brainres.2008.05.060] [Cited by in Crossref: 55] [Cited by in F6Publishing: 55] [Article Influence: 3.9] [Reference Citation Analysis]
|
| 665 |
Gerashchenko D, Kohls MD, Greco M, Waleh NS, Salin-Pascual R, Kilduff TS, Lappi DA, Shiromani PJ. Hypocretin-2-saporin lesions of the lateral hypothalamus produce narcoleptic-like sleep behavior in the rat. J Neurosci 2001;21:7273-83. [PMID: 11549737 [PMID: 11549737 DOI: 10.1523/jneurosci.21-18-07273.2001] [Cited by in Crossref: 165] [Cited by in F6Publishing: 1] [Article Influence: 7.9] [Reference Citation Analysis]
|
| 666 |
Hayatdavoudi P, Sadeghnia HR, Mohamadian-Roshan N, Hadjzadeh MA. Beneficial Effects of Selective Orexin-A Receptor Antagonist in 4-aminopyridine-induced Seizures in Male Rats. Adv Biomed Res 2017;6:162. [PMID: 29387673 DOI: 10.4103/abr.abr_262_16] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
|
| 667 |
Xu T, Yang Y, Ward R, Gao L, Liu Y. Orexin receptors: Multi-functional therapeutic targets for sleeping disorders, eating disorders, drug addiction, cancers and other physiological disorders. Cellular Signalling 2013;25:2413-23. [DOI: 10.1016/j.cellsig.2013.07.025] [Cited by in Crossref: 68] [Cited by in F6Publishing: 65] [Article Influence: 7.6] [Reference Citation Analysis]
|
| 668 |
Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG. Central nervous system control of food intake. Nature 2000;404:661-71. [PMID: 10766253 DOI: 10.1038/35007534] [Cited by in Crossref: 3867] [Cited by in F6Publishing: 3615] [Article Influence: 175.8] [Reference Citation Analysis]
|
| 669 |
Eriksson KS, Sergeeva O, Brown RE, Haas HL. Orexin/hypocretin excites the histaminergic neurons of the tuberomammillary nucleus. J Neurosci 2001;21:9273-9. [PMID: 11717361 [PMID: 11717361 DOI: 10.1523/jneurosci.21-23-09273.2001] [Cited by in Crossref: 348] [Article Influence: 17.4] [Reference Citation Analysis]
|
| 670 |
Patel AX, Miller SR, Nathan PJ, Kanakaraj P, Napolitano A, Lawrence P, Koch A, Bullmore ET. Neuroendocrine and sympathetic responses to an orexin receptor antagonist, SB-649868, and alprazolam following insulin-induced hypoglycemia in humans. Psychopharmacology (Berl) 2014;231:3817-28. [PMID: 24770625 DOI: 10.1007/s00213-014-3520-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 671 |
Nuñez A, Moreno-balandrán ME, Rodrigo-angulo ML, Garzón M, De Andrés I. Relationship between the perifornical hypothalamic area and oral pontine reticular nucleus in the rat. Possible implication of the hypocretinergic projection in the control of rapid eye movement sleep. European Journal of Neuroscience 2006;24:2834-42. [DOI: 10.1111/j.1460-9568.2006.05159.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 672 |
Huang HP, Zhu FP, Chen XW, Xu ZQ, Zhang CX, Zhou Z. Physiology of quantal norepinephrine release from somatodendritic sites of neurons in locus coeruleus. Front Mol Neurosci 2012;5:29. [PMID: 22408604 DOI: 10.3389/fnmol.2012.00029] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 673 |
España RA. Hypocretin/orexin involvement in reward and reinforcement. Vitam Horm 2012;89:185-208. [PMID: 22640614 DOI: 10.1016/B978-0-12-394623-2.00010-X] [Cited by in Crossref: 21] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 674 |
Suzuki M, Beuckmann CT, Shikata K, Ogura H, Sawai T. Orexin-A (hypocretin-1) is possibly involved in generation of anxiety-like behavior. Brain Research 2005;1044:116-21. [DOI: 10.1016/j.brainres.2005.03.002] [Cited by in Crossref: 112] [Cited by in F6Publishing: 105] [Article Influence: 6.6] [Reference Citation Analysis]
|
| 675 |
Arch J. Orexins, feeding and the big picture. Br J Nutr 2000;84:401-3. [DOI: 10.1017/s0007114500001707] [Cited by in Crossref: 16] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 676 |
Mair RD, Zhang Y, Bailey KR, Toupin MM, Mair RG. Effects of clonidine in the locus coeruleus on prefrontal- and hippocampal-dependent measures of attention and memory in the rat. Psychopharmacology (Berl) 2005;181:280-8. [PMID: 15830223 DOI: 10.1007/s00213-005-2263-x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 677 |
Chen XW, Mu Y, Huang HP, Guo N, Zhang B, Fan SY, Xiong JX, Wang SR, Xiong W, Huang W, Liu T, Zheng LH, Zhang CX, Li LH, Yu ZP, Hu ZA, Zhou Z. Hypocretin-1 potentiates NMDA receptor-mediated somatodendritic secretion from locus ceruleus neurons. J Neurosci 2008;28:3202-8. [PMID: 18354023 DOI: 10.1523/JNEUROSCI.4426-07.2008] [Cited by in Crossref: 29] [Cited by in F6Publishing: 10] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 678 |
Cai XJ, Liu XH, Evans M, Clapham JC, Wilson S, Arch JR, Morris R, Williams G. Orexins and feeding: special occasions or everyday occurrence? Regulatory Peptides 2002;104:1-9. [DOI: 10.1016/s0167-0115(01)00343-3] [Cited by in Crossref: 26] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 679 |
Hirota K, Kushikata T, Kudo M, Kudo T, Smart D, Matsuki A. Effects of central hypocretin-1 administration on hemodynamic responses in young-adult and middle-aged rats. Brain Res 2003;981:143-50. [PMID: 12885435 DOI: 10.1016/s0006-8993(03)03002-6] [Cited by in Crossref: 36] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 680 |
Hwang LL, Chen CT, Dun NJ. Mechanisms of orexin-induced depolarizations in rat dorsal motor nucleus of vagus neurones in vitro. J Physiol 2001;537:511-20. [PMID: 11731582 DOI: 10.1111/j.1469-7793.2001.00511.x] [Cited by in Crossref: 64] [Cited by in F6Publishing: 63] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 681 |
Vitiello B, Lederhendler I. Research on eating disorders: current status and future prospects. Biological Psychiatry 2000;47:777-86. [DOI: 10.1016/s0006-3223(99)00319-4] [Cited by in Crossref: 41] [Cited by in F6Publishing: 6] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 682 |
Wise A, Gearing K, Rees S. Target validation of G-protein coupled receptors. Drug Discov Today 2002;7:235-46. [PMID: 11839521 DOI: 10.1016/s1359-6446(01)02131-6] [Cited by in Crossref: 261] [Cited by in F6Publishing: 83] [Article Influence: 13.7] [Reference Citation Analysis]
|
| 683 |
Samson WK, Taylor MM. Hypocretin/orexin suppresses corticotroph responsiveness in vitro. Am J Physiol Regul Integr Comp Physiol 2001;281:R1140-5. [PMID: 11557621 DOI: 10.1152/ajpregu.2001.281.4.R1140] [Cited by in Crossref: 45] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 684 |
López JM, Domínguez L, Moreno N, González A. Comparative immunohistochemical analysis of the distribution of orexins (hypocretins) in the brain of amphibians. Peptides 2009;30:873-87. [DOI: 10.1016/j.peptides.2009.01.013] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 685 |
Akanmu MA, Honda K. Selective stimulation of orexin receptor type 2 promotes wakefulness in freely behaving rats. Brain Research 2005;1048:138-45. [DOI: 10.1016/j.brainres.2005.04.064] [Cited by in Crossref: 52] [Cited by in F6Publishing: 53] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 686 |
Xu Y, Jackson VR, Civelli O. Orphan G protein-coupled receptors and obesity. European Journal of Pharmacology 2004;500:243-53. [DOI: 10.1016/j.ejphar.2004.07.029] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 687 |
Mang GM, Dürst T, Bürki H, Imobersteg S, Abramowski D, Schuepbach E, Hoyer D, Fendt M, Gee CE. The dual orexin receptor antagonist almorexant induces sleep and decreases orexin-induced locomotion by blocking orexin 2 receptors. Sleep 2012;35:1625-35. [PMID: 23204605 DOI: 10.5665/sleep.2232] [Cited by in Crossref: 61] [Cited by in F6Publishing: 61] [Article Influence: 6.1] [Reference Citation Analysis]
|
| 688 |
Heydendael W, Sengupta A, Beck S, Bhatnagar S. Optogenetic examination identifies a context-specific role for orexins/hypocretins in anxiety-related behavior. Physiol Behav 2014;130:182-90. [PMID: 24140988 DOI: 10.1016/j.physbeh.2013.10.005] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 689 |
Parekh B. Mechanisms of the blunting of the sympatho-adrenal response: a theory. Curr Diabetes Rev 2009;5:79-91. [PMID: 19442093 DOI: 10.2174/157339909788166846] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 690 |
Scammell TE, Winrow CJ. Orexin receptors: pharmacology and therapeutic opportunities. Annu Rev Pharmacol Toxicol 2011;51:243-66. [PMID: 21034217 DOI: |
